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Low back pain may be caused by a direct, acute injury or degeneration of the intervertebral disc (IVD).
Intradiscal replacement of the nucleus pulposus (NP) with a tissue engineered hydrogel scaffold may
provide a biologic therapy capable of restoring the structure and mechanical function of the IVD.
Therefore, the global objective of this dissertation was to develop and optimize a novel, cell-laden,
covlently crosslinkable carboxymethylcellulose (CMC) hydrogel construct as a functional tissue
engineered NP replacement. The versatility of the photocrosslinkable CMC system was explored by
examining the resultant differences in material and mechanical properties due to varying the macromer
concentration and molecular weight of the starting material. These biomaterials were shown to support
NP cell viability and exhibited tunable material properties that may be easily tailored for specific
applications. Culture conditions (medium formulation and TGF-beta3 supplementation) were also
investigated in order to enhance matrix deposition and improve construct material and mechanical
properties. Scaffolds cultured in serum-free medium supplemented with TGF-beta3 showed
approximately a ten-fold increase in glycosaminoglycan (GAG) accumulation and a five-fold increase in
mechanical properties (Ey). Given the load-bearing function of the NP, biomechanical stimulation, via
hydrostatic pressurization, was utilized in conjunction with biochemical mediators to further augment
tissue formation by engineered CMC constructs. However, TGF-beta3 supplementation alone was shown
to have a more profound effect on the functional development of NP-seeded CMC constructs. Finally, the
long-term effects of in vitro pre-conditioning with TGF-beta3 were examined in vitro, as well as in vivo,
using a subcutaneous murine pouch model. Constructs maintained without TGF-beta3 exhibited no
quantifiable changes in matrix content or mechanical properties over time. In contrast, TGF-beta3-treated
scaffolds experienced a significant increase in matrix accumulation and Ey during the in vitro preconditioning period. TGF-beta3-treated scaffolds cultured in vitro following the pre-culture period were
able to sustain these properties, while TGF-beta3-treated scaffolds maintained in vivo exhibited a
significant loss in matrix accumulation and Ey, possibly due to scaffold stiffness and diffusion limitations.
Although TGF-beta3 pre-conditioning produced long-term effects in vitro, the degradative properties of the
CMC scaffold must be tailored for in vivo conditions. Taken together, cell-laden, covalently crosslinkable
CMC hydrogel constructs may serve as potential NP tissue engineered replacements but will require
further optimization prior to use in regenerative therapies.
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ABSTRACT

BIOCHEMICAL AND BIOMECHANICAL MODULATION OF NUCLEUS
PULPOSUS CELLS ENCAPSULATED IN NOVEL CELLULOSE-BASED
HYDROGELS

Anna T. Reza

Advisor: Steven B. Nicoll, Ph.D.

Low back pain may be caused by a direct, acute injury or degeneration of the
intervertebral disc (IVD). Intradiscal replacement of the nucleus pulposus (NP) with a
tissue engineered hydrogel scaffold may provide a biologic therapy capable of restoring
the structure and mechanical function of the IVD. Therefore, the global objective of this
dissertation was to develop and optimize a novel, cell-laden, covlently crosslinkable
carboxymethylcellulose (CMC) hydrogel construct as a functional tissue engineered NP
replacement. The versatility of the photocrosslinkable CMC system was explored by
examining the resultant differences in material and mechanical properties due to varying
the macromer concentration and molecular weight of the starting material.

These

biomaterials were shown to support NP cell viability and exhibited tunable material
properties that may be easily tailored for specific applications.

Culture conditions

(medium formulation and TGF-β3 supplementation) were also investigated in order to
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enhance matrix deposition and improve construct material and mechanical properties.
Scaffolds cultured in serum-free medium supplemented with TGF-β3 showed
approximately a ten-fold increase in glycosaminoglycan (GAG) accumulation and a fivefold increase in mechanical properties (Ey). Given the load-bearing function of the NP,
biomechanical stimulation, via hydrostatic pressurization, was utilized in conjunction
with biochemical mediators to further augment tissue formation by engineered CMC
constructs.

However, TGF-β3 supplementation alone was shown to have a more

profound effect on the functional development of NP-seeded CMC constructs. Finally,
the long-term effects of in vitro pre-conditioning with TGF-β3 were examined in vitro, as
well as in vivo, using a subcutaneous murine pouch model.

Constructs maintained

without TGF-β3 exhibited no quantifiable changes in matrix content or mechanical
properties over time. In contrast, TGF-β3-treated scaffolds experienced a significant
increase in matrix accumulation and Ey during the in vitro pre-conditioning period. TGFβ3-treated scaffolds cultured in vitro following the pre-culture period were able to sustain
these properties, while TGF-β3-treated scaffolds maintained in vivo exhibited a
significant loss in matrix accumulation and Ey, possibly due to scaffold stiffness and
diffusion limitations. Although TGF-β3 pre-conditioning produced long-term effects in
vitro, the degradative properties of the CMC scaffold must be tailored for in vivo
conditions.

Taken together, cell-laden, covalently crosslinkable CMC hydrogel

constructs may serve as potential NP tissue engineered replacements but will require
further optimization prior to use in regenerative therapies.
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Chapter 1: An Introduction to the Intervertebral Disc and Tissue
Engineering

1.1. Intervertebral Disc Anatomy and Composition
The intervertebral disc (IVD) is a heterogeneous, fibrocartilaginous tissue that is
located between the vertebral bodies of the spine and confers motion and flexibility to
this otherwise bony structure1. The IVD is a complex composite, comprised of the
central, gelatinous nucleus pulposus (NP) and the fibrous, lamellar annulus fibrosus,
which surrounds the NP laterally (Figure 1.1). The IVD is bordered inferiorly and
superiorly by the cartilaginous endplates of the vertebral bodies that serve as the source
of diffusion-based nutrient delivery for the avascular, aneural IVD.

Figure 1.1. Anatomy of the spine and the intervertebral disc (in cross-section).

The NP is a hydrated tissue, characterized biochemically by a high content of
negatively charged, water-retaining proteoglycans, such as aggrecan, and randomly
oriented collagen fibers (mainly type II collagen)2 which allow the IVD to resist
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compressive forces through the generation of a hydrostatic swelling pressure, similar to
other cartilaginous tissues. Aggrecan, the primary proteoglycan in the IVD, consists of a
core protein chain to which the glycosaminoglycans (GAGs) chondroitin sulfate and the
shorter, keratin sulfate bind. With age, the proportion of chondroitin sulfate to keratin
sulfate decreases, and the ability of the disc to retain water correspondingly decreases as
these shorter keratin sulfate GAGs are less effective at maintaining a strong interaction
with water2.

The aggrecan monomer interacts with hyaluronic acid present in the

extracellular matrix (ECM) through a link protein to form large proteoglycan aggregates,
capable of efficiently trapping water2 (Figure 1.2).

The number of proteoglycan

aggregates, however, decreases with age in relation to the total number of proteoglycans
in the disc3, as the increased population of non-aggregating proteoglycans are thought to
be a consequence of proteolytic degradation. These fragments are retained within the
disc due to their size, structure, and charge, but lack the amino terminal globular region
of aggrecan that is necessary for interaction with hyaluronic acid2. The proteoglycan and
water content of the NP (14% and 77% of tissue wet weight, respectively) greatly exceed
that in the annulus (5% and 70%, respectively)4. In contrast, collagen accounts for only
4% of NP wet weight in comparison to 15% in the annulus4.
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Figure 1.2. Extracellular matrix of the NP, consisting of aggrecan, chondroitin sulfate (CS),
keratin sulfate (KS), link protein (LP), hyaluronic acid (HA), and type II collagen.

The annulus fibrosus is comprised of a series of concentric lamellae which
contain collagen fibers arranged in parallel within each lamellar sheet that alternate in
angles from 28º - 44º with respect to the transverse plane5. The annulus fibrosus can be
further subdivided into the outer annulus (OA) and inner annulus (IA) based on the
biochemical composition and structure of each tissue (Figure 1.3). The OA is a highly
organized, densely packed, lamellar tissue rich in type I collagen, with minimal
proteoglycan content.

The IA serves as a transition zone between the lamellar

organization of the OA and the random orientation of the NP. As such, the IA contains a
less dense matrix in comparison to the OA, composed of both type I and type II collagen
and proteoglycans which reside between layers of collagen fibrils. Progressing radially
from the OA to the NP, there is an increase in proteoglycan and type II collagen content
and a decrease in type I collagen1.
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Figure 1.3.

Gross image (left) and alcian blue/picrosirius red histological staining of a

transverse section of a rat IVD with anatomical regions identified by arrows. Proteoglycans are
indicated in blue, while collagens are stained red.

The IVD has a low cell density, even in comparison to other cartilaginous tissues.
The cell density in the human annulus fibrosus of a mature adult is about 9 x 106 cells/mL
while that in the NP is less than half that, at a density of about 4 x 106 cells/mL6. These
values fall well below that seen in hyaline cartilage (14 x 106 cells/mL).
Cells isolated from the OA, IA, and NP show distinct differences in morphology
and ECM production. When examined in vitro in monolayer culture, OA cells display an
elongated, fibroblast-like shape and are positioned in parallel with collagen fibril
orientation7. Consistent with fibroblastic tissues typically loaded in tension, OA cells
exhibit high levels of type I collagen gene expression8. Morphologically, IA cells are
more polygonal and produce a fibrocartilaginous ECM that includes both type I and type
II collagen, while NP cells display a rounded, chondrocyte-like morphology and secrete
the largest amounts of type II collagen amongst these three cell populations8.

These

morphological and biochemical differences are retained in monolayer culture through
passage two in bovine caudal IVD cells. However, similar to articular chondrocytes, IVD
cells may lose characteristic phenotypic differentiation markers after this point, and threedimensional culture systems must be used in order to prevent cell de-differentiation9.
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1.2. Intervertebral Disc Mechanical Function
As a whole, the IVD serves to stabilize and align the spine by functionally
connecting neighboring vertebral bodies. The IVD is a soft tissue which allows for
movement between the vertebrae, giving the spine flexibility, while also absorbing and
distributing loads1.

These complex mechanical functions are possible due to the

composite, heterogeneous structure of the disc. The high proteoglycan and water content
of the NP allow this tissue to effectively support approximately 70% of the compressive
axial loads placed upon the spine7 through the generation of a hydrostatic swelling
pressure. However, this results in a bulging of the tissue, which is minimized and
contained by the dense cross-ply of the circumferential collagenous lamellae of the OA.
These lamellae additionally resist annular strains created during more complex motions,
such as bending and torsional loading10. Under cases of extreme compressive load, the
less dense, semi-hydrated matrix of the IA also aids in load absorption by creating fluid
flow to dissipate energy1. Disc height is a function of disc hydration and fluid flow. As
loads are placed upon the spine, interstitial water is forced out, resulting in a diurnal
decrease in height over the course of the day. Disc height is recovered during sleep,
when the body is in a recumbent position, largely due to the Donnan osmotic pressure
generated by the negatively charged proteoglycans in the disc1.
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1.3. Intervertebral Disc Aging and Degeneration
The structure and biochemical composition of the IVD continually change from
birth through old age10. Nutrient transport and waste removal are most efficient just after
birth due to small blood vessels located at the disc periphery and extending between
lamellae of the OA; these vessels may even penetrate into the IA. Anatomically, the NP
occupies almost half of the disc just after birth and is populated by notochordal cells,
derived from the notochord in embryonic development. These cells elaborate large
proteoglycan aggregates (i.e., many aggrecan molecules bound to a central hyaluronic
acid filament) similar to that seen in healthy articular cartilage10. Notochordal cells
disappear with skeletal maturity and chondrocyte-like cells of mesenchymal origin which
reside in the cartilaginous endplate or IA migrate into the NP11-15.
In adulthood, the vascular supply becomes more limited and is largely restricted
to capillaries originating in the vertebral bodies, as peripheral blood vessels once present
at birth and persisting through adolescence disappear with age4. The avascular, aneural
nature of the IVD limits the capacity for self-repair. Calcification of the cartilaginous
endplates also occurs over time, which decreases endplate permeability and further limits
the diffusion- and bulk fluid flow-based nutrient supply and waste transport of the disc,
resulting in a perpetuating cycle of decline in disc health16. The decreased oxygen supply
causes cells to rely on anaerobic metabolism, resulting in the production and
accumulation of lactic acid due to impaired waste removal. This lowers the local pH,
which compromises cell metabolism and may precipitate cell death, as up to 50% of cells
in adult discs have been reported necrotic13. Additionally, the acidic environment favors
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the activation of matrix proteinases that are normally inactive at the neutral pH found in
healthy connective tissues2.
In conjunction with an overall decline in the cell population and an increase in
matrix proteinases, the percentage of aggregating proteoglycans in the NP decreases from
around 30% at 6 months to as low as 10% in the adult17. Additionally, the concentration
of chondroitin sulfate present in the disc decreases with age, while that of keratin sulfate
increases2. Keratin sulfate is a shorter GAG, which reduces the capacity to retain water
in comparison to chondroitin sulfate. Moreover, proteolytic processing, instigated due to
decreased pH and activation of proteinases, can degrade aggrecan molecules such that
these fragments are able to leach from the tissue, producing a significant alteration in the
biochemical composition of the disc.

The loss of these negatively charged GAG

molecules decreases the osmotic pressure of the disc and thus precipitates a loss of
hydration4. The NP is subsequently rendered more fibrous in content, resulting in an
altered distribution of loads and further impairment of nutrient transport and waste
removal18. In addition, type II collagen fibrils undergo proteolytic processing2 and are
often replaced by type I collagen as the annulus begins to encroach on the NP16,
contributing to the fibrotic nature of the aged disc. However, the reduced capability for
matrix turnover (due to impaired diffusion), allows collagen molecules to become
crosslinked as a result of interaction effects which, in the short term, enables the disc to
entrap fragmented proteoglycans and thereby retain water16. Unfortunately, the increased
crosslinking further inhibits matrix turnover and disc repair, compounding the damage to
the disc.
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While all discs undergo changes with age, not all discs degenerate. To clarify this
ambiguity, Adams and Roughley proposed to define a degenerate disc as one with cellmediated structural failure combined with accelerated or advanced signs of aging in
conjunction with pain16. Approximately 80% of Americans will experience at least one
episode of significant back pain during their lifetime19, and annual related medical
expenses attributed to back pain alone total over $80 billion20.
While any of the factors described above in relation to aging of the disc may
contribute to disc degeneration, it is unclear what serves as the trigger to progress into
degeneration. Environmental and lifestyle factors such as an occupation requiring heavy
and repetitive mechanical loading21,

22

or an occupation involving high frequency

vibration (driving, flying), smoking23, vascular disease, diabetes, or immobilization18 may
all increase the rate and severity of age-related changes in the disc to precipitate
degeneration. As seen in older discs, degenerated discs display decreased proteoglycan
and water content and an increased collagen concentration, which all contribute to a
decreased ability to maintain disc height and distribute loads. The degenerated NP
exhibits an increased shear modulus, as the loss of water increases tissue stiffness, and
the disc becomes more elastic, likely due to the increased collagen content from the
encroaching annulus10.
Late stage disc degeneration may be associated with osteophyte formation in the
vertebral bodies or facet joint arthritis10. Additionally, small blood vessels may extend
from the vertebral bodies and grow into the periphery of degenerated discs24,

25

accompanied by the ingrowth of nerves to the inner part of the disc24, 26, 27. Given the loss
of disc structure and mechanical properties and the release of potential inflammatory
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factors which sensitize newly established nerve endings, degenerated discs may give rise
to back pain. Cell necrosis may further contribute to back pain by sensitizing nociceptive
nerve endings due to cytokine release, free radicals, and matrix debris from
degradation18.

1.4. Current Treatments for Disc Degeneration and Low Back Pain
Traditionally, clinical interventions for disc degeneration have largely focused on
alleviation of the pain associated with this pathological condition, rather than repair of the
disc itself to restore the essential mechanical functions which this tissue provides.
Although up to 80% of adults will experience at least one episode of severe back pain,
most will improve without any formal treatment28. Because of this, discogenic pain is
often treated initially with a conservative, nonsurgical approach, which includes
administration of analgesics, muscle relaxants, or corticosteroid injections4.

Other

therapies may include lifestyle modifications, such as weight reduction, smoking
cessation, and exercise29.

Up to 90% of patients with disc degeneration obtain

satisfactory pain relief by conservative treatment methods, though this may take many
months to achieve4. More severe cases may require surgical intervention, and recently
developed techniques provide a minimally invasive option to major surgery. These
options include various forms of discectomy, such as chemonucleolysis, to remove a
portion of the NP to reduce impingement on spinal nerves in cases of herniation, and
annuluoplasty, which seals fissures and burns nociceptors (thereby reducing sensitivity to
pain) in the annulus via electrothermal or radiofrequency thermal energy4.
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The most severe cases of late-stage disc degeneration may necessitate major
surgery and total disc excision. Disc excision is typically followed by spinal fusion, and
approximately 200,000 of these procedures were performed in the United States in
200228. However, the outcome of this procedure is often unpredictable and many adverse
effects have been reported, such as posterior muscular atrophy and a limited range of
motion and associated stiffness. Fusion results in an altered distribution of loads along
the spine, increasing stress on adjacent spinal levels, which may result in facet
hypertrophy, spinal stenosis, and accelerate degeneration in neighboring discs30-32.
One option to spinal fusion following total disc excision is the placement of a
prosthetic disc. The most popular disc prosthesis is the SB Charité III (DePuy, Johnson
& Johnson), with over 5,000 implants worldwide from 1987 to 2003. The Charité is a
three-piece articulating device which attempts to mimic normal disc biomechanics by
allowing translation and rotation within the artificial disc33. The Charité disc consists of
a sliding polyethylene core placed between two cobalt-chromium alloy endplates which
are anchored to the adjacent vertebral bodies by small teeth on the metal surfaces. In
over ten years of clinical use, there have been no published reports of device failure or
spinal displacement and no data to indicate the formation of wear debris from the
polyethylene core33. However, as with all major spinal surgeries there are possible
complications, including immune reactions to the implant, spinal cord or nerve damage,
and leakage of spinal fluid.
Although spinal fusion and disc prosthetics are options for the treatment of latestage disc degeneration, if the patient presents with an intact annulus, nucleus pulposus
augmentation, following a partial or full nucleotomy, may serve as an alternative to
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restore biomechanical function of the diseased disc and slow degeneration of adjacent
level discs34. The main goal of nucleus pulposus replacement procedures is to rehydrate
the central portion of the disc via minimally invasive methods, which subsequently
restores annular tension, thereby re-establishing the biomechanical function of the disc.
The mechanical properties of the NP replacement material should closely match that of
the native tissue to prevent a modulus mismatch and any associated abnormalities of load
distribution or implant extrusion28. Current NP replacement materials can be categorized
as intradiscal implants, which are placed into the disc in a dehydrated, semi-solid state, or
in situ curing polymers, which are injected in liquid form and polymerize in the nuclear
cavity.

Examples of intradiscal implants include the Prosthetic Disc Nucleus

(Raymedica, Inc.), a polyacrylamide/polyacrylonitrile copolymer hydrogel encased in an
ultrahigh molecular weight polyethylene jacket, the Aquarelle (Stryker Spine), a semihydrated polyvinyl alcohol hydrogel, and the NeuDisc (Replication Medical, Inc.), a
hydrolyzed polyacrylonitrile polymer reinforced by a Dacron mesh. Additionally, the
Newcleus (Zimmer, Spine) is a polycarbonate urethane elastomer inserted as a curled,
preformed spiral which absorbs water and expands upon implantation, similar to the
above described materials28,

34, 35

. Some in situ curing implants include the Injectable

Disc Nucleus (Spine Wave), a synthetic silk-elastin copolymer created through DNA
bacterial synthesis fermentation, the Dascor nuclear replacement (Disc Dynamics), an
injectable polyurethane, and the Biodisc (Cryolife), a bovine albumin/glutaraldehyde
hydrogel28, 34, 35. Although some of these prosthetics have shown promise in pre-clinical
and clinical studies, further data are required to examine their long-term ability to
maintain the viscoelastic properties of the disc and sustain multidirectional loads.
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While these more recent techniques for the treatment of disc degeneration not
only alleviate the pain associated with this disease but also attempt to restore mechanical
function of the disc, tissue engineering strategies may be able to additionally address the
biological facet of disc degeneration to create a truly functional disc replacement.

1.5. Intervertebral Disc Tissue Engineering
Tissue engineering presents an alternative to current clinical treatment
modalities, with the objective of developing a biological substitute that restores,
maintains, or improves tissue function through the combination of cells, signaling factors,
and/or biocompatible scaffolds36 (Figure 1.4). The degree of disc degeneration will
ultimately dictate what combination of the above stated components must be utilized for
a tissue engineered solution37. Ideally, clinical intervention will occur in the early stages
of degeneration, and growth factor therapy alone may stimulate matrix production by
resident NP cells7. However, patients often do not present with lower back pain until the
later stages of degeneration, so improved detection methods must be developed. Middlestage disc degeneration may still be addressed by tissue engineering techniques if the
annulus is intact. Treatment options at this stage may include growth factor treatment (as
in early stages), placement of a cell-seeded scaffold in the NP following a nucleotomy, or
placement of a cell-seeded scaffold in the NP in the presence of growth factors7.
However, if the patient presents with a compromised annulus that would be unable to
retain a repaired NP, a complete in vitro-developed disc composite which recapitulates
both the annulus and nucleus may be required.
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Figure 1.4.

Tissue engineering strategies utilize cells, signaling factors, and biomaterial

scaffolds alone or in conjunction to develop constructs for tissue repair or regeneration.

1.6. Cell Sources for Intervertebral Disc Tissue Engineering
The IVD is less characterized at the cellular and tissue levels in comparison to
other orthopaedic tissues, such as cartilage. As a result, most IVD tissue engineering
research has utilized cells derived from the native tissue in order to determine
benchmarks for the behavior of these primary cells. Studies have incorporated human
cells from both healthy and degenerate discs38-42 and cells isolated from a wide variety of
animal sources, including rat43, bovine8,

44-49

, rabbit50,

51

, ovine52-54, canine11,

55

, and

swine56-59. However, as research in the field has progressed, interest has turned to more
clinically relevant cell sources, such as autologous mesenchymal stem cells (MSCs),
since allogeneic and xenogeneic cells carry the potential to illicit an immune response.
Multipotent MSCs are present in various adult tissues, such as bone marrow, trabecular
bone, cartilage, muscle, adipose60, and have been recently identified within the disc61.
These cells have the ability to differentiate along various lineages of mesenchymal origin,
13

such as those found in the IVD, given the proper biochemical environment. Recent
studies examined the effects of MSCs embedded in an atelocollagen matrix which was
injected into rabbit IVDs following nucleotomy.

This therapy resulted in a partial

restoration of disc height and disc hydration, as injected cells were found to have
differentiated along a cartilaginous lineage and expressed type II collagen, keratin sulfate,
and chondroitin-4-sulfate62-64.

1.7. Biomaterial Scaffolds for Intervertebral Disc Tissue Engineering
Biomaterial scaffolds used in tissue engineering applications often attempt to
mimic the multi-dimensional structure of the given native tissue. However, the disparity
in phenotype observed when comparing the fibroblastic cell population found in the OA
and the chondrocyte-like cells of the NP prevents the use of a singular scaffold for IVD
cell culture. Cells from highly oriented, collagenous tissues, such as tendons, ligaments,
and the annulus fibrosus, are routinely cultured on fibrous scaffolds which may be
fabricated in an aligned or random orientation using synthetic or natural polymers, such
as resorbable polyesters or collagen65-69. In contrast, cells from highly hydrated, loadbearing tissues, such as cartilage and the NP, are often encapsulated within a hydrogel
scaffold in order to maintain the rounded cell morphology and expression of
characteristic ECM components, such as type II collagen and aggrecan, observed in
vivo32, 70. Various natural and synthetic polymers, including alginate8, 45, 46, 50, 52, 55, 58, 71-74,
agarose57, chitosan75-77, hyaluronic acid78-80, and poly(ethylene glycol)81, have been
investigated for use in the repair of cartilaginous tissues.
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1.7.1. Fibrous Scaffolds for Annulus Fibrosus Tissue Engineering
Early work in annulus fibrosus tissue engineering utilized commercially available
scaffolds, such as poly(glycolic acid) (PGA) meshes, which were then reinforced with a
poly(L-lactic acid) (PLLA) solution to slow degradation of the polymer8,

47, 53, 54

.

However, these materials possess a random fiber orientation, in contrast to the
circumferential lamellae observed in the native disc. Additionally, the fiber size of these
scaffolds is on the macroscale, while the collagen fibers in the ECM measure on the
nanoscale. Electrospinning has emerged as a technique that can recapitulate the scale and
unique architecture of highly organized tissues, such as the annulus.

Nanofibrous

electrospun poly(ε-caprolactone) scaffolds seeded with bovine annulus fibrosus cells
have recently been shown to allow for GAG and collagen accumulation, and these
constructs exhibited tensile properties comparable to that of the native annulus5. Other
polymers used to create electrospun scaffolds for annulus fibrosus tissue engineering
include PLLA and polycarbonate polyurethane78, 82.

1.7.2 Hydrogels for Nucleus Pulposus Tissue Engineering
The highly hydrated nature of the NP is similar to that of hydrogel networks,
making such polymeric structures prime candidates to serve as scaffolds for NP
regeneration. A wide variety of polymers have been used to create such hydrogels,
including hyaluronic acid78-80, collagen40, 41, 63, 64, and agarose57. Chitosan, derived from
the shells of crustaceans, has also been recently investigated as a potential hydrogel
scaffold as its cationic charge theoretically allows the gel to trap anionic proteoglycans
produced by encapsulated cells75-77. Additionally, chitosan is a thermosensitive polymer
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which transitions from a liquid to a viscoelastic solid at 37ºC and could potentially serve
as an injectable scaffold83,

84

. A thermogelling chitosan/glycerophosphate system has

been developed for drug delivery85 and studied for use as a tissue engineering scaffold,
but was found to lack a firm structure76, which would prove deleterious for a load bearing
structure, such as the NP.
The prevailing mode of NP cell culture has been cell encapsulation within
alginate, a naturally-derived polysaccharide originating from brown algae8, 45, 46, 50, 52, 55, 58,
71-74

(Figure 1.5).

Figure 1.5. Alginate chemical structure, with a representative carboxylic acid moiety circled in
red.

The traditional method of alginate gelation is through ionic crosslinking, achieved via
diffusion of divalent cations, such as calcium, to carboxylic acid moieties on the polymer
to produce a crosslinked network. Although this initially produces stable gels, studies
have shown that cell-seeded, ionically crosslinked alginate hydrogels lose mechanical
integrity over time in long-term static in vitro and in vivo culture9, 45, possibly due to a
loss of crosslinking ions through diffusion into the culture medium or depletion by
encapsulated cells.
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1.7.3. Photocrosslinkable Hydrogels for Tissue Engineering
The reversible nature of conventional ionic crosslinking techniques has led to the
investigation of more stable, covalent crosslinking methods. Photopolymerization is a
well-established method used in dental applications for the in situ crosslinking of
polymer networks86,

87

.

This technique employs biocompatible, light-sensitive

photoinitiators which produce covalently crosslinked 3-D networks via radical
polymerization87. Photopolymerization provides spatial and temporal control of gelation
and can be performed in situ using a liquid cell-polymer solution to completely fill
irregularly shaped defect sites while maintaining good contact with the surrounding
tissue.
Elisseeff et al. first described use of a modified, methacrylated poly(ethylene
oxide) (PEO) polymer for cartilage tissue engineering applications86,

88

.

Radicals

produced by the photoinitiator react with methacrylate groups along the polymer
backbone to polymerize the cell-laden mixture and form a crosslinked hydrogel network.
This scaffold was able to retain GAGs and collagen elaborated by encapsulated
chondrocytes. This technique was modified by Bryant et al. to incorporate degradable
lactic acid units into poly(ethylene glycol)-based (PEG) hydrogels to enhance the spatial
distribution of ECM components in these otherwise inert polymers81.

Smeds et al.

utilized

and created

these same principles

to

investigate natural

polymers

photocrosslinked polysaccharide-based hydrogels from modified alginate and hyaluronic
acid macromers89. Methacrylated hyaluronic acid was used as a scaffold in cartilage
tissue engineering applications by Burdick et al. and Nettles et al. who confirmed
accumulation of GAGs and type II collagen elaborated by encapsulated chondrocytes90,
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91

. These constructs were shown to allow for functional matrix production following in

vivo implantation in a subcutaneous murine pouch model92.

Additionally, studies

conducted by Burdick et al. and Chung et al. have demonstrated that hyaluronic acid
hydrogels can be fabricated with tunable material properties by altering the macromer
concentration (weight/volume) and molecular weight90, 93.
This approach has recently been applied to NP tissue engineering using
methacrylated alginate to produce photocrosslinkable, mechanically stable hydrogel
constructs capable of supporting NP cell growth and viability45.

Similar to results

observed for hyaluronic acid constructs, alginate hydrogel material properties increased
with increasing macromer concentration and methacrylation. Nevertheless, raw alginate
has been shown to stimulate an immune response in vivo in mice and requires additional
processing to remove impurities for biomedical applications94.

Similar purification

procedures are required for animal-derived products, such as hyaluronic acid, chitosan,
and chondroitin sulfate, which have also been used to engineer cartilaginous tissues76, 84,
89-92, 95, 96

. However, the results observed for these photocrosslinkable hydrogels indicate

the potential of comparable polysaccharide-based systems for use in additional
orthopaedic tissue engineering applications.

1.7.4. Cellulose-based Materials for Tissue Engineering Applications
Cellulose, the major structural component of plant cell walls, is a naturallyoccurring polysaccharide that is FDA-approved, biocompatible, and commercially
available. In addition, as a plant-derived polysaccharide, cellulose and its derivatives
represent a class of renewable, environmentally-friendly biomaterials.

Although

18

cellulose has been studied in limited biomedical applications, the rigid, symmetric
molecular structure of the polymer backbone minimizes flexibility, and hydrogen
bonding of hydroxyl groups, both within the molecule and across cellulose chains, forms
non-soluble crystalline structures97 (Figure 1.6).

However, modification of these

hydroxyl groups with more hydrophobic groups, such as methyl or carboxymethyl
groups, reduces hydrogen bonding and improves water affinity98.

Figure 1.6. Chemical structure of cellulose

Methylcellulose, a water-soluble derivative of cellulose which substitutes methyl
groups in place of some hydroxyl hydrogen atoms, is similarly a non-toxic,
biocompatible, FDA-approved material that is commercially available at low-cost99
(Figure 1.7).

Figure 1.7. Chemical structure of methylcellulose

Although methacrylated methylcellulose has recently been shown to form stable,
photocrosslinkable cell-free hydrogels for dermal filler applications100, these gels were
not able to support the viability of encapsulated NP cells when examined in vitro. NP
cells encapsulated at 10 x 106 cells/mL experienced ~70% reduction in viability over 21
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days (Figure 1.8). This may be due, in part, to the hydrophobic methyl groups which
prevent any significant degree of swelling and result in a stiffer environment.

Figure 1.8.

Viability data for NP cells encapsulated in 2% and 3% methacrylated

methylcellulose hydrogels at a density of 10x106 cells/mL. *: significant vs. all other time
points. +: Significant vs. D1 and D7.

Carboxymethylcellulose (CMC) is also a biocompatible, water-soluble derivative
of cellulose that is likewise low-cost, FDA-approved, and commercially available in high
purity forms. At physiological pH, the carboxylic acid of the carboxymethyl group is
deprotonated, resulting in a negatively-charged polymer network, which is similar to that
provided by the GAGs in the ECM of cartilaginous tissues (Figure 1.9).
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Figure 1.9 Chemical structure of carboxymethylcellulose

This negative charge alters the properties of the biomaterial, allowing for a greater degree
of swelling in comparison to cellulose and methylcellulose. Similar to methylcellulose,
CMC has been studied for use in dermal filler applications, and when combined with
PEO, produces an easily injectable solution without necessitating chemical crosslinking
agents101.

CMC-based hydrogels have also been investigated for tissue engineering

applications, applying various crosslinking chemistries102-105.

Cytotoxicity has been

tested in these investiations using multiple cell lines with positive results. These studies,
combined with the work by Stalling et al. to develop a photocrosslinkable
methylcellulose

platform100,

demonstrate

the

potential

of

a

similar

photocrosslinkable CMC-based hydrogel for NP cell encapsulation.

1.8. Biochemical Signals for Intervertebral Disc Tissue Engineering
Growth factors, found circulating in body fluids such as blood and the synovium,
bind to cell transmembrane receptors and initiate an intracellular signaling cascade that
can affect cell proliferation, differentiation, migration, apoptosis, matrix production, and
repair via the endocrine, paracrine, or autocrine systems106.

Growth factor
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supplementation is a biologic approach to address disc degeneration, possibly preventing,
ceasing, or reversing its effects by increasing ECM synthesis107. A variety of growth
factors have been identified within the native disc tissue, including insulin-like growth
factor-1 (IGF-1)108, basic fibroblast growth factor (bFGF)109, platelet-derived growth
factor (PDGF)110, transforming growth factor-β (TGF- β)111, and members of the bone
morphogenetic protein (BMP) family112, 113. These growth factors have thus served as a
starting point for investigations into the effects of in vitro biochemical stimulation of
tissue engineered constructs.
1.8.1. Exogenous Growth Factor Delivery
The exogenous delivery of growth factors, also called protein therapy, is
accomplished in vitro as an additive to cell culture medium. However, it is important to
note that several variables can affect the efficacy and outcome of growth factor
supplementation, including concentration and timing of delivery, culture conditions (i.e.,
3-D vs. monolayer culture, serum-containing medium vs. serum-free medium, etc.), and
cell source114. Although this makes it difficult to compare between studies, exogenous
growth factor delivery has been shown, to varying degrees, to stimulate matrix
production and cell proliferation.
A wide range of growth factors, including IGF-144, 115, TGF-β isoforms44, 72, 115-117,
and members of the BMP family14, 118 have been investigated in IVD tissue engineering.
An early study by Thompson et al. examined the effects of multiple growth factors on
proteoglycan synthesis and cell proliferation by mature canine disc tissues and found the
greatest response with TGF-β1 and epidermal growth factor (EGF) supplementation,
while the effects of IGF-1 supplementation were marginal115. However, a study by
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Gruber et al. showed a decrease in the apoptosis of monolayer human annulus fibrosus
cells cultured in low serum conditions when supplemented with IGF-1119.
A systematic study by Alini et al. examined the independent and combinatorial
effects of TGF-β1, IGF-1, and bFGF on annulus fibrosus and NP cells cultured on a 3-D
collagen/hyaluronic acid scaffold under serum-free conditions44.

This investigation

found that the combination of TGF-β1 and bFGF resulted in the greatest increase in
retained proteoglycans, although this value never exceeded 10% of the native NP, even
after 60 days of culture. Work by Risbud et al. compared two commonly used isoforms
of TGF-β, TGF-β1 and TGF-β3117. Using whole disc organ culture maintained in serumcontaining medium, Risbud et al. reported that TGF-β3 produced a differential increase in
the expression of critical matrix genes and elevated proteoglycan synthesis. Kim et al.
studied the effect of BMP-2 on monolayer IVD cells (mixed population of annulus and
NP cells) and found increased proteoglycan synthesis along with an upregulation of
aggrecan, type I collagen, and type II collagen gene expression without increasing the
expression of the bone-associated gene, osteocalcin14.

Taken together, these studies

highlight the beneficial effect of exogenous growth factor supplementation on in vitro
IVD cell culture systems.

1.8.2. Gene Therapy
While exogenous growth factor delivery is a feasible option for in vitro studies,
the short half-life of these proteins serves as a limitation for their clinical applicability.
Gene therapy is an alternative approach in which cells are genetically modified in order
to induce sustained synthesis of such growth factors endogenously. The goal of ex vivo
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gene therapy is to transduce cells in vitro using viral (i.e., adenoviral, retroviral,
baculoviral) vector or non-viral (i.e., plasmids, liposomes, polymers) techniques and then
deliver these transduced cells in vivo.

Although viral vectors carry greater safety

concerns, such as induction of viral protein production that may stimulate a host immune
reaction, these vectors have high transfection efficiency, whereas non-viral delivery
methods carry fewer safety concerns but also exhibit lower transfection efficiencies.
Gilbertson et al. examined the effect of adenoviral BMP-12 on matrix synthesis
by human annulus fibrosus and NP cells in pellet culture maintained in serum-free
medium over six days120. This study showed an increase in matrix protein synthesis and
cell proliferation by both populations, supporting its use as a potential therapy for the
disc. Lee et al. utilized adenoviral TGF-β1 to transfect IVD cells and compared the
effects of alginate bead culture to pellet culture. After three weeks in vitro, both culture
systems displayed increased proteoglycan synthesis, with the most pronounced results
observed in pellet culture, indicating the importance of both growth factor delivery and
cell culture environment121.

1.9. Biomechanical Stimulation in Intervertebral Disc Tissue Engineering
The unique structure and function of each tissue within the IVD allows this
integral load-bearing tissue to absorb and distribute the daily forces to which it is
exposed. Gravity and muscle tension produced during movement result in a wide variety
of mechanical stimuli applied to the disc, such as compression, hydrostatic pressure,
shear, torsion, and flexion122. These forces induce a biologic response at the cellular
level and are thought to be key regulators of IVD matrix content122. It is hypothesized
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that such forces, applied within physiologic levels, act as anabolic factors and stimulate
the synthesis of matrix proteins, while forces that fall below or exceed this range may
inhibit matrix synthesis123,

124

.

These principals serve as the general guidelines in

applying mechanical loads which mimic those experienced in vivo in order to modulate
the matrix production and functional properties of tissue engineered constructs.

1.9.1. Deformational Loading
As with many other forms of mechanical loading, the effect of compressive
loading is highly dependent upon the magnitude and frequency at which it is applied.
Static compression applied to intact disc tissue over eight hours in vitro was shown to
increase proteoglycan and collagen synthesis at low magnitudes (5-10 kg load) and
decrease synthesis at higher magnitudes (15 kg)125. However, dynamic compression
applied at low frequency (0.01 Hz) and/or high stress (1.3 MPa) was found to increase
proteoglycan content and anabolic matrix gene expression, while also increasing cell
death when applied in vivo using a mouse tail model126. A study by MacLean et al.
reported a similar dependence on frequency, as 1 MPa dynamic compression applied at
0.01 Hz increased anabolic gene expression in the NP, while 1 MPa compression applied
at 1 Hz increased the expression of catabolic factors in the same tissue127. Dynamic
compression has also been applied in vitro by Korecki et al. to NP cell-laden alginate
hydrogels to compare the effects of frequency (0.1, 1, and 3 Hz) and donor age. They
demonstrated that maturation was a significant factor in the cellular response to
mechanical loading, though the impact of loading frequency was minimal128.
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Cyclic tensile strain (1-8% applied at 1 Hz) has also been shown to produce
beneficial effects, increasing type II collagen and aggrecan gene expression while
decreasing MMP-3 expression in annulus fibrosus cells encapsulated in collagen gels40.
Additionally, a study by Iatridis et al. found that permanent deformation, induced by
cyclic tensile strain, was dependent on the magnitude of the strain and the number of
cycles, as the most damage occurred in samples undergoing a fatigue loading protocol129.

1.9.2. Hydrostatic Pressure
The IVD responds to axial compression with a radial, bulging deformation that
loads the annulus fibrosus in tension, while the NP responds predominantly as a fluid and
generates a large hydrostatic pressure1. As such, hydrostatic pressure has been studied as
a method to modulate NP construct development in vitro, with investigations primarily
focusing within the range of pressure observed in vivo, 0.1 – 3 MPa40, 41, 55, 74. An early
study by Ishihara et al. determined that hydrostatic pressure applied at 2.5 MPa
stimulated proteoglycan synthesis in human NP tissue fractions, while 10 MPa pressure
inhibited synthesis124. Similarly, Handa et al. concluded that physiologic levels (0.3
MPa) of hydrostatic pressure increased proteoglycan synthesis in NP tissue fractions and
increased the production of TIMP-1, an inhibitor of matrix metalloproteinases (MMPs),
while excessive (3 MPa) or insufficient (0.1 MPa) pressures decreased proteoglycan
synthesis and increased MMP-3 production123.
More recent work has examined the effects of pressure on tissue engineered
constructs. Hutton et al. examined the effects of static hydrostatic pressure (1 MPa
continuously applied for 9 days) applied to NP cells encapsulated in alginate and found
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increased collagen and proteoglycan synthesis, along with increased aggrecan, type I
collagen, and type II collagen gene expression in comparison to unloaded controls55.
Kasra et al. examined a wide range of frequencies (1-20 Hz) and magnitudes (0-3 MPa)
and surprisingly found that high magnitude, high frequency (3 MPa, 20 Hz) loading
resulted in the largest increases in collagen production and the greatest reduction in
collagen degradation by NP cells encapsulated in alginate50. In contrast, a study by
Neidlinger-Wilke observed a decrease in aggrecan and type II collagen gene expression
in response to 2.5 MPa pressure, accompanied by an increase in MMP-3 expression by
NP cells cultured in a collagen gel41.
While there have been many studies examining the effects of hydrostatic pressure
on tissue engineered constructs, there is yet no consensus on the most physiologically
relevant loading regimen. Furthermore, though many studies have concluded a beneficial
effect of hydrostatic pressurization, previous experiments have only examined the shortterm impact of mechanical stimulation, characterizing gene expression and matrix
biosynthesis without determining if this form of loading was effectively translated into
altered functional properties for these engineered constructs. As such, future studies
should examine both the biochemical and biomechanical properties of tissue engineered
constructs which have been subjected to hydrostatic pressurization.

1.10. Motivation and Research Overview
Low back pain, experienced by as much as 80% of the American population19,
may be caused by a direct, acute injury or degeneration of the IVD.

Intradiscal

replacement of the NP with a synthetic hydrogel presents a less invasive alternative to
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conventional surgery techniques to mechanically re-establish structure and function to the
IVD. However, most hydrogels currently investigated for this use are non-degrading
polymers which do not support cell growth, and thus do not address the biological
component of the IVD structure and function34.

Tissue engineering strategies may

provide a biologic alternative capable of restoring both the structure and mechanical
function of the IVD through the use of a cell-laden scaffold. As such, the governing
hypothesis of this thesis is that CMC may be chemically modified to form a stable,
photocrosslinkable hydrogel capable of supporting the viability and matrix
production of encapsulated NP cells. In addition, we hypothesized that the functional
properties of these cell-laden constructs could be modulated biochemically, through
growth factor supplementation, and biomechanically, through the application of dynamic
hydrostatic pressure to enhance the development of this tissue engineered scaffold.
To test these hypotheses, the following specific aims were proposed:
Specific Aim 1. Modify CMC with photopolymerizable methacrylate groups
to form covalently crosslinked hydrogels capable of supporting NP cell viability and
matrix production. CMC will be chemically modified with functional methacrylate
groups which may be crosslinked using photoinitiated radical polymerization to create a
three-dimensional network.

Hydrogels will be formed at various macromer

concentrations (weight/volume) using CMC of various molecular weights and these gels
will be characterized by determining the swelling and mechanical properties. In addition,
the viability of encapsulated NP cells and the associated matrix elaboration will be
assessed to determine a mechanically stable hydrogel formulation.
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Specific Aim 2. Identify a cell culture medium to enhance the development of
NP tissue engineered constructs by comparing the effects of medium formulation
and TGF-β
β3 on functional matrix development. A standard serum-containing medium
will be compared to a serum-free formulation commonly used in cartilage tissue
engineering applications and both media will be additionally supplemented with TGF-β3.
NP cell-laden CMC hydrogels maintained under these conditions will be examined to
assess swelling properties, cell viability, matrix production, and construct mechanical
properties in order to optimize in vitro culture conditions.
Specific Aim 3. Examine the effects of hydrostatic pressurization and growth
factor supplementation on the matrix production and functional properties of NP
cells encapsulated in photocrosslinked CMC hydrogels. NP cell-laden hydrogels will
be cultured with and without TGF-β3 and will be subjected to dynamic hydrostatic
pressure or maintained at atmospheric pressure to determine the effects of these
biochemical and biomechanical stimuli.

Swelling properties, cell viability, matrix

production, and mechanical properties will be measured to determine if the external
stimuli enhance the functional and material properties of these constructs in an
independent, additive, or synergistic manner.
Specific Aim 4.

Evaluate the tissue formation and functional properties of

subcutaneously implanted NP cell-laden CMC hydrogels that have been precultured in vitro in the presence of TGF-β
β 3. Constructs will be pre-cultured for 14 days
in vitro with and without TGF-β3 prior to subcutaneous implantation in vivo for up to 8
weeks using a murine pouch model.

Corresponding controls will be maintained to

additionally compare long-term in vitro and in vivo culture conditions by assessing the
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swelling properties, cell viability, matrix production, and mechanical properties of these
constructs.
Taken together, these studies will establish a novel scaffold for IVD tissue
engineering and will provide insight into the effects of biochemical and biomechanical
stimulation on matrix elaboration by NP cells encapsulated in these hydrogels.

1.11. Overview of Present Investigation
The objective of this thesis project was to develop and optimize a novel, cellladen CMC hydrogel able to support NP cell viability and matrix accumulation in order
to create a functional tissue engineered replacement. To accomplish this, the versatility
of the photocrosslinkable CMC system was explored by examining the resultant
differences in material and mechanical properties due to varying the macromer
concentration and molecular weight of the starting material, as is presented in Chapter 2.
This study demonstrated the utility of photocrosslinkable CMC hydrogels for NP cell
encapsulation, as these biomaterials were shown to support NP cell viability and may be
easily tailored for specific applications.
Although the system described in Chapter 2 produced stable hydrogels which
supported NP cell viability and promoted phenotypic matrix deposition capable of
maintaining initial mechanical properties in vitro, in order to create a truly functional
tissue engineered NP replacement, culture conditions were examined to enhance matrix
deposition and improve construct material and mechanical properties.

Chapter 3

compared the effects of medium formulation and TGF-β3 supplementation on the in vitro
culture of cell-laden CMC constructs in an effort to improve matrix deposition and
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functional material properties. This work showed approximately a ten-fold increase in
GAG accumulation and a five-fold increase in mechanical properties when specimens
were cultured in serum-free medium supplemented with TGF-β3.
Building upon the investigation of biochemical stimuli described in Chapter 3,
Chapter 4 examined biochemical and biomechanical stimulation, via hydrostatic
pressurization, utilized in conjunction to further develop tissue formation by engineered
CMC constructs.

This work assessed the effect of each stimulus, when applied

independently and in concert, and determined a more pronounced impact of growth factor
supplementation alone on the functional development of NP-seeded CMC constructs in
support of the results from Chapter 3. Chapter 5 evaluated the long-term effect of TGFβ3 supplementation applied over a two-week in vitro pre-culture period prior to
subcutaneous implantation in a murine pouch model for up to eight weeks.

This

investigation also examined the mechanical, biochemical, and material properties of
subcutaneous constructs following excision and compared these values to those measured
prior to implantation and those of samples maintained under in vitro culture conditions.
Constructs maintained without TGF-β3 exhibited no quantifiable changes in matrix
content or mechanical properties over time under both in vitro and in vivo conditions. In
contrast, scaffolds pre-treated with TGF-β3 and maintained in vitro demonstrated a longterm enhancement in matrix accumulation and mechanical properties. However, samples
which were exposed to TGF-β3 and subsequently implanted in vivo experienced a
significant decrease in matrix content and mechanical properties, indicating a differential
effect on construct maturation in response to TGF-β3 supplementation, which is
dependent upon culture condition.
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Chapter 6 details the overall conclusions of this thesis and future directions for
related work. This section has outlined limitations to the studies presented and describes
pilot studies investigating a redox initiation system which would further improve the
versatility of this system for use as an injectable NP replacement.
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Chapter 2: Characterization of Novel Photocrosslinked
Carboxymethylcellulose Hydrogels for Encapsulation of Nucleus
Pulposus Cells

2.1. Introduction
The intervertebral disc (IVD) is a heterogeneous tissue that permits motion and
flexibility, supports and distributes loads, and dissipates energy in the spine1. The IVD is
comprised of the collagenous, lamellar annulus fibrosus, which maintains disc shape and
allows the spine to resist tensile loads2, and the gelatinous nucleus pulposus (NP). The
NP is a hydrated tissue, characterized by high proteoglycan (i.e., aggrecan) and type II
collagen content1.

This region functions to resist compressive loads through the

generation of a hydrostatic swelling pressure.
Degeneration of the IVD is strongly associated with back pain, a significant
healthcare problem, afflicting approximately 80% of Americans during their lifetime3 and
costing over $80 billion in annual related medical expenses4. Disc degeneration often
results from traumatic injury or occurs naturally with aging. This pathological condition
is commonly attributed to increased degradation of aggrecan molecules, giving rise to
significant alterations in disc biochemical composition and a loss of hydration5. The NP
is thus rendered more fibrous in structure and content, which reduces nutrient diffusion
and waste removal6. The resulting increase in lactate concentration within the tissue
lowers the local pH7. The increased acidity compromises cell metabolism and may
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precipitate cell death, as up to 50% of cells in adult discs have been reported as necrotic8.
Disc degeneration may be asymptomatic, or the change in extracellular matrix (ECM)
content may contribute to increased disc stiffness and low back pain from the altered
distribution of loads9. Current clinical treatments focus on alleviation of pain rather than
restoring the structure and function of the disc.

Tissue engineering strategies may

provide a biologic alternative capable of restoring both the structure and mechanical
function of the IVD.
Biomaterial scaffolds used in tissue engineering applications often attempt to
mimic the native structure of the respective tissue. The highly hydrated nature of the NP
is similar to that of hydrogel networks, making such materials prime candidates to serve
as scaffolds for NP regeneration. Hydrogels are hydrophilic, crosslinked polymers which
absorb large volumes of water and swell without dissolution of the polymer10. Nucleus
pulposus cells are routinely cultured by encapsulation in hydrogels made from alginate, a
naturally-derived polysaccharide originating from brown algae11-15.

Alginate cell

encapsulation promotes a rounded, chondrocyte-like morphology in contrast to the
elongated, fibroblast-like morphology seen in monolayer cultures. The predominant
method of alginate gelation is through ionic crosslinking, achieved via diffusion of
divalent cations to carboxylic acid moieties on the polymer, resulting in a crosslinked
network. Although this initially produces stable gels, mechanical integrity has been
found to decrease over time, possibly due to a loss of ions through diffusion11 or
depletion by the encapsulated cells.
Photopolymerization has been widely used in situ to covalently crosslink polymer
networks in dental applications10, 16 . This method employs biocompatible, light-sensitive
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photoinitiators that absorb light, creating free radicals that can initiate polymerization to
covalently crosslink functional groups along the polymer backbone10. Elisseeff et al.
developed a photopolymerization method to successfully encapsulate chondrocytes in
poly(ethylene oxide)-based (PEO) hydrogels for tissue engineering applications16. This
technique was modified by Bryant et al. to incorporate degradable lactic acid units into
poly(ethylene glycol)-based (PEG) hydrogels to enhance the spatial distribution of ECM
components in these otherwise inert polymers17. Photopolymerization has also been
employed to create polysaccharide-based hydrogels using alginate and hyaluronic acid
macromers modified with functional methacrylate groups18. In an extension of this work,
methacrylated hyaluronic acid was used to engineer hydrogels for cartilage cell
encapsulation19,

20

.

These constructs were shown to allow for functional matrix

production following in vivo implantation in a subcutaneous murine pouch model21.
Although hyaluronic acid-based hydrogels have shown promising results, these
biomaterials are often derived from an animal source, which presents the risk of batch-tobatch variations and the need for additional purification steps to reduce the possibility of
stimulating an immune response upon implantation. Nevertheless, the results observed
for hyaluronic acid-based hydrogels indicate the potential of similar polysaccharidebased systems for use in orthopaedic tissue engineering applications.
One such candidate polysaccharide is carboxymethylcellulose (CMC), a watersoluble derivative of cellulose, the primary structural component of plant cell walls.
CMC is a biocompatible, low-cost, FDA-approved material that is commercially
available in high purity forms, making this polymer a highly attractive option for
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biomedical applications22.

However, CMC-based materials have not been used

previously for IVD repair.
Therefore, the objective of this study was to create photocrosslinked CMC
hydrogels with tunable material properties for NP cell encapsulation. We hypothesized
that CMC macromers could be synthesized with methacrylate groups that would allow
for photopolymerization. Moreover, an increase in CMC molecular weight and weight
percent would be expected to give rise to an inverse relationship between the equilibrium
Young’s modulus and the swelling ratio of the resulting hydrogels.

2.2. Materials and Methods
2.2.1. Macromer Synthesis
Methacrylated carboxymethylcellulose (Me-CMC) was synthesized through
esterification of hydroxyl groups based on previously described protocols18,

19

(Figure

2.1). Briefly, 1 gram of 90 kDa or 250 kDa CMC (Sigma, St. Louis, MO) was dissolved
in 100 mL of RNAse/DNAse-free water at 50ºC and stirred for 30 minutes. The mixture
was then stirred at room temperature for one hour and finally, placed on an orbital shaker
for 48 hours at 4ºC to yield a 1 wt % solution. Methacrylic anhydride (Sigma) at 20-fold
excess was reacted with 1% CMC over 24 hours at 4ºC with 12 periodic adjustments to
pH 8.0 using 3N NaOH to modify hydroxyl groups of the polymer with functional
methacrylate groups. The modified CMC solution was purified via dialysis for 96 hours
against RNAse/DNAse-free water (Spectra/Por1, MW 5-8 kDa, Rancho Dominguez, CA)
to remove excess, unreacted methacrylic anhydride. Purified Me-CMC was recovered by
lyophilization and stored at -20ºC. The degree of substitution was confirmed using 1H53

NMR (360 MHz, DMX360, Bruker, Madison, WI) following acid hydrolysis of purified
Me-CMC. Briefly, a 20 mg sample of lyophilized Me-CMC was dissolved in 20 mL of
RNAse/DNAse-free water and hydrolyzed at a pH of 2.0 at 80ºC for 2.3 hours. The pH
of the hydrolyzed solution was readjusted to 7.0, recovered via lyophilization, and
resuspended in deuterium oxide. Molar percent of methacrylation was determined by the
relative integrations of methacrylate proton peaks (methylene, δ = 6.2 ppm and 5.8 ppm
and the methyl peak, δ = 2.0 ppm) to carbohydrate protons.

Figure 2.1. Schematic of the synthesis of methacrylated carboxymethylcellulose.
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2.2.2. Cell Isolation
All cell culture supplies, including media, antibiotics, and buffering agents, were
purchased from Invitrogen (Carlsbad, CA) unless otherwise noted. Discs C2-C4 were
isolated from bovine caudal IVDs obtained from a local abattoir, and the NP was
separated through gross visual inspection based on previous protocols23, 24. Tissue was
maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 20%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 0.075% sodium bicarbonate, 100 U/mL
penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL Fungizone reagent at 37°C, 5% CO2
for two days prior to digestion to ensure no contamination occurred during harvesting. A
single serum lot was used for all experiments to reduce potential variability in the cellular
response.
Tissue was diced and NP cells were released by collagenase (Type IV, Sigma)
digestion at an activity of 7000 U collagenase per gram of tissue. Following incubation
in collagenase, undigested tissue was removed using a 40 µm mesh filter. Cells from
multiple levels (C2-C4) were pooled and rinsed in sterile Dulbecco’s Phosphate Buffered
Saline (DPBS). These primary cells were plated onto tissue culture flasks, designated as
passage 0, and maintained in DMEM with 10% FBS, 0.075% sodium bicarbonate, 100
U/mL penicillin, and 100 µg/mL streptomycin (growth medium). Cells were subcultured
twice to obtain the necessary number of cells, and passage 2 cells were used in all
experiments23.
2.2.3. Cell Encapsulation in Photocrosslinked Hydrogels
Cell-encapsulated photocrosslinked constructs were prepared at various weight
percents.

Prior to dissolution, lyophilized Me-CMC was sterilized by a 30-minute
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exposure to germicidal UV light. The sterilized product was then dissolved in filtersterilized 0.05 wt% photoinitiator, 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl1-propanone (Irgacure 2959, I2959, Ciba Specialty Chemicals, Basel, Switzerland), in
sterile DPBS at 4°C to various weight percents (90 kDa Me-CMC: 3.2, 4.2, and 5.2%;
250 kDa: 1.2, 2.2, and 3.2%). Passage 2 NP cells were resuspended in a small volume of
0.05% photoinitiator and then homogeneously mixed with dissolved Me-CMC at 30 ×
106 cells/mL. The seeding density was selected based on previous studies using cellseeded constructs for engineering of cartilaginous tissues25-29. Solutions were cast at final
concentrations of 3, 4, and 5% (90 kDa Me-CMC) and 1, 2, and 3% (250 kDa Me-CMC)
in a custom-made glass casting device. The mixtures were exposed to long-wave UV
light (EIKO, Shawnee, KS, peak 368 nm, 1.2W) for 10 minutes to produce covalently
crosslinked hydrogel disks of 8-mm diameter x 2-mm thickness. Each hydrogel was
incubated in 3 mL of growth medium at 37ºC, 5% CO2. At day 1, the medium was fully
exchanged with L-ascorbic acid supplemented medium (growth medium with 50 µg/mL
L-ascorbic acid), which was used for the remainder of the study and replaced every 2-3
days. Initial viability studies (described below) were performed using gels cast at 5-mm
diameter x 2-mm thickness, incubated in 1.5 mL of L-ascorbic acid supplemented growth
medium.
2.2.4. Cell Viability and Dynamic Mechanical Testing
Preliminary screening studies examined the effects of weight percent and
molecular weight on cell viability and the elastic mechanical properties of 3, 4, and 5%
90 kDa Me-CMC and 1, 2, and 3% 250 kDa Me-CMC. Cell viability was assessed at
days 1 and 7 using the MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium
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bromide) proliferation assay kit (ATCC, Manassas, VA). Photocrosslinked Me-CMC
hydrogels (n=4) were incubated in 1 mL of growth medium supplemented with 100 µL of
yellow tetrazolium MTT for 4 hours at 37ºC, 5% CO2, shielded from light. Hydrogels
were then homogenized and formazan crystals were extracted using the MTT detergent
solution (MTT cell proliferation assay kit, ATCC), incubating for an additional 4 hours at
room temperature, shielded from light. Total absorbance of the solubilized product was
quantified at 570 nm using a Bio-Tek Synergy-HT microplate reader (Winooski, VA).
MTT absorbance values were compared between samples and to cell-free control gels to
quantify relative viability. Day 7 measurements were also evaluated against day 1 values
to determine loss of viability over time.
Cell viability of 2% 250 kDa Me-CMC constructs was visually assessed at day 0
(one hour after casting) and day 1 using the Live/Dead kit (Invitrogen). Samples were
rinsed in DPBS and then incubated in Live/Dead solution (1 mM calcein AM, 1 mM
ethidium homodimer-2) for 45 minutes. Images were captured using a Zeiss Axiovert
200 microscope with fluorescent capabilities at excitation/emission wavelengths of
494/517 nm (calcein) and 528/617 nm (ethidium homodimer-2/DNA complex). Live and
dead cells were counted using Image J software (National Institutes of Health).
At day 7, a Dynamic Mechanical Analyzer (DMA) 8000 (PerkinElmer, Inc.,
Waltham, MA) testing apparatus was used to determine the elastic modulus of Me-CMC
hydrogels at the weight percents described above. Samples (n=5) were rinsed in DPBS
and loaded into the DMA. Unconfined compression testing was performed at 25ºC at a
strain rate of 10%/minute. The modulus was determined from the linear region of the
stress versus strain curves at strains between 5% and 20%.
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2.2.5. Swelling Ratio
Following the initial studies examining cell viability and elastic mechanical
properties, 4% 90 kDa, 2% 250 kDa, and 3% 250 kDa Me-CMC hydrogels were chosen
for further characterization. The equilibrium weight swelling ratio, Qw, was determined
for these formulations at days 1, 7, and 14 for cell-laden and cell-free control samples
(n=4). Constructs were weighed to determine the wet weight (Ws), lyophilized, and then
weighed again to determine the dry weight (Wd). Qw was calculated using the following
equation:
Qw = Ws/Wd
2.2.6. Characterization of Equilibrium Mechanical Properties
Based on the early screening studies, unconfined compression testing was
conducted on 4% 90 kDa, 2% 250 kDa, and 3% 250 kDa Me-CMC cell-laden and cellfree control samples (n=5) at days 1, 7, and 14 to measure the equilibrium Young's
modulus (Ey). The mechanical testing device is based on a similar setup described by
Soltz and Ateshian30. The device consists of a computer-controlled stepper motor (Oriel
Corp., Model 18515, Stratford, CT) that prescribed a displacement on the specimen using
a steel indenter with glass platen attachment.

A data card and LabVIEW software

(National Instruments, Austin, TX) were used for controlling the stepper motor and data
acquisition. Displacement was measured using a linear variable differential transformer
(Schaevitz, Model PR812, Hampton, VA), and the load applied was measured using a
250 g load cell (Sensotec, Model 31, Columbus, OH).

Samples were compressed

between two impermeable glass platens in a DPBS bath. The unconfined compression
testing protocol was comprised of a creep test followed by a multi-ramp stress-relaxation
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test. The creep test consisted of a 1 g tare load applied at a 10 µm/s ramp velocity for
1800 seconds until equilibrium was reached (equilibrium criteria: <10 µm change in 10
minutes). The multi-ramp stress-relaxation test consisted of three 5% strain ramps at a 10
µm/s ramp velocity, each followed by a 2000 second relaxation period (equilibrium
criteria: <0.5 g change in 10 minutes). Equilibrium stress was calculated at the end of
each ramp using surface area measurements and plotted against the applied strain. An
average equilibrium Young’s modulus was calculated from the stress versus strain curves
and reported for each sample.
2.2.7. Histology and Immunohistochemistry
Cell-laden hydrogels were fixed for 45 minutes in acid formalin at room
temperature and processed for paraffin embedding after graded serial ethanol
dehydration. Samples were sectioned at a thickness of 8 µm, and hematoxylin and eosin
staining was conducted to visualize cellular distribution throughout the hydrogel.
Immunohistochemical analyses were performed to assess extracellular matrix
accumulation of chondroitin sulfate proteoglycan (CSPG). Samples were treated with
0.5N acetic acid for two hours at 4°C. Non-specific binding was blocked using 10% goat
serum (Invitrogen) in DPBS.

A monoclonal antibody to CSPG (1:100 dilution in

blocking solution) (Sigma) was used, followed by incubation in biotinylated goat/antimouse IgM secondary antibody (1:50 dilution in blocking solution) (Vector Labs,
Burlingame, CA). A peroxidase-based detection system (Vectastain Elite ABC, Vector
Labs) and 3,3’ diaminobenzidine (Vector Labs) as the chromagen were used according to
the manufacturer’s protocols to detect ECM localization. Non-immune controls were
processed in blocking solution without primary antibody. Samples were viewed with a
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Zeiss Axioskop 40 optical microscope and images were captured using AxioVision
software.
2.2.8. Statistical Analysis
A one-way analysis of variance (ANOVA) was performed on MTT viability
measurements to determine the effect of weight percent and the effect of time. A twoway ANOVA was conducted on elastic modulus data to determine the effects of weight
percent and cells (cell-laden vs. cell-free control constructs). A three-way ANOVA was
conducted on swelling and Ey data for 4% 90 kDa, 2% 250 kDa, and 3% 250 kDa MeCMC constructs to determine the effects of time, cells, and starting material. A two-way
ANOVA was performed on equilibrium Young’s modulus measurements for 3% 250
kDa Me-CMC constructs to examine the effects of time and cells. A Tukey’s post-hoc
test was performed on all ANOVA calculations to detect significant differences between
groups.

All results are presented as mean + standard deviation with statistical

significance defined as p<0.05. Statistical analyses were completed using JMP software
(SAS Institute, Cary, NC).

2.3. Results
CMC was successfully modified (90 kDa CMC: 3.29% methacrylation; 250 kDa
CMC: 2.87% methacrylation), as verified by 1H-NMR (Figure 2.2).

Initial studies

examined the effects of weight percent and molecular weight on cell viability and elastic
mechanical properties. Weight percent ranges were selected based on ease of handling (a
function of pre-crosslinked polymer solution viscosity) and stable hydrogel formation.
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Figure

2.2.

Representative

1

H-NMR

spectra

of

unmodified

and

methacrylated

carboxymethylcellulose, with methacrylate peaks indicated by arrows.

The formulations selected for initial analysis were 3, 4, and 5% 90 kDa CMC and 1, 2,
and 3% 250 kDa CMC. Bovine NP cells were encapsulated in these gel formulations and
samples were isolated at days 1 and 7 to assess cell viability using the MTT assay.
Overall, evenly distributed, viable cells were observed for all groups at both time points
(Figure 2.3 B-G). There were no significant differences in viability based on weight
percent for 90 kDa CMC constructs at either time point (Figure 2.3A). Day 1 viability in
3% 250 kDa CMC hydrogels was significantly lower than 1% 250 kDa CMC samples;
however, this was not significant in comparison to 2% 250 kDa CMC constructs. By day
7, viability in 2% 250 kDa CMC samples was significantly higher than that for 1 and 3%
counterparts (Figure 2.3A). There was no significant loss in viability over time for any
group except 1% 250 kDa CMC constructs, as measured using the MTT assay (Figure
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Figure 2.3.

Mitochondrial activity measurements (MTT) at days 1 and 7 for (A)

photocrosslinked 90 kDa and 250 kDa CMC hydrogels (n=4) at various weight percents
encapsulated with bovine nucleus pulposus cells at 30 x 106 cells/mL. Representative day 7
MTT stereomicrograph images of 3% 90kDa (B), 4% 90 kDa (C), 5% 90 kDa (D), 1% 250 kDa
(E), 2% 250 kDa (F), and 3% 250 kDa (G) CMC cell-laden hydrogels (scale in mm). Live/Dead
images of 2% 250 kDa CMC samples at days 0 (H) and 1 (I) with live cells stained green and
dead cells shown in red (bar = 100 µm). Significance set at p<0.05. *: Significant vs. 1% 250
kDa CMC within time point. #: Significant vs. 1 and 3% 250 kDa CMC within time point. +:
Significant effect of time within group.
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2.3A). Stable disks were formed for all groups at both molecular weights, with the
exception of 1% 250 kDa CMC, which was not able to retain structural integrity (Figure
2.3E).
Viability was also visually assessed early on at days 0 and 1 for 2% 250 kDa
CMC constructs.

A highly viable cell population (~83%, indicated in green) was

observed on day 0 (one hour after casting) (Figure 2.3H) and at day 1 (~76%) (Figure
2.3I), with some dead cells present (red).
Elastic mechanical properties of cell-laden and cell-free control gels at these six
formulations were also quantified at day 7. Although 3% 90 kDa CMC formed stable
constructs, these samples were too weak to be mechanically tested and were excluded, as
were the amorphous 1% 250 kDa CMC gels. Quantification of the elastic modulus
determined no significant differences between cell-laden and cell-free hydrogels at day 7
in any group (Figure 2.4). There was a significant overall effect of weight percent, as
samples at higher concentrations exhibited a higher modulus (4% vs. 5% 90 kDa CMC
and 2% vs. 3% 250 kDa CMC). From these preliminary studies, 4% 90 kDa CMC and
2% 250 kDa CMC were selected for further characterization.
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Figure 2.4. Elastic modulus of day 7 photocrosslinked 90 kDa (A) and 250 kDa (B) CMC
hydrogels encapsulated with bovine nucleus pulposus cells at 30 x 106 cells/mL and
corresponding cell-free control gels (n=5) at various weight percents. Significance set at p<0.05.
*: Significant effect of weight percent.

Cell-laden and cell-free hydrogels composed of 4% 90 kDa CMC and 2% 250
kDa CMC were cast and analyzed at days 1, 7, and 14 to determine the swelling ratio and
the equilibrium Young’s modulus. Overall, there were no significant differences in
swelling between cell-laden and cell-free hydrogels at either molecular weight at any
time point (Qw: 46.45 + 3.15 and 48.55 + 2.91 for 90 kDa and 250 kDa CMC,
respectively). In addition, there was no significant effect of molecular weight (90 kDa
vs. 250 kDa) at any time point, nor was there a significant effect of time, as Qw was stable
over the 14-day study for all groups.
Unconfined compression testing of 4% 90 kDa CMC and 2% 250 kDa CMC
constructs revealed a significant loss in mechanical properties over time for all groups
(Figure 2.5). Cell-laden and cell-free control hydrogels at both 4% 90 kDa CMC and 2%
250 kDa CMC exhibited a significant decrease in Ey by day 14. Overall, there was no
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significant effect of CMC molecular weight (90 kDa vs. 250 kDa) nor of cells (cell-laden
samples vs. cell-free controls) for any group, except 4% 90 kDa CMC at day 1.

Figure 2.5. Equilibrium Young’s modulus for 4% 90 kDa and 2% 250 kDa CMC cell-free
control and cell-laden hydrogels (n=5) over 14 days of in vitro culture. Significance set at
p<0.05. *: Significant vs. day 1 within group. +: Significant vs. days 1 and 7 within group. #:
Significant vs. corresponding cell-free control.

Based on the steady decrease in mechanical properties observed for both 4% 90
kDa CMC and 2% 250 kDa CMC constructs, a higher weight percent gel was chosen to
provide a stiffer initial environment.

Cell-laden and cell-free 3% 250 kDa CMC

hydrogels were cast and again analyzed at days 1, 7, and 14 to determine the swelling
ratio, mechanical properties, and ECM accumulation. In contrast to 2% 250 kDa CMC
constructs, the presence of cells in 3% 250 kDa CMC gels resulted in a significantly
lower degree of swelling than was observed for cell-free controls (Qw: 40.14 + 1.80 vs.
44.67 + 2.27, respectively). However, as for 2% 250 kDa CMC constructs, Qw for 3%
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250 kDa CMC samples was stable over the 14-day study, with no effect of time observed
for either cell-laden or cell-free control gels. Overall, Qw was significantly lower for 3%
250 kDa samples in comparison to both 4% 90 kDa and 2% 250 kDa CMC hydrogels
(42.41 + 3.06 vs. 46.45 + 3.14 and 48.55 + 2.91, respectively).
3% 250 kDa CMC samples were tested in unconfined compression to determine
the equilibrium Young’s modulus.

A significant temporal decrease in mechanical

properties was again observed for cell-free control gels (Figure 2.6). In contrast, there
was no significant effect of time observed for cell-laden constructs. By day 14, cell-free
control gels were significantly weaker than their cell-laden counterparts. Overall, the
average equilibrium Young’s modulus for 3% 250 kDa CMC samples was significantly
higher in comparison to both 4% 90 kDa and 2% 250 kDa CMC hydrogels (3.53 + 0.87
kPa vs. 1.37 + 0.44 kPa and 1.27 + 0.35 kPa, respectively).

Figure 2.6. Equilibrium Young’s modulus for 3% 250 kDa CMC cell-free control and cellladen hydrogels (n=5) over 14 days of in vitro culture. Significance set at p<0.05. *: Significant
vs. day 1 within group. #: Significant vs. corresponding cell-free control.
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Histological analyses conducted on 3% 250 kDa CMC constructs at day 14
confirmed a phenotypic rounded cellular morphology within the hydrogel, as determined
by hematoxylin and eosin staining (Figure 2.7A). By day 14, cells were localized in
limited lacunae at the center of the construct and well-developed, extensive lacunae at the
scaffold periphery.

Immunohistochemical staining verified pericellular deposition of

CSPG throughout the construct, with more pronounced interterritorial staining present at
the periphery (Figure 2.7B). Non-immune control samples exhibited no positive staining.

Figure 2.7.

Hematoxylin and eosin staining (A) and chondroitin sulfate proteoglycan

immunohistochemical staining (B) of cell-laden 3% 250 kDa CMC constructs at day 14. Bar =
50 µm.

2.4. Discussion
In this study, CMC was successfully modified with methacrylate groups to
produce photocrosslinked hydrogels with tunable properties. In addition, this is the first
investigation to demonstrate successful encapsulation of NP cells in photocrosslinked
CMC hydrogels, suggesting that these materials may serve as alternate scaffolds for IVD
replacement therapies.
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Alginate is the most widely used biomaterial in NP tissue engineering
applications11-15.

However, the reversible nature of conventional ionic crosslinking

techniques has led to investigation of photopolymerization methods. This approach has
recently been applied to alginate to produce mechanically stable hydrogel constructs
capable of supporting NP cell growth and viability31. Nevertheless, raw alginate has been
shown to stimulate an immune response in vivo in mice and requires additional
processing to remove impurities for biomedical applications32.

Similar purification

procedures are required for animal-derived products, such as hyaluronic acid, chitosan,
and chondroitin sulfate, which have also been used to engineer cartilaginous tissues18-21,
33-36

.
CMC is a well-established derivative of cellulose, which is rendered water-

soluble through the introduction of carboxymethyl groups along the polymer backbone.
At physiological pH, the carboxylic acid of the carboxymethyl group is deprotonated,
resulting in a negatively-charged polymer network, which is similar to that provided by
the glycosaminoglycans in the ECM of cartilaginous tissues. CMC is commercially
available in high-purity forms, making it an appealing low-cost alternative to other
natural polysaccharides and inert polymers currently used in tissue engineering
applications. Additionally, as a derivative of the plant-based polysaccharide, cellulose,
CMC represents a renewable, environmentally-friendly biomaterial.
Recent work has examined the efficacy of CMC-based hydrogels for cell
encapsulation22,

37-39

. These studies have successfully utilized various chemistries for

CMC crosslinking, including phenol modification of CMC carboxylic acid (COOH)
groups22, 37, acrylation of CMC38, amidation of CMC COOH groups39, and electrostatic
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interactions40, highlighting the versatility of the CMC polymer. Cytotoxicity has been
tested using multiple cell lines with positive results.

However, some studies have

examined CMC hydrogels in sheet or membrane form, which may not be ideal for
orthopaedic applications. Additionally, modification of CMC COOH groups limits the
availability of charged moieties, thereby reducing the swelling capability of the hydrogel
and neutralizing the negatively-charged polymer network.

Moreover, gels formed

through electrostatic interactions may not be as stable as covalently crosslinked hydrogels
– an important feature of an orthopaedic scaffold for load-bearing tissues.
Our early screening studies examined the effects of molecular weight and
macromer concentration on cell viability and elastic modulus.

Metabolic activity

measurements using the MTT assay showed no significant decrease over time for any
group except for the amorphous 1% 250 kDa CMC constructs. The lack of structural
integrity in these samples resulted in a significant loss of material during transfer and
may have contributed to the lower than expected activity/viability measurements.
Although the MTT assay is routinely used to assess cell viability16,

31, 41-43

, this assay

measures the activity of the mitochondrial enzyme, succinate dehydrogenase. Since the
number of mitochondria can vary between cells, the MTT assay may not accurately
reflect cell viability44.

Live/Dead fluorescent staining was used as a more direct

evaluation of cell viability. Contrary to the MTT results, the staining demonstrated a
noticeable loss of viability over time. However, decreased cell viability in such hydrogel
systems is not surprising, as this trend has also been observed for bovine articular
chondrocytes encapsulated in PEO hydrogels and bovine NP cells encapsulated in
alginate, suggesting that additional environmental factors may influence cell growth in
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photopolymerized hydrogels31, 41. Although cell-interactive signals (i.e., growth factors,
adhesive peptides) have been shown to play an important role in modulating cellular
viability and function in engineered constructs45, 46, the objective of this first study was to
investigate cell-polymer interactions in these novel photocrosslinkable CMC hydrogels,
excluding the influence of any exogenous factors.
Our initial screening study demonstrated the effects of CMC molecular weight
(90 and 250 kDa) and macromer concentration on hydrogel properties. These studies
underscore the influence of crosslinking density on hydrogel material properties.
Crosslinking density is increased at higher macromer concentrations due to a greater
number of methacrylate functional groups available for photoinitiated crosslinking. The
theory of rubber elasticity predicts that an increase in crosslinking density gives rise to an
increase in hydrogel stiffness and a concomitant decrease in swelling ratio47.

The

significant increases in elastic modulus associated with increasing CMC molecular
weight (as determined in our initial studies), combined with the marked differences in
swelling ratio and equilibrium modulus of 2 versus 3% 250 kDa CMC are consistent with
the theory and with our original hypothesis.
Based on the results from our initial screening, the swelling ratio was
characterized in cell culture medium for three formulations of CMC: 4% 90 kDa CMC
and 2 and 3% 250 kDa CMC. Qw remained steady over time for all groups. Additional
studies demonstrated similar results in physiological saline and simulated body fluid. A
stable swelling ratio is important for potential IVD clinical applications as an intradiscal
replacement material in order to prevent bulging and extrusion into the annulus fibrosus.
Although Qw remained unchanged, the mechanical properties (Ey) of 4% 90 kDa CMC
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and 2% 250 kDa CMC constructs experienced a significant decrease over time for both
cell-laden and cell-free constructs (Figure 2.4). These two formulations were originally
chosen for more extensive characterization based on a study by Chou and Nicoll in which
bovine NP cells were encapsulated in photocrosslinked methacrylated alginate hydrogels
and implanted subcutaneously in nude mice for 8 weeks48. The equilibrium Young’s
modulus of these alginate constructs was ~1.25 kPa at day 1 and increased to ~4.31 kPa
at 8 weeks, which indicated the elaboration of a functional matrix that closely
approximates values of the native NP (~5 kPa) reported by Cloyd et al49. The results of
our initial study showed that the elastic modulus for 4% 90 kDa CMC and 2% 250 kDa
CMC constructs was ~1 kPa at day 7 (Figure 2.4). As such, these formulations were
selected for a more detailed analysis with the belief that the starting mechanical
properties of the scaffold would allow for matrix accumulation, resulting in a temporal
increase in modulus. However, Ey exhibited a continual decrease over time for both
groups. Because CMC is a derivative of cellulose, the polymer backbone is degraded by
the plant-derived enzyme, cellulase. As this enzyme was not introduced into the system,
the loss in mechanical properties was surprising. The decrease in modulus was observed
for both cell-laden and cell-free constructs, indicating a non-cellular mediator of hydrogel
weakening.

Although the schematic in Figure 2.1 indicates methacrylation of the

hydroxyl group off of the C2 carbon, theoretically, this could also occur at a hydroxyl
bonded to the C6 carbon. This arm would be more susceptible to ester hydrolysis as the
longer chain is less sterically hindered, thereby resulting in the cleavage of periodic
interchain crosslinks without a significant loss in mass. Future analyses may evaluate
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CMC modification using higher resolution 1H-NMR (i.e., 900 MHz vs. 360 MHz) in
order to distinguish between modification sites.
Due to the decrease in mechanical properties observed for 4% 90 kDa CMC and
2% 250 kDa CMC, a higher weight percent formulation was chosen to provide a higher
crosslinking density. Although viability was robust in all concentrations of 90 kDa CMC
(Figure 2.3A), a higher weight percent at this molecular weight was not selected due to
the large amount of starting material necessary and the increased concentration of free
radicals during polymerization.

Therefore, the 3% 250 kDa CMC formulation was

selected. Similar to 4% 90 kDa and 2% 250 kDa hydrogels, 3% 250 kDa cell-free control
samples also experienced a temporal decrease in mechanical properties (Figure 2.6).
However, the stiffer initial environment (~4 kPa) was on par with native NP tissue (~5
kPa)49 and cell-laden constructs elaborated a matrix that was able to overcome the
decrease in mechanics and maintain the original modulus. Unlike the softer 4% 90 kDa
and 2% 250 kDa CMC hydrogels, the partial hydrolysis of the stiffer 3% 250 kDa CMC
constructs provided void space for the accumulation of secreted matrix macromolecules
while maintaining sufficient structural integrity.

Histological analyses showed cells

localized in lacunae throughout the scaffold, as is typical of cartilaginous tissues (Figure
2.7A), and the pericellular deposition of CSPG was observed with pronounced
interterritorial staining at the periphery of the construct (Figure 2.7B).
Although this study concentrated on characterizing the material properties (degree
of swelling and modulus) of cell-free and cell-laden hydrogels, histological analyses
confirmed the phenotypic rounded morphology and elaboration of characteristic
proteoglycans (i.e., CSPG) by encapsulated NP cells at 14 days in vitro. While robust
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viability was verified at 7 days for all formulations, future work will investigate the
effects of time and environmental stimuli, such as growth factor supplementation (i.e.,
TGF-β3)50-53 and mechanical loading (i.e., hydrostatic pressurization)54-59, on cell
viability and the functional assembly of phenotypic ECM components.
Taken together, these findings indicate the utility of photocrosslinkable CMC
hydrogels for NP cell encapsulation, as these biomaterials support NP cell viability and
may be easily tailored for specific applications. Moreover, photocrosslinkable CMC may
serve as a cost-effective, biocompatible alternative to inert polymers, including PEO and
PEG, and expensive bacterial- and animal-derived polysaccharides, such as hyaluronic
acid and chondroitin sulfate, for use in the engineering of hydrated cartilaginous tissues.
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Chapter 3: Serum-Free, Chemically-Defined Medium with TGF-β
β3
Enhances Functional Properties of Nucleus Pulposus Cell-laden
Carboxymethylcellulose Hydrogel Constructs

3.1. Introduction
The intervertebral disc (IVD) is a heterogeneous tissue that functions to permit
motion and flexibility, support and distribute loads, and dissipate energy in the spine1.
The IVD is comprised of the collagenous, lamellar annulus fibrosus, which maintains
disc shape and allows the spine to resist tensile loads2, and the gelatinous nucleus
pulposus (NP). The NP is a hydrated tissue located at the center of the disc, characterized
by high proteoglycan (i.e., aggrecan) and type II collagen content1. This region functions
to resist compressive loads through the generation of a hydrostatic swelling pressure.
Similar to articular cartilage, the IVD is a largely avascular, aneural tissue, dependent
upon bulk diffusion for nutrient transport, which thus limits its capacity for self-repair3.
Intervertebral disc degeneration occurs naturally with aging or may be accelerated
by injury. This pathological condition is commonly attributed to increased degradation
of aggrecan molecules, giving rise to significant alterations in disc biochemical
composition and a subsequent loss of hydration4. The NP is thus rendered more fibrous
in structure and content, which reduces nutrient diffusion and waste removal5. The
accompanied increase in lactate concentration lowers the local pH6 and may precipitate
cell death7.

Disc degeneration may be asymptomatic, or the associated change in
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extracellular matrix (ECM) composition and altered loading pattern may contribute to
increased disc stiffness and low back pain8.
Tissue engineering strategies may provide a viable NP replacement therapy as an
alternative to current surgical procedures for alleviating back pain.

Growth factor

supplementation can affect the maturation of such tissue engineered constructs9. For
example, transforming growth factor-β3 (TGF-β3), a member of the TGF-β superfamily
which is known to affect proliferation, differentiation, and gene expression of ECM
components10, has been shown to enhance cell survival and matrix deposition in rat
lumbar IVD organ culture11. Furthermore, TGF-β3 is known to improve the functional
properties of tissue engineered cartilage constructs, as chondrocyte-seeded agarose gels
achieved compressive moduli and proteoglycan content comparable to native tissue
levels9, 12.
Although tissue engineered nucleus pulposus constructs are typically cultured in
serum-containing medium13-18, animal-derived sera, such as fetal bovine serum (FBS),
are not well-characterized and may present batch-to-batch variations in constituent
composition19, 20. Moreover, medium formulations utilizing animal-derived serum may
face regulatory barriers for any human clinical applications. Related work in cartilage
tissue engineering has demonstrated the additional benefit of serum-free medium, as
these formulations typically resulted in improved construct maturation in comparison to
serum-containing medium9,

21

.

Therefore, identifying a chemically-defined medium

formulation that supports NP construct maturation without the use of serum may not only
improve clinical applicability, but may also enhance construct development.
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Scaffold selection is another major factor impacting the success of any tissue
engineered implant. The highly hydrated nature of the NP is similar to that of hydrogel
networks, making such polymeric structures prime candidates to serve as scaffolds for
NP regeneration. Although NP cells are routinely cultured by encapsulation in ionically
crosslinked alginate hydrogels22-26, these materials have been found to lose mechanical
integrity over time, possibly due to a loss of crosslinking calcium ions through diffusion22
or depletion by the encapsulated cells.

Moreover, raw alginate has been shown to

stimulate an immune response in vivo in mice and requires additional processing to
remove impurities for biomedical applications27. Similar purification procedures are
required for animal-derived products, such as hyaluronic acid, chitosan, and chondroitin
sulfate, which have also been used to engineer cartilaginous tissues28-35, thus motivating
the investigation of alternative natural biomaterials.
One potential candidate material is carboxymethylcellulose (CMC), a watersoluble polysaccharide derivative of cellulose, the primary structural component of plant
cell walls.

CMC is a biocompatible, low-cost, FDA-approved material that is

commercially available in high purity forms, making this polymer a highly attractive
option for biomedical applications36. Photocrosslinked CMC has been recently shown to
produce stable hydrogels, support NP cell viability, and promote phenotypic matrix
deposition capable of maintaining initial mechanical properties in vitro37. However, in
order to further enhance the development of CMC constructs, culture conditions must be
optimized.
Therefore, the objective of this study was to identify an optimal cell culture
medium for NP tissue engineering by comparing the effects of medium formulation and
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TGF-β3 on the in vitro culture of cell-laden CMC constructs. We hypothesized that a
chemically-defined, serum-free medium would support stability of the NP cellular
phenotype, as evidenced by proteoglycan accumulation and type II collagen retention,
and growth factor supplementation would further improve matrix deposition and
functional material properties.

3.2. Materials and Methods
3.2.1. Macromer Synthesis
Methacrylated carboxymethylcellulose was synthesized through esterification of
hydroxyl groups based on previously described protocols13, 28, 29, 37 (Figure 3.1). Briefly,
a 20-fold excess of methacrylic anhydride (Sigma, St. Louis, MO) was reacted with a 1
wt% solution of 250 kDa CMC (Sigma) in RNAse/DNAse-free water over 24 hours at
4ºC. The pH was periodically adjusted to 8.0 using 3N NaOH to modify hydroxyl groups
of the polymer with functional methacrylate groups. The modified CMC solution was
purified via dialysis for 96 hours against RNAse/DNAse-free water (Spectra/Por1, MW
5-8 kDa, Rancho Dominguez, CA) to remove excess, unreacted methacrylic anhydride.
Purified methacrylated CMC was recovered by lyophilization and stored at -20ºC. The
degree of substitution was confirmed using 1H-NMR (360 MHz, DMX360, Bruker,
Madison, WI) following acid hydrolysis of purified methacrylated CMC37.

Molar

percent of methacrylation was determined by the relative integrations of methacrylate
proton peaks (methylene, δ = 6.2 ppm and 5.8 ppm and the methyl peak, δ = 2.0 ppm) to
carbohydrate protons.
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Figure 3.1. Schematic of the synthesis of methacrylated CMC and nucleus pulposus cell
encapsulation.

3.2.2. Primary Cell Culture and Isolation
All cell culture supplies, including media, antibiotics, and buffering agents, were
purchased from Invitrogen (Carlsbad, CA) unless otherwise noted. Discs C2-C4 were
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isolated from bovine caudal IVDs obtained from a local abattoir, and the NP was
separated through gross visual inspection based on previous protocols38, 39. Tissue was
maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 20%
FBS (Hyclone, Logan, UT), 0.075% sodium bicarbonate, 100 U/mL penicillin, 100
µg/mL streptomycin, and 0.25 µg/mL Fungizone reagent at 37°C, 5% CO2 for two days
prior to digestion to ensure no contamination occurred during harvesting. A single serum
lot was used for all experiments to reduce potential variability in the cellular response.
Tissue was diced and NP cells were released by collagenase (Type IV, Sigma)
digestion at an activity of 7000 U collagenase per gram of tissue. Following incubation
in collagenase, undigested tissue was removed using a 40 µm mesh filter. Cells from
multiple levels (C2-C4) were pooled and rinsed in sterile Dulbecco’s Phosphate Buffered
Saline (DPBS). These primary cells were plated onto tissue culture flasks, designated as
passage 0, and maintained in DMEM with 10% FBS, 0.075% sodium bicarbonate, 100
U/mL penicillin, and 100 µg/mL streptomycin (growth medium). Cells were subcultured
twice to obtain the necessary number of cells, and passage 2 cells38 were used in all
experiments, as these cells have been shown to retain phenotypic differences observed in
vivo up to the second passage39. Medium was changed three times per week.
3.2.3. Cell Encapsulation in Photocrosslinked Hydrogels
Prior to dissolution, lyophilized methacrylated CMC was sterilized by a 30minute exposure to germicidal UV light. The sterilized product was then dissolved to
2.75%

in

filter-sterilized

0.05

wt%

photoinitiator,

2-hydroxy-1-[4-(2-

hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, I2959, Ciba Specialty
Chemicals, Basel, Switzerland), in sterile DPBS at 4°C.

Passage 2 NP cells were
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resuspended in a small volume of 0.05% I2959 and then homogeneously mixed with
dissolved methacrylated CMC at 30 × 106 cells/mL for a final concentration of 2.5%.
The seeding density was selected based on previous studies using cell-seeded constructs
for engineering of cartilaginous tissues40-45. The 2.5% CMC solution was cast in a
custom-made glass casting device and exposed to long-wave UV light (EIKO, Shawnee,
KS, peak 368 nm, 1.2W) for 10 minutes to produce covalently crosslinked hydrogel disks
of 5-mm diameter x 2-mm thickness. Each hydrogel was incubated in 1.5 mL of growth
medium at 37ºC, 5% CO2. At day 1, growth medium was fully exchanged with the
respective media formulations utilized for the remainder of the study.
formulations of media were compared.

Two base

Growth medium, described above, was

supplemented with 50 µg/mL L-ascorbic acid as previously described37 and is designated
as DMEM. Chemically defined medium (CDM) was comprised of Dulbecco’s Modified
Eagle Medium with 1% insulin-transferrin-selenium + universal culture supplement (BD
Biosciences, San Jose, CA), 100 U/mL penicillin, 100 µg/mL streptomycin, 40 µg/mL Lproline (Sigma), 1 mM sodium pyruvate (Mediatech, Inc., Manassas, VA), 50 µg/mL
ascorbic acid 2-phosphate (Sigma), and 100 nM dexamethasone (Sigma)46. Both base
formulations (DMEM and CDM) were further supplemented with 10 ng/mL rhTGF-β3
(R&D Systems, Minneapolis, MN). These formulations are referred to as DMEM+ and
CDM+, respectively. The TGF-β3 concentration utilized was chosen based on previous
IVD and cartilage tissue engineering studies9, 11, 12, 46, 47. Media were changed three times
per week.
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3.2.4. Swelling Ratio
The equilibrium weight swelling ratio, Qw, was calculated at days 3, 14, and 28
(n=4). Constructs were weighed to determine the wet weight (Ws), lyophilized, and then
weighed again to measure the dry weight (Wd). Qw was calculated using the following
equation:
Qw = Ws/Wd
3.2.5. Biochemistry
Following lyophilization, total protein and DNA (n=4) were extracted at days 3,
14, and 28 by pepsin digestion based on previous studies39. Briefly, lyophilized samples
were homogenized and treated with pepsin (Sigma) in 0.05N acetic acid (1.9 mg/mL) for
48 hrs at 4ºC. Afterwards, pepsin was neutralized by the addition of 10X tris buffered
saline. Cell-free hydrogels (n=3) were maintained for all groups to serve as negative
controls.

Total DNA content was measured using the PicoGreen DNA assay48

(Molecular Probes, Eugene, OR) with calf thymus DNA (Sigma) as the standard39.
Samples were analyzed at 480 nm excitation and 520 nm emission using a Bio-Tek
Instruments microplate reader (Synergy HTTM, Winooski, VT).
Total sulfated glycosaminoglycan (GAG) content was measured at days 3, 14, and
28 using the 1,9 dimethylmethylene blue (DMMB) assay49.

The DMMB dye was

reduced to pH 1.5 to minimize the formation of CMC carboxyl group-DMMB dye
complexes50 and absorbance was determined at 595 nm using a chondroitin-6 sulfate
standard curve (Sigma).
Collagen production was quantified at day 28 via an indirect enzyme-linked
immunosorbent assay using monoclonal antibodies to type I collagen (COL I, Sigma) and
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type II collagen (COL II) (II-II6B3, Developmental Studies Hybridoma Bank, University
of Iowa, Iowa City, IA) based on previous protocols39. Protein values for each sample
were determined using a standard curve generated from bovine COL I and COL II
(Rockland Immunochemicals, Gilbertsville, PA). Absorbance was measured at 450 nm.
DNA, GAG, and collagen content are presented normalized to wet weight.
3.2.6. Histology and Immunohistochemistry
Constructs were fixed for 45 minutes in acid formalin at room temperature and
processed for paraffin embedding after graded serial ethanol dehydration. Samples were
sectioned at a thickness of 8 µm using a Leica microtome (Model 2030, Nussloch,
Germany), and hematoxylin and eosin staining was conducted to visualize cellular
distribution throughout the hydrogel. Immunohistochemical analyses were performed to
assess extracellular matrix accumulation according to previous studies39.

Briefly,

monoclonal antibodies to COL I (1:200 dilution in blocking solution, comprised of 10%
horse serum diluted in DPBS), COL II (1:3 dilution in blocking solution, composed of
10% horse serum diluted in DPBS), and chondroitin sulfate proteoglycan (1:100 dilution
in blocking solution, consisting of 10% goat serum diluted in DPBS) (CSPG, Sigma)
were used. A peroxidase-based system (Vectastain Elite ABC, Vector Labs) and 3,3’
diaminobenzidine (Vector Labs) as the chromagen were employed to visualize ECM
localization. Non-immune controls were processed without primary antibody. Samples
were viewed with a Zeiss Axioskop 40 optical microscope and images were captured
using AxioVision software (Carl Zeiss, Inc., Thornwood, NY).
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3.2.7. Mechanical Testing
Unconfined compression testing was conducted on CMC hydrogels (n=5) at day
28 using a custom-built apparatus, as previously described13,

37, 51

.

Briefly, the

unconfined compression testing protocol was comprised of a creep test followed by a
multi-ramp stress-relaxation test. The creep test consisted of a 1 g tare load applied at a
10 µm/s ramp velocity for 1800 seconds until equilibrium was reached (equilibrium
criteria: <10 µm change in 10 minutes). Transient creep strain at 30 seconds after the
onset of the tare load (εt=30s) and the equilibrium creep strain (εeq) in the axial direction
were determined by measuring the change in specimen thickness at the respective time
point divided by the initial, unloaded thickness. Following creep, the multi-ramp stressrelaxation test consisted of three 5% strain ramps at a 10 µm/s ramp velocity, each
followed by a 2000 second relaxation period (equilibrium criteria: <0.5 g change in 10
minutes). Peak stress (σpk) and equilibrium stress (σeq) were measured at the third ramp,
corresponding to 15% strain, and were used to calculate % relaxation:

 σ 
% Relaxation = 1− eq  ×100%
 σ pk 
Equilibrium stress was calculated at each ramp using surface area measurements and
plotted against the applied strain. An average equilibrium Young’s modulus, Ey, was
calculated from the slope of the stress versus strain curves and reported for each sample.
3.2.8. Statistical Analysis

A three-way ANOVA was used to determine the effects of time, medium, and
TGF-β3 on wet weight, dry weight, Qw, DNA content, and GAG accumulation (n=4). A
Tukey’s post-hoc test was performed on the three-factor interaction.

A two-way
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ANOVA was used to determine the effects of medium and TGF-β3 on collagen content
(n=4), thickness, diameter, and mechanical properties (n=5) at day 28. A Tukey’s posthoc test was performed on the two-factor interaction. Significance was set at p<0.05.
Data represent the mean ± standard deviation. All statistical analyses were performed
using JMP software (SAS Institute, Cary, NC).

3.3. Results

250 kDa CMC was methacrylated at a 5.63% modification, as verified by 1HNMR.

Constructs were isolated at days 3, 14, and 28 to determine swelling ratio

measurements, DNA content, and GAG accumulation. TGF-β3-treated groups (DMEM+
and CDM+) experienced significant increases in both wet weight and dry weight at each
time point, while measurements for untreated groups (DMEM and CDM) remained
unchanged from day 3 values and significantly lower in comparison (Table 3.1). A
significant temporal decrease in Qw was measured for DMEM+ and CDM+ groups,
whereas the swelling ratio of corresponding untreated samples stayed constant and
markedly higher.

DNA content significantly decreased in DMEM constructs but

increased in both TGF-β3 supplemented groups and was highest in DMEM+ samples.
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Table 3.1. Physical properties and normalized DNA content of CMC constructs (n=4) at days 3,
14, and 28 as a function of medium formulation. * Significant vs. all other time points within
group. + Significant vs. corresponding TGF-β3-treated group (i.e., DMEM vs. DMEM+) within
time point. # Significant vs. opposing media type (i.e., DMEM+ vs. CDM+) within time point.
† Significant vs. D14 within group.

GAG accumulation significantly increased over time in both TGF-β3-treated
groups and was highest in CDM+ constructs (Figure 3.2). There was no quantifiable
GAG content in untreated DMEM hydrogels and no effect of medium formulation when
comparing untreated groups (DMEM versus CDM).
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Figure 3.2. Normalized GAG content (n=4) at days 3, 14, and 28 as a function of medium
formulation.

* Significant vs. all other time points within group.

+ Significant vs.

corresponding TGF-β3-treated group (i.e., DMEM vs. DMEM+) within time point. # Significant
vs. opposing media type (i.e., DMEM+ vs. CDM+) within time point.

Immunohistochemical analyses conducted at day 28 revealed limited pericellular
deposition of CSPG in untreated DMEM samples with enhanced interterritorial staining
for DMEM+ constructs (Figure 3.3 A, B). Although staining was more intense in CDM
samples, CSPG deposition remained highly concentrated in lacunae whereas CDM+
groups exhibited uniform interterritorial CSPG accumulation throughout the construct
(Figure 3.3D). Non-immune control samples exhibited no positive staining.
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Figure 3.3. Immunohistochemical staining for CSPG content of CMC constructs at day 28
cultured in DMEM (A, B) and CDM (C, D) with (B, D) and without (A, C) TGF-β3, with
representative non-immune control inlayed in Panel A. Bar = 50 µm.

At 28 days, quantification of COL II accumulation was significantly greater in
both CDM groups in comparison to corresponding DMEM samples and was highest in
CDM+ constructs (Figure 3.4A). There was no detectable COL II in untreated DMEM
samples. These measurements were verified by COL II immunohistochemistry. By day
28, there was still no detectable COL II staining in untreated DMEM samples and light,
pericellular staining at the periphery of DMEM+ samples (Figure 3.4 B, C). Both CDM
groups were positive for pericellular COL II throughout the construct, with the most
intense staining observed for CDM+ samples (Figure 3.4E).

Non-immune controls

exhibited no positive staining.
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Figure 3.4. Normalized COL II content (n=4) (A) and immunohistochemical staining at day 28
for CMC constructs cultured in DMEM (B, C) and CDM (D, E) with (C, E) and without (B, D)
TGF-β3, with representative non-immune control inlayed in Panel B.

Bar = 50 µm.

+

Significant vs. corresponding TGF-β3-treated group (i.e., DMEM vs. DMEM+). # Significant
vs. opposing media type (i.e., DMEM+ vs. CDM+).

Type I collagen content was highest in DMEM+ samples after 28 days, while
there

was

no

detectable

COL

I

in

either

CDM

group

(Figure

3.5A).

Immunohistochemical analyses revealed light COL I deposition at the periphery of
DMEM and DMEM+ samples (Figure 3.5 B, C).

In addition, DMEM+ constructs

possessed a thick (100-200 µm) outer ring of fibroblastic cells, which stained positive for
COL I (Figure 3.5C), while there was minimal COL I staining observed in either CDM
group. As with CSPG and COL II, non-immune control samples exhibited no positive
staining.
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Figure 3.5. Normalized COL I content (n=4) (A) and immunohistochemical staining of the
scaffold periphery at day 28 for CMC constructs cultured in DMEM (B, C) and CDM (D, E)
with (C, E) and without (B, D) TGF-β3, with representative non-immune control inlayed in
Panel E. Bar = 50 µm. + Significant vs. corresponding TGF-β3-treated group (i.e., DMEM vs.
DMEM+). # Significant vs. opposing media type (i.e., DMEM+ vs. CDM+).

Constructs were tested in unconfined compression at day 28 to determine the
mechanical properties. Hydrogel diameter and thickness measurements in both TGF-β3treated groups (DMEM+ and CDM+) were significantly greater than those for
corresponding untreated groups and were largest in CDM+ constructs, as TGF-β3-treated
constructs grew in both the radial and axial directions (Table 3.2).

Table 3.2. Diameter and thickness measurements of mechanical testing samples (n=5) at day 28
as a function of medium formulation. + Significant vs. corresponding TGF-β3-treated group
(i.e., DMEM vs. DMEM+). # Significant vs. opposing media type (i.e., DMEM+ vs. CDM+).
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Sample thickness was assessed thirty seconds after the application of a one gram
tare load in the creep test to determine the transient strain in the axial direction, εt=30s
(Figure 3.6A). Untreated DMEM constructs experienced the most deformation shortly
after loading (εt=30s: 13.074 ± 0.958%) while there was no significant difference between
TGF-β3-treated groups (DMEM+ vs. CDM+, 3.642 ± 0.623%). The equilibrium creep
strain, εeq, followed the same trend (Figure 3.6A), with untreated DMEM samples
displaying the greatest deformation (13.91 ± 0.494%), with no significant difference
between TGF-β3 supplemented groups (average deformation = 4.46 ± 0.80%).

Figure 3.6. Mechanical properties (A) of CMC constructs (n=5) at day 28, as demonstrated by
the transient (30s after loading) and equilibrium creep strain (εt=30s and εeq, respectively), and
peak stress (σpk), equilibrium stress (σeq), and percent relaxation at 15% strain. Representative
stress vs. time curves for DMEM+ (B) and CDM+ (C) samples. + Significant vs. corresponding
TGF-β3-treated group (i.e., DMEM vs. DMEM+). # Significant vs. opposing media type (i.e.,
DMEM+ vs. CDM+).

98

After creep, samples were subjected to a multi-ramp stress-relaxation test.
DMEM+ constructs exhibited the highest σpk (7.788 ± 1.842 kPa), almost a full order of
magnitude greater than untreated groups (Figure 3.6A). However, DMEM+ constructs
were unable to sustain this stress and displayed a rapid relaxation (Figure 3.6B) which
corresponded to the highest % relaxation among all groups. Conversely, CDM+ samples
maintained a higher σeq to σpk ratio (Figure 3.6C), with a % relaxation significantly less
than DMEM+ scaffolds. The equilibrium Young’s modulus was significantly greater in
both TGF-β3-treated groups and was highest for CDM+ (CDM+: 18.54 ± 1.92 kPa;
DMEM+: 11.82 ± 0.92 kPa) (Figure 3.7). TGF-β3-treated constructs were most opaque
in gross appearance, with the highest degree of opacity observed for CDM+ constructs
(Figure 3.7). There was no effect of medium formulation on diameter, thickness, σeq, σpk,
% relaxation, or Ey values when comparing untreated groups (DMEM versus CDM).

99

Figure 3.7. Equilibrium Young’s modulus of CMC constructs (n=5) at day 28 as a function of
medium formulation with representative corresponding stereomicrograph images shown below.
Scale in mm. + Significant vs. corresponding TGF-β3-treated group (i.e., DMEM vs. DMEM+).
# Significant vs. opposing media type (i.e., DMEM+ vs. CDM+).

3.4. Discussion

This study is the first to examine the effects of medium formulation and growth
factor supplementation on NP cells encapsulated in CMC hydrogels. Although serumfree, chemically-defined medium alone produced increased COL II accumulation and
improved CSPG distribution, there were no significant differences in GAG quantification
or mechanical properties when comparing CDM and DMEM constructs. However, COL
II elaboration is a key distinguishing characteristic when comparing cartilaginous tissue,
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such as the NP, to fibrous tissue, thereby indicating a trend in support of our first
hypothesis. Consistent with our second hypothesis, we demonstrated that serum-free,
chemically-defined medium supplemented with TGF-β3 resulted in increased GAG and
COL II accumulation and maintenance of the NP cellular phenotype, as well as enhanced
functional properties (i.e., Ey). These findings underscore the importance of medium
formulation on the development of engineered NP constructs.
CMC is a well-established derivative of cellulose, which is rendered watersoluble through the introduction of carboxymethyl groups along the polymer backbone.
CMC is commercially available in high-purity forms, making it an appealing low-cost
alternative to other natural polysaccharides (i.e., hyaluronic acid and chondroitin sulfate)
and inert polymers, such as poly(ethylene glycol), currently used in tissue engineering
applications. Additionally, as a derivative of the plant-based polysaccharide, cellulose,
CMC represents a renewable, environmentally-friendly biomaterial. At physiological
pH, the carboxylic acid of the carboxymethyl group is deprotonated, resulting in a
negatively-charged polymer network, similar to that provided by the GAGs in the ECM
of cartilaginous tissues, such as the NP. In addition, the hydrolysis of periodic ester
crosslinks between methacrylated CMC chains under physiologic conditions provides
void space for the accumulation of secreted matrix macromolecules while maintaining
sufficient structural integrity37. Furthermore, photocrosslinked CMC hydrogels have
been shown to support NP cell viability and promote phenotypic matrix production37.
In this study, the effects of two variables, medium formulation and
supplementation with TGF-β3, were examined by comparing a standard serum-containing
medium to a chemically-defined, serum-free medium first described by Mackay et al.46.
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In general, the addition of TGF-β3 resulted in enhanced matrix deposition by both groups
(DMEM+ and CDM+), in support of our hypothesis. As a result of the marked temporal
increases in wet and dry weight, Qw for both TGF-β3-treated groups at day 28 was 22.44
± 0.71, closely approaching the Qw for the native NP tissue (19.94 ± 3.09, unpublished
data).
Although similar overall trends were observed in comparison to corresponding
untreated controls for both DMEM+ and CDM+ samples, the effect of base medium
(DMEM versus CDM) was clearest when measuring ECM components most often
associated with the NP phenotype. The combination of CDM and TGF-β3 resulted in
dramatic increases in GAG accumulation. By day 28, CDM+ samples retained 9.46 ±
1.51 µg GAG/mg wet weight, while DMEM+ constructs retained less than five times this
amount (1.80 ± 0.11 µg/mg) (Figure 3.2). This 28-day value for CDM+ samples is ~40%
of that obtained after 16 weeks of in vivo culture (24.14 ± 0.71 µg/mg) using a
subcutaneous murine pouch model for NP cells encapsulated in alginate at a similar
initial seeding density17. In addition, when normalized to dry weight, CDM+ GAG
content approaches 210 µg/mg, also ~40% of that measured in the native NP (~550
µg/mg)52.
The distinct effects of CDM media were also evident when examining collagen
production. There was no quantifiable COL II present in either untreated or TGF-β3treated DMEM groups, while both CDM groups displayed significant accumulation, in
support of our first hypothesis. COL II accumulation was highest in CDM+ samples,
though limited to pericellular deposition.

In addition, TGF-β3 supplementation of

DMEM resulted in a multilayered ring of fibroblastic cells encapsulating the CMC
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hydrogel which stained positive for COL I, contrary to the native NP phenotype (Figure
3.5C). The peripheral cell layer, not observed in any serum-free constructs, may have
contributed to the significant increase in DNA content observed for DMEM+ samples.
This phenomenon was also reported by Byers et al. when evaluating the effect of TGF-β3
supplemented DMEM on the development of engineered cartilage.

The authors

postulated that the external cell layer may have been due to the presence of serum
proteins and adhesion molecules which then promoted cell outgrowth and proliferation at
the construct periphery9.
The increased GAG and COL II deposition observed as a result of TGF-β3
supplementation also translated into enhanced functional mechanical properties for cellladen constructs.

Consistent with greater matrix deposition, DMEM+ and CDM+

constructs displayed the lowest axial deformation in creep. In examining the transient
mechanical response, DMEM+ constructs exhibited the highest σpk among all groups,
although σpk differed greatly from σeq for these samples. This disparity in the transient
versus equilibrium response may be due to the fibrous ring encircling DMEM+
constructs, as this extra reinforcing layer may have restricted radial distension in
compression, thereby requiring a greater force to achieve the given displacement for a
prescribed 15% strain. However, the fibrous outer layer was comprised primarily of type
I collagen, a protein most effective in resisting tensile forces, and DMEM+ constructs
were unable to sustain the compressive peak stress and subsequently underwent a rapid
relaxation. In contrast, CDM+ samples equilibrated at a stress closer to their peak stress,
indicating an ability to better withstand and carry loads. This property is particularly
important for the nucleus pulposus which is under almost constant load due to gravity and
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other physiological forces. In agreement with trends observed in GAG and COL II
quantification, Ey values were largest for CDM+ samples and significantly greater than
all other groups.
Although untreated CDM constructs produced small, but quantifiable amounts of
COL II by day 28, which was significantly greater than that produced by untreated
DMEM samples, there was no difference in Ey between the untreated groups. This may
be due to the fact that both DMEM and CDM constructs produced similar amounts of
water-retaining GAGs, as evidenced by the DMMB assay, allowing the scaffold to resist
comparable compressive forces through the generation of a hydrostatic swelling pressure.
Although immunohistochemical staining indicated a better distributed, more intense
CSPG-containing matrix in untreated CDM cultures (Figure 3.3 A, C), this staining
technique employs an antibody specific to CSPG, whereas the DMMB assay detects all
sulfated GAGs.
The temporal effect of TGF-β3 delivery was also examined prior to completing
this larger study. A subset of DMEM and CDM samples were supplemented with TGFβ3 for the first two weeks of culture, at which time growth factor delivery was
discontinued and constructs were maintained in their respective, untreated medium for an
additional two weeks. Material and mechanical properties (Qw and Ey, respectively) as
well as biochemical content (GAGs and DNA) were greater for those specimens than for
untreated constructs at 4 weeks, but values were less than those measured for samples
with continuous TGF-β3 supplementation, regardless of medium formulation. These data
support the use of steady TGF-β3 treatment employed in the present investigation but
contradict the findings of Byers et al. who reported a superior maturation response of
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chondrocyte-laden agarose gels cultured with a transient, two-week exposure to TGF-β3
in serum-free medium9. However, given the differences in cell type and scaffold, it is
difficult to make direct comparisons between these two studies.
While growth factor supplementation is commonly recognized as a required
additive to stem cell differentiation medium, it is important to acknowledge its utility in
the culture of native cells as well. Various growth factors have been shown to affect IVD
cell matrix deposition. A systematic study by Alini et al. examined the effects of various
combinations of growth factors on annulus fibrosus (AF) and NP cells cultured on a 3-D
fibrous collagen-hyaluronan scaffold53. The growth factors examined included TGF-β1,
basic fibroblast growth factor (bFGF), and insulin-like growth factor (IGF)-1 in serumfree DMEM. This study found that although the combination of TGF-β1 and bFGF
produced the greatest increase in retained chondroitin sulfate, this value never exceeded
10% of the native NP, even after 60 days of culture. An investigation by Risbud et al.
compared the effects of TGF-β1 and TGF-β3 on whole disc culture in DMEM with 10%
fetal calf serum over one week and found that TGF-β3 produced a differential increase in
the expression of critical matrix genes and elevated proteoglycan synthesis11. A study by
Zhang et al. examined the effects of TGF-β1 and IGF-1 on NP proliferation when grown
in monolayer in F12 medium with 1% or 10% FBS54. This work noted morphologic
changes characteristic of nutrient deficiency when cultured in 1% FBS; however, cell
morphology returned to normal when the low serum medium was supplemented with
TGF-β1. Using a gene therapy approach, Lee and coworkers conducted an experiment
examining the efficacy of pellet culture as an alternative to alginate bead culture,
assessing matrix production by IVD cells transduced with a TGF-β1 adenovirus55. After
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3 weeks in vitro, both culture systems experienced increased proteoglycan synthesis with
the most pronounced increases observed in pellet culture.

In our investigation, we

utilized a serum-free, chemically-defined medium formulation supplemented with TGFβ3 based on previous work in which articular chondrocytes encapsulated in agarose
hydrogels exhibited improved matrix elaboration and mechanical properties under such
conditions9,

12

. Further experiments may evaluate the response to additional growth

factors, including IGF-1 and bFGF, by NP cells encapsulated in CMC hydrogels.
As with all experiments, there were potential limitations to this study. The effects
of many growth factors on cells of the IVD, including bFGF, IGF-1, and TGF-β1, have
been previously examined and are described above. Our study focused on the effect of
just one growth factor, TGF-β3. However, this molecule was chosen because it has been
shown to be highly effective in promoting a chondrogenic phenotype when delivered
using serum-free medium9, 12. Another limitation to this study is that matrix biosynthesis
was not assessed, rather, only matrix accumulation.

Quantifying matrix production

through radiolabeling techniques and assaying the culture medium for GAG and collagen
content would allow us to discern whether increased ECM biosynthesis or the ability of
the scaffold to retain elaborated matrix molecules were responsible for the development
of improved functional properties of CDM+ constructs. Additionally, examining gene
expression would help determine if the differences observed in protein accumulation as a
function of medium and growth factor supplementation are initiated at the transcriptional
level.
Although many studies have described enhanced matrix deposition by IVD cells
following growth factor supplementation, the effects of these cytokines on the functional
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properties of the tissue-engineered constructs were not evaluated. Our study has shown a
differential effect of both medium formulation and TGF-β3 supplementation on cell-laden
CMC hydrogel constructs, as the combination of serum-free medium and TGF-β3
produced marked increases in GAG and COL II content and Ey, with the measured value
of Ey comparable to that reported for the native NP56. However, straight comparisons
between studies are difficult due to the differences in medium formulation and scaffold
selection.

Future work will examine the effects of mechanical stimulation (i.e.,

hydrostatic pressurization)57-62 to further increase GAG content in an attempt to match
that of the native NP and enhance COL II distribution, as pressure has been shown to
improve chondrogenic differentiation of mesenchymal stem cells when used in
conjunction with TGF-β3 supplemented, serum-free medium47. Additional studies will
assess matrix elaboration and functional properties of NP cell-laden CMC hydrogels
following in vivo subcutaneous implantation63, prior to use in a clinically relevant IVD
degeneration model.
Taken together, these findings suggest that photocrosslinked CMC hydrogels
support functional ECM assembly by encapsulated NP cells, which can be enhanced
when cultured in serum-free, chemically-defined medium supplemented with TGF-β3.
This system may eventually have application in intradiscal nucleus replacement therapy.
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Chapter 4: Hydrostatic Pressure Modulates Collagen Production but
Does Not Affect the Functional Properties of Nucleus Pulposus Cellladen Carboxymethylcellulose Hydrogel Constructs

4.1. Introduction

The intervertebral disc (IVD) is a fibrocartilaginous tissue located between the
vertebrae of the spine, which functions to permit motion and flexibility. The IVD is a
heterogeneous tissue comprised of the collagenous, lamellar annulus fibrosus, and the
central gel-like nucleus pulposus (NP). The NP is primarily composed of negatively
charged, water-retaining proteoglycans, such as aggrecan, and type II collagen, resulting
in a highly hydrated tissue that allows the IVD to support and distribute loads through the
generation of a hydrostatic swelling pressure1.
IVD degeneration, a pathological condition frequently associated with back pain,
often results from traumatic injury or occurs naturally with aging and is characterized by
a decrease in aggregating proteoglycans2. This alteration in the biochemical composition
of the disc results in a decreased ability to retain water, which thus renders the disc more
fibrous in structure and content3 and may hinder the ability to sustain loads placed upon
the body4. Similar to articular cartilage, the IVD is a largely avascular, aneural tissue,
dependent upon bulk diffusion for nutrient transport5. However, a fibrotic, degenerated
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IVD impedes nutrient diffusion and waste removal, which further compromises the
overall health of the tissue and additionally limits the capacity for self-repair.
Tissue engineering strategies may provide a biologic alternative capable of
restoring both the structure and mechanical function of the IVD.

Growth factor

supplementation can affect the maturation of such tissue engineered constructs, as has
been shown utilizing transforming growth factor-beta 3 (TGF-β3)6-8. TGF-β3 is known to
improve the functional properties of tissue engineered cartilage constructs, increasing the
compressive moduli and proteoglycan content of chondrocyte-seeded agarose hydrogels
to values comparable to native tissue levels7, 8. Additionally, work in our lab has shown
that serum-free, chemically-defined medium supplemented with TGF-β3 resulted in
increased glycosaminoglycan (GAG) and type II collagen accumulation and enhanced
functional

properties

by

NP

cells

encapsulated

in

photocrosslinked

carboxymethylcellulose (CMC) hydrogels6.
NP construct development may also be modulated through the application of
mechanical loads to mimic those experienced in vivo. Deformational loading applied at
physiologic magnitudes and frequencies has been reported to have beneficial effects,
increasing production of extracellular matrix (ECM) macromolecules, including type II
collagen and GAGs, and decreasing production of catabolic factors in the NP9,

10

.

Hydrostatic pressurization has similarly been shown to affect matrix production by NP
tissue. An early study by Ishihara et al. found a stimulatory effect of a short term (20s)
application of 1 MPa hydrostatic pressure, while pressurization at 10 MPa inhibited
sulfate incorporation of NP tissue fractions11. A subsequent investigation by Handa et al.
determined that physiologic levels of hydrostatic pressure stimulated proteoglycan
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synthesis in NP tissue fractions while inhibiting production of matrix metalloproteinases
(MMPs)12. Pressures applied outside of the physiologic range of 0.1-3 MPa reduced
proteoglycan synthesis and increased the production of catabolic factors.
Hydrostatic pressure has also been shown to enhance the development of IVD
tissue engineered constructs when applied in vitro. NP cells encapsulated in collagen or
polysaccharide-based hydrogel scaffolds have been reported to respond to hydrostatic
pressurization with increased production of collagen and GAGs when subjected to
physiologic ranges of mechanical stimulation (0.1 – 3.0 MPa)13-16. For example, a study
by Neidlinger-Wilke et al. found that NP cells encapsulated in collagen gels increased
aggrecan gene expression and decreased expression of MMPs in response to 0.25 MPa
hydrostatic pressure applied at a frequency of 0.1 Hz15.
Recent studies have also examined the effect of combining growth factor
supplementation and mechanical stimulation on the matrix production and functional
properties of engineered constructs for various orthopaedic tissues.

Mauck et al.

investigated the effects of dynamic deformational loading and supplementation with
TGF-β1 or insulin-like growth factor-1 on the development of articular chondrocytes
seeded in agarose and showed a synergistic effect, as proteoglycan and collagen content
and mechanical properties all increased over controls when subjected to mechanical
stimulation in the presence of growth factors17.

Elder and Athanasiou also found a

synergistic effect between static hydrostatic pressure and TGF-β1 supplementation on
GAG accumulation, collagen content, and functional properties of articular chondrocytes
encapsulated in agarose hydrogels18. Gunjaa et al. similarly reported increased collagen
and GAG deposition and enhanced compressive properties of meniscus cell-seeded
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poly(L-lactic acid) scaffolds that were subjected to static hydrostatic pressure and
cultured with TGF-β119.
Therefore, the objective of this study was to examine the effects of hydrostatic
pressurization and TGF-β3 supplementation on the matrix production and functional
properties of NP cells encapsulated in photocrosslinked CMC hydrogels.

We

hypothesized that the application of dynamic hydrostatic pressure would increase the
matrix accumulation (GAGs, type II collagen) and functional properties of NP cell-laden
constructs and that these values would be further enhanced by TGF-β3 supplementation.

4.2. Materials and Methods
4.2.1. Macromer Synthesis

Methacrylated carboxymethylcellulose was synthesized through esterification of
hydroxyl groups based on previously described protocols20-23. Briefly, a 20-fold excess
of methacrylic anhydride (Sigma, St. Louis, MO) was reacted with a 1 wt% solution of
250 kDa CMC (Sigma) in RNAse/DNAse-free water over 24 hours at 4ºC. The pH was
periodically adjusted to 8.0 using 3N NaOH to modify hydroxyl groups of the polymer
with functional methacrylate groups. The modified CMC solution was purified via
dialysis for 96 hours against RNAse/DNAse-free water (Spectra/Por1, MW 5-8 kDa,
Rancho Dominguez, CA) to remove excess, unreacted methacrylic anhydride. Purified
methacrylated CMC was recovered by lyophilization and stored at -20ºC. The degree of
substitution was confirmed using 1H-NMR (360 MHz, DMX360, Bruker, Madison, WI)
following acid hydrolysis of purified methacrylated CMC22.

Molar percent of
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methacrylation was determined by the relative integrations of methacrylate proton peaks
(methylene, δ = 6.2 ppm and 5.8 ppm and the methyl peak, δ = 2.0 ppm) to carbohydrate
protons.
4.2.2. Primary Cell Culture and Isolation

All cell culture supplies, including media, antibiotics, and buffering agents, were
purchased from Invitrogen (Carlsbad, CA) unless otherwise noted. Discs C2-C4 were
isolated from bovine caudal IVDs obtained from a local abattoir, and the NP was
separated through gross visual inspection based on previous protocols24, 25. Tissue was
maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 20%
fetal bovine serum (FBS) (Hyclone, Logan, UT), 0.075% sodium bicarbonate, 100 U/mL
penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL Fungizone reagent at 37°C, 5% CO2
for two days prior to digestion to ensure no contamination occurred during harvesting. A
single serum lot was used for all experiments to reduce potential variability in the cellular
response.
Tissue was diced and NP cells were released by collagenase (Type IV, Sigma)
digestion at an activity of 7000 U collagenase per gram of tissue. Following incubation
in collagenase, undigested tissue was removed using a 40 µm mesh filter. Cells from
multiple levels (C2-C4) were pooled and rinsed in sterile Dulbecco’s Phosphate Buffered
Saline (DPBS). These primary cells were plated onto tissue culture flasks, designated as
passage 0, and maintained in DMEM with 10% FBS, 0.075% sodium bicarbonate, 100
U/mL penicillin, and 100 µg/mL streptomycin (growth medium). Cells were subcultured
twice to obtain the necessary number of cells, and passage 2 cells24 were used in all
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experiments, as these cells have been shown to retain phenotypic differences observed in
vivo up to the second passage25. Medium was changed three times per week.
4.2.3. Cell Encapsulation in Photocrosslinked Hydrogels

Lyophilized methacrylated CMC was sterilized by a 30-minute exposure to
germicidal UV light. The sterilized product was then dissolved to 2.75% in filtersterilized 0.05 wt% photoinitiator, 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl1-propanone (Irgacure 2959, I2959, Ciba Specialty Chemicals, Basel, Switzerland), in
sterile DPBS at 4°C. Passage 2 NP cells were resuspended in a small volume of 0.05%
I2959 and then homogeneously mixed with dissolved methacrylated CMC at 30 × 106
cells/mL for a final concentration of 2.5%. The seeding density was selected based on
previous studies using cell-seeded constructs for engineering of cartilaginous tissues26-30.
The 2.5% CMC solution was cast in a custom-made glass casting device and exposed to
long-wave UV light (EIKO, Shawnee, KS, peak 368 nm, 1.2W) for 10 minutes to
produce covalently photocrosslinked hydrogel disks of 5-mm diameter x 2-mm thickness.
Each hydrogel was incubated in 1.5 mL of growth medium at 37ºC, 5% CO2. At day 1,
growth medium was fully exchanged with chemically defined medium (CDM-), which
was comprised of DMEM with 1% insulin-transferrin-selenium + universal culture
supplement (BD Biosciences, San Jose, CA), 100 U/mL penicillin, 100 µg/mL
streptomycin, 40 µg/mL L-proline (Sigma), 1 mM sodium pyruvate (Mediatech, Inc.,
Manassas, VA), 50 µg/mL ascorbic acid 2-phosphate (Sigma), and 100 nM
dexamethasone (Sigma)31. CDM- was further supplemented with 10 ng/mL rhTGF-β3
(R&D Systems, Minneapolis, MN) (CDM+). The TGF-β3 concentration utilized was
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chosen based on previous IVD and cartilage tissue engineering studies7, 8, 31-33. Media
were changed three times per week.
4.2.4. Dynamic Hydrostatic Pressurization

Constructs cultured in CDM- or CDM+ were subjected to dynamic hydrostatic
pressure at a magnitude of 2 or 5 MPa and a frequency of 0.5 Hz for four hours a day,
five days a week, based on prior studies34-36 and were designated as Dyn- or Dyn+.
Loading began at day 3 and continued through day 28. Scaffolds were transferred to UVsterilized, heat-sealed bags (Daigger, Vernon Hills, IL) filled with 10 mL of CDMduring the four hour loading period, and were placed in a water-filled pressure chamber
housed at 37°C. Unloaded bagged control (BC) specimens for each condition (i.e., BCand BC+) were similarly placed in UV-sterilized, heat-sealed bags and maintained in a
vessel filled with warmed distilled water in the incubator that contained the pressure
device, but were not subjected to mechanical stimulation. After 4 hours, all samples
(BC-, BC+, Dyn-, and Dyn+) were removed from the heat-sealed bags, returned to their
respective medium formulations, and cultured in tissue culture polystyrene dishes under
standard culture conditions (37°C, 5% CO2).
A custom-designed, stainless steel hydrostatic pressure device based on a prior
design was used to apply the specified dynamic loading conditions37. The device consists
of a stainless steel pressure chamber filled with distilled water, connected to a stainless
steel piston. The piston rod is driven via an air cylinder controlled by double acting
solenoid valves in line with a compressed air source (SilentAire Technology, Houston,
TX). The device was purged of air bubbles through the repeated advancement of the
piston against the chamber medium. Experimental samples were placed in the chamber
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medium; the chamber was then filled completely and sealed. Pressure magnitude was
specified by the user and feedback-controlled by a LabVIEW program (National
Instruments, Austin, TX) custom-written for this application. Frequency was controlled
by varying the inlet pressure of air to the device.
Magnitude and frequency were verified using a custom-written MATLAB
program. Average maximum and minimum pressures for the 2 MPa study were 2.05 +
0.17 MPa and 0.12 + 0.02 MPa, respectively, while the average frequency was 0.55 +
0.09 Hz. The average maximum and minimum pressures for the 5 MPa study were 4.98
+ 0.05 MPa and 0.21 + 0.03 MPa, respectively, with an average frequency of 0.49 + 0.02
Hz. The hydrostatic pressure chamber and bagged control samples were housed in an
incubator at 37○C. The hydrostatic pressure device and representative dynamic loading
cycles at 2 and 5 MPa are shown in Figure 4.1.

Figure 4.1. Hydrostatic pressure device (A) and representative 2 MPa (B) and 5 MPa (C)
dynamic loading cycles.
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4.2.5. Swelling Ratio

The equilibrium weight swelling ratio, Qw, was calculated at day 3 (prior to the
start of loading) and day 28 (n=4). Constructs were weighed to determine the wet weight
(Ws), lyophilized, and then weighed again to measure the dry weight (Wd). Qw was
calculated using the following equation:
Qw = Ws/Wd
4.2.6. Biochemistry

Following lyophilization, total protein and DNA (n=4) were extracted at days 3
and 28 by pepsin digestion based on previous studies25. Briefly, lyophilized samples
were homogenized and treated with pepsin (Sigma) in 0.05N acetic acid (1.9 mg/mL) for
48 hrs at 4ºC. Afterwards, pepsin was neutralized by the addition of 10X tris buffered
saline. Cell-free hydrogels (n=3) were maintained for all groups to serve as negative
controls.

Total DNA content was measured using the PicoGreen DNA assay38

(Molecular Probes, Eugene, OR) with calf thymus DNA (Sigma) as the standard25.
Samples were analyzed at 480 nm excitation and 520 nm emission using a Bio-Tek
Instruments microplate reader (Synergy HTTM, Winooski, VT).
Total sulfated GAG content was measured at day 3 and day 28 using the 1,9
dimethylmethylene blue (DMMB) assay39. The DMMB dye was reduced to pH 1.5 to
minimize the formation of CMC carboxyl group-DMMB dye complexes40 and
absorbance was determined at 595 nm using a chondroitin-6 sulfate standard curve
(Sigma).
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Collagen production was quantified at days 3 and 28 via an indirect enzymelinked immunosorbent assay using monoclonal antibodies to type I collagen (COL I,
Sigma) and type II collagen (COL II) (II-II6B3, Developmental Studies Hybridoma
Bank, University of Iowa, Iowa City, IA) based on previous protocols25. Protein values
for each sample were determined using a standard curve generated from bovine COL I
and COL II (Rockland Immunochemicals, Gilbertsville, PA). Absorbance was measured
at 450 nm. DNA, GAG, and collagen content are presented normalized to wet weight.
4.2.7. Histology and Immunohistochemistry

Constructs were fixed for 45 minutes in acid formalin at room temperature and
processed for paraffin embedding after graded serial ethanol dehydration. Samples were
sectioned at a thickness of 8 µm using a Leica microtome (Model 2030, Nussloch,
Germany), and hematoxylin and eosin staining was conducted to visualize cellular
distribution throughout the hydrogel. Immunohistochemical analyses were performed to
assess ECM accumulation according to previous studies25.

Briefly, monoclonal

antibodies to COL I (1:200 dilution in blocking solution, comprised of 10% horse serum
diluted in DPBS), COL II (1:3 dilution in blocking solution, composed of 10% horse
serum diluted in DPBS), and chondroitin sulfate proteoglycan (1:100 dilution in blocking
solution, consisting of 10% goat serum diluted in DPBS) (CSPG, Sigma) were used,
followed by incubation in biotinylated horse/anti-mouse IgG/anti-rabbit IgG (H+L) (COL
I, COL II) or biotinylated goat/anti-mouse IgM (CSPG) secondary antibody (1:50
dilution in blocking solution) (Vector Labs, Burlingame, CA).

A peroxidase-based

detection system (Vectastain Elite ABC, Vector Labs) and 3,3’ diaminobenzidine (Vector
Labs) were employed to visualize ECM localization.

Non-immune controls were
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processed in blocking solution without primary antibody. Samples were viewed with a
Zeiss Axioskop 40 optical microscope and images were captured using AxioVision
software (Carl Zeiss, Inc., Thornwood, NY).
4.2.8. Mechanical Testing

Unconfined compression testing was conducted on CMC hydrogels (n=5) isolated
at day 3, prior to the start of loading, and at day 28 using a custom-built apparatus, as
previously described21, 22, 41. Briefly, the unconfined compression testing protocol was
comprised of a creep test followed by a multi-ramp stress-relaxation test. The creep test
consisted of a 1 g tare load applied at a 10 µm/s ramp velocity for 1800 seconds until
equilibrium was reached (equilibrium criteria: <10 µm change in 10 minutes). The multiramp stress-relaxation test consisted of three 5% strain ramps at a 10 µm/s ramp velocity,
each followed by a 2000 second relaxation period (equilibrium criteria: <0.5 g change in
10 minutes).

Equilibrium stress was calculated at each ramp using surface area

measurements and plotted against the applied strain. An average equilibrium Young’s
modulus, Ey, was calculated from the slope of the stress versus strain curves and reported
for each sample.
4.2.9. Statistical Analysis

A three-way ANOVA was used to determine the effects of time, TGF-β3, and
hydrostatic pressure on wet weight, dry weight, Qw, DNA content, GAG and collagen
accumulation (n=4), and Ey (n=5). A Tukey’s post-hoc test was performed on the threefactor interaction. A two-way ANOVA was used to determine the effects of TGF-β3 and
pressure magnitude (2 MPa vs. 5 MPa) on DNA, GAG, and collagen content (n=4) and
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Ey (n=5) at day 28. A Tukey’s post-hoc test was performed on the two-factor interaction.
Significance was set at p<0.05. Data represent the mean ± standard deviation. All
statistical analyses were performed using JMP software (SAS Institute, Cary, NC). The
correlation (r) between GAG or COL II content and Ey was determined in EXCEL using
day 3 and day 28 measurements for all groups. The coefficient of determination (R2) was
calculated using a least-squares fitting process for a linear trend line.

4.3. Results

250 kDa CMC was methacrylated at a 5.63% modification, as verified by 1HNMR.

Cell-laden constructs were subjected to dynamic hydrostatic pressure at a

magnitude of 2 MPa. Samples were isolated at day 3, prior to beginning pressurization,
and at day 28, following the completion of the experiment. All groups (BC-, BC+, Dyn-,
and Dyn+) experienced a significant increase in wet weight over time; however, only
TGF-β3-treated samples exhibited a corresponding increase in dry weight (Table 4.1).
Wet weights and dry weights were highest in growth factor-treated samples in
comparison to their respective controls. A significant temporal decrease in Qw was
measured for BC+ and Dyn+ groups, whereas the swelling ratio of corresponding
untreated controls stayed constant and markedly higher.

DNA content significantly

decreased in BC- constructs but remained unchanged in Dyn- samples, while DNA
content increased in both TGF-β3-supplemented groups and was highest in Dyn+
samples.
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Table 4.1. Material properties and DNA content of 2 MPa constructs. +: significant effect of
time within group. *: significant vs. corresponding TGF-β3-treated group within time point
(i.e., BC- vs. BC+). #: significant vs. corresponding loaded group within time point (i.e., BCvs. Dyn-).

GAG content in BC- and Dyn- samples remained unchanged from day 3
measurements, while BC+ and Dyn+ constructs experienced a significant increase in
accumulation over time, indicating a marked effect of growth factor treatment (Figure
4.2A). However, there was no effect of mechanical stimulation detected in either group.
Immunohistochemical analyses of CSPG conducted at day 28 revealed uniform
interterritorial staining in both BC+ and Dyn+ samples (Figure 4.2 D, E). BC- and Dynconstructs also exhibited some interterritorial staining; however, CSPG deposition in
these samples remained strongly localized pericellularly in lacunae (Figure 4.2 B, C).
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Figure 4.2. GAG quantification (A) and day 28 CSPG deposition of unloaded controls (B, D)
and constructs pressurized at 2 MPa (C, E) with (D, E) and without (B, C) TGF-β3. Bar = 50
µm. +: significant effect of time within group. *: significant vs. corresponding TGF-β3-treated
group within time point (i.e., BC- vs. BC+).

There was no detectable COL I in any group throughout the study. COL II
content increased over time for all groups, with the highest normalized values observed in
BC- samples (Figure 4.3A). There was no effect of loading within TGF-β3-treated
groups.

Immunohistochemical analyses of samples at day 28 verified punctate,

intracellular COL II deposition in both BC- and Dyn- samples (Figure 4.3 B, C), while
staining in TGF-β3-treated groups displayed slightly enhanced distribution into the
pericellular matrix (Figure 4.3 D, E).
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Figure 4.3. COL II quantification (A) and day 28 deposition of unloaded controls (B, D) and
constructs pressurized at 2 MPa (C, E) with (D, E) and without (B, C) TGF-β3. Bar = 50 µm. +:
significant effect of time within group. *: significant vs. corresponding TGF-β3-treated group
within time point (i.e., BC- vs. BC+). #: significant vs. corresponding loaded group within time
point (i.e., BC- vs. Dyn-).

Constructs were tested in unconfined compression to determine the mechanical
properties. Hydrogel diameter and thickness measurements at day 28 remained
unchanged from day 3 values in BC- and Dyn- samples, with no significant effect of
pressurization (5.85 ± 0.13 mm and 2.48 ± 0.06 mm, respectively). By day 28, BC+ and
Dyn+ samples displayed increases in both diameter and thickness which were significant
in comparison to untreated counterparts (i.e., BC- and Dyn-); however, there was no
significant effect of pressurization (6.96 ± 0.20 mm and 3.30 ± 0.09 mm, respectively).
BC- and Dyn- constructs maintained initial mechanical properties over the 28-day study,
with no significant increase in Ey over time (Figure 4.4). BC+ and Dyn+ samples
exhibited a four-fold increase in Ey by day 28, which was significantly greater than their
corresponding untreated controls.

131

Figure 4.4. Equilibrium Young’s modulus of unloaded controls and constructs pressurized at 2
MPa. +: significant effect of time within group. *: significant vs. corresponding TGF-β3treated group within time point (i.e., BC- vs. BC+).

There was no effect of pressurization on the mechanical properties of either untreated or
TGF-β3-treated scaffolds. Overall, there was a significant positive, linear correlation (r)
between GAG content and Ey (r = 0.98, R2 = 0.96), while the correlation between COL II
deposition and Ey was not as pronounced (r = 0.68, R2 = 0.46) (Figure 4.5).

Figure 4.5. Correlation analyses of matrix content and the functional properties of 2 MPa
constructs.
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Given that hydrostatic pressure applied within the physiologic range (2 MPa) had
no effect, the study was repeated at a hyperphysiologic magnitude of 5 MPa. All groups
in the 5 MPa experiment experienced a significant increase in wet weight over time,
while only TGF-β3-treated groups experienced a corresponding temporal increase in dry
weight (Table 4.2). Wet weight and dry weight values at day 28 were highest in BC+ and
Dyn+ samples, indicating a significant effect of growth factor treatment, with no effect of
loading observed. BC+ and Dyn+ constructs also exhibited a significant decrease in Qw
over time, while Qw stayed at initial values and was significantly higher in BC- and Dynsamples, with no effect of pressurization for either group. DNA content decreased over
time in untreated groups but increased in both BC+ and Dyn+ constructs and was
markedly higher than untreated counterparts at day 28, with no effect of pressurization
observed between loaded samples and controls.

Table 4.2.

Material properties and DNA content of unloaded controls and constructs.

pressurized at 5 MPa +: significant effect of time within group. *: significant vs. corresponding
TGF-β3-treated group within time point (i.e., BC- vs. BC+).
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GAG content increased in both TGF-β3-treated groups but remained at day 3
values and significantly lower in BC- and Dyn- constructs, with no effect of
pressurization at 5 MPa for any group (Figure 4.6A). CSPG immunohistochemical
analyses at day 28 revealed interterritorial deposition in both untreated groups with strong
pericellular localization in lacunae (Figure 4.6 B, C), while BC+ and Dyn+ samples
exhibited uniform interterritorial accumulation throughout the construct (Figure 4.6 D,
E).

Figure 4.6. GAG quantification (A) and day 28 CSPG deposition of unloaded controls (B, D)
and constructs pressurized at 5 MPa (C, E) with (D, E) and without (B, C) TGF-β3. Bar = 50
µm. +: significant effect of time within group. *: significant vs. corresponding TGF-β3-treated
group within time point (i.e., BC- vs. BC+).

All samples were negative for COL I accumulation.

Normalized COL II

accumulation increased over time for all groups, and was highest in Dyn- samples (Figure
4.7A). COL II content in Dyn- constructs was significantly higher than in corresponding
BC- controls, indicating an effect of pressurization; however, there was no effect of load
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in TGF-β3-treated constructs (BC+ vs. Dyn+). COL II immunohistochemical analyses
showed localized intracellular deposition in untreated samples (Figure 4.7 B, C) with
improved, though limited, pericellular accumulation in BC+ and Dyn+ constructs (Figure
4.7 D, E).

Figure 4.7. COL II quantification (A) and day 28 deposition of unloaded controls (B, D) and
constructs pressurized at 5 MPa (C, E) with (D, E) and without (B, C) TGF-β3. Bar = 50 µm. +:
significant effect of time within group. *: significant vs. corresponding TGF-β3-treated group
within time point (i.e., BC- vs. BC+). #: significant vs. corresponding loaded group within time
point (i.e., BC- vs. Dyn-).

Constructs from the 5 MPa loading experiment were also tested in unconfined
compression. All groups experienced a significant increase in diameter over time, with
the largest values seen in BC+ and Dyn+ samples, indicating an effect of growth factor
treatment. There was, however, no effect of pressurization. The average diameter for
untreated constructs at day 28 was 5.81 ± 0.14 mm, while the average diameter of TGFβ3-treated samples was 6.78 ± 0.11 mm. Hydrogel thickness increased over time in all
groups except Dyn-, and was largest in both TGF-β3-treated groups, with no effect of
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pressure. The average thickness for untreated constructs at day 28 was 2.50 ± 0.04 mm,
while the average thickness in treated samples was 3.32 ± 0.10. BC- and Dyn- samples
exhibited no change from day 3 values for Ey (Figure 4.8). BC+ and Dyn+ samples both
experienced a significant increase in Ey by day 28, indicating a marked effect of growth
factor treatment, although there was no effect of mechanical stimulation for any group.
As seen in the 2 MPa study, overall, there was a strong positive and linear correlation
between GAG content and Ey at 5 MPa (r = 0.95, R2 = 0.91), while COL II accumulation
and Ey were not as directly related (r = 0.68, R2 = 0.46) (Figure 4.9).

Figure 4.8. Equilibrium Young’s modulus of unloaded controls and constructs pressurized at 5
MPa. +: significant effect of time within group. *: significant vs. corresponding TGF-β3treated group within time point (i.e., BC- vs. BC+).
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Figure 4.9. Correlation analyses of matrix content and the functional properties of 5 MPa
constructs.

The effect of pressure magnitude was also examined to compare the 2 MPa and 5
MPa studies (Table 4.3). Pressurization to 5 MPa resulted in significantly decreased
DNA content in Dyn- and Dyn+ groups at day 28, though these values did not differ from
corresponding unloaded controls, as well as a slight but significant decrease in GAG
content in Dyn+ constructs. However, there was no effect of pressure magnitude on
GAG content in Dyn- samples and no effect on the functional properties (Ey) of any
group. Pressurization to 5 MPa significantly increased COL II content in both Dyn- and
Dyn+ samples.
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Table 4.3. Day 28 pressure magnitude comparison for mechanically stimulated constructs.
Significance (p<0.05) vs. 2 MPa indicated by ↓ and ↑ arrows.

No significant difference

indicated by ↔.

4.4. Discussion

To the best of our knowledge, this is the first study to compare the combinatorial
effect of dynamic hydrostatic pressure and TGF-β3 supplementation on the matrix
deposition and functional properties of NP tissue-engineered constructs.

Although

previous IVD studies examining the effects of hydrostatic pressure on the NP have found
a beneficial effect of mechanical stimulation applied within the physiologic range (0.1 – 3
MPa)13-16, we saw no effect of pressure when applied at 2 MPa.

Instead, TGF-β3

supplementation was the only variable shown to affect NP construct development, as it
gave rise to an increase in dry weight and DNA content and a decrease in Qw that
approached native values (Qw native = 19.94 ± 3.09, unpublished data). Additionally, TGFβ3 supplementation resulted in significant increases in matrix accumulation, as
demonstrated by GAG and COL II quantification and immunohistochemistry, and
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marked improvements in mechanical properties, in support of our previous study6.
However, no significant differences in Ey were observed between untreated or TGF-β3treated pressurized samples and corresponding unloaded controls (Dyn- vs. BC- and
Dyn+ vs. BC+, respectively), indicating that the structure-function relationships were not
positively impacted by pressurization.
Earlier work from our laboratory examined the effect of pressure on outer and
inner annulus fibrosus cells seeded on a fibrous poly(L-lactic acid) reinforced
poly(glycolic acid) mesh and found significantly increased COL II deposition and
improved matrix distribution when pressure was increased to the hyperphysiologic level
of 5 MPa, with no effects observed at 2 MPa42. Although there is an obvious difference
in cell type and scaffold selection, this served as the motivation to repeat the current
study at the higher pressure magnitude of 5 MPa.
As with the 2 MPa study, growth factor supplementation had a significant impact
on NP construct development at the higher magnitude. TGF-β3 treatment (Dyn+, BC+)
again resulted in a significant increase in dry weight, a marked decrease in Qw to near
native measurements, as well as an increase in DNA content in comparison to untreated
pressurized (Dyn-) and control (BC-) groups, which experienced significant decreases in
DNA over time.

There was, however, no effect of pressure on any of these

measurements. Additionally, TGF-β3 supplementation produced marked improvements
in GAG accumulation for both pressurized samples (Dyn+) and unloaded controls (BC+).
Nonetheless, there was no effect of 5 MPa dynamic hydrostatic pressure on GAG
deposition or distribution.
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Interestingly, mechanical stimulation at 5 MPa did give rise to a significant
increase in normalized COL II accumulation in untreated constructs (Dyn-).

This

measurement (96.76 ± 9.17 ng/mg) was nearly double that of untreated, unloaded
controls (51.97 ± 3.81 ng/mg), and also exceeded normalized COL II accumulation by
TGF-β3-treated samples.

Pressure did not result in a corresponding increase in

accumulation for mechanically stimulated TGF-β3-treated scaffolds (Dyn+), indicating
that the effects of pressure were muted, rather than additive or synergistic, when
accompanied by growth factor supplementation.
Although the application of 5 MPa hydrostatic pressure increased normalized
COL II deposition in untreated constructs (Dyn-) over both unloaded controls (BC-) and
TGF-β3-treated, pressurized samples (Dyn+), this was not accompanied by a pressuredriven increase in mechanical properties (Ey) for Dyn- samples, which remained
unchanged from day 3 measurements and indistinguishable from unloaded controls.
Furthermore, although normalized COL II measurements were greater in Dyn- specimens
in comparison to Dyn+ or BC+ constructs, the growth factor-treated scaffolds retained
markedly greater amounts of GAGs and possessed mechanical properties over threetimes higher than corresponding untreated controls (Dyn-, BC-). GAG content was found
to have a very strong positive correlation with Ey (r = 0.95), as the increased amount of
water-retaining proteoglycans allowed the constructs to better resist compressive loads,
while COL II accumulation did not have as direct an effect (r = 0.68).
Even though hydrostatic pressure applied at 5 MPa did not result in any
substantial improvements in NP construct development, it is also important to note that
mechanical loading at this magnitude did not have any deleterious effects on the cells, as
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there was no significant reduction in any of the material, biochemical, or mechanical
outcome measures when compared to unloaded controls. Moreover, the application of 5
MPa hydrostatic pressure produced a beneficial response by significantly increasing COL
II accumulation in comparison to samples subjected to a pressure at 2 MPa.
Hydrostatic pressure has been previously shown to have an anabolic effect on NP
matrix metabolism and may suppress expression of some catabolic factors12,

15, 16

;

however, there is no clear consensus on the most effective loading regimen. Recent work
has examined a variety of magnitudes (0.25-6 MPa) and frequencies (0-20 Hz), duty
cycles (30 min/day to 12 hr/day) and loading durations (1 day to 4 weeks)13-16, 43-47. In
addition, multiple cell sources (human, bovine, rabbit, porcine, and canine), seeding
densities (0.15 x 106 to 20 x 106 cells/mL), and biomaterial scaffolds (alginate, collagen I
gel, agarose)13-16,

43-47

have been employed, which results in a considerable number of

variables that may impact experimental outcomes (Table 4.4).
Many IVD pressure studies have examined the effect of a short term application
of hydrostatic pressure on the gene expression or synthesis of relevant matrix
macromolecules. A study by Kasra et al. compared the effects of pressure magnitude
(0.75, 1.5, and 3 MPa) and frequency (1, 10, and 20 HZ) when applied for 30
minutes/day for 3 days to rabbit NP cells encapsulated in alginate. They found that a
high magnitude, high frequency (3 MPa, 20 Hz) load resulted in the greatest increase in
collagen production and decreased collagen degradation, despite the fact that a 20 Hz
frequency greatly exceeds the physiologic range43. A subsequent experiment by Kasra et
al. examined the effect of 1 MPa pressure applied at lower frequencies which spanned the
natural frequency of the disc (4-6 Hz)44. They reported maximum protein degradation
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and minimum protein synthesis when constructs were pressurized at 3-5 Hz, indicating
that loading near the natural frequency of the disc is most destructive. Neidlinger-Wilke
et al. examined the effects of low magnitude, low frequency pressure (0.25 MPa, 0.1 Hz)
on human NP cells seeded within a type I collagen gel and found little influence of low
magnitude pressure, although there was a trend for increased aggrecan and COL I gene
expression along with a significant decrease in expression of the matrix degrading
enzymes MMP-2 and MMP-315. A later investigation by this group compared the effects
of pressure magnitude (0.25 vs. 2.5 MPa at 0.1 Hz) when applied once for 30 minutes,
and again found minimal impact of low magnitude pressure. However, there was a
significant decrease in aggrecan and COL II gene expression and increased MMP-3
expression at 2.5 MPa, indicating a harmful effect on cellular transcriptional activity by
the short-term application of a higher magnitude load16.
In contrast, earlier studies by Hutton et al. comparing the effects 0.35 and 1 MPa
pressure applied statically and continuously for 9 days to canine NP cells encapsulated in
alginate beads showed enhanced proteoglycan synthesis at the higher magnitude,
although there was a slight decrease in collagen synthesis. Nevertheless, it is important
to note that this effect was observed after 9 days of continuous loading with no
significant decrease in DNA content versus controls13,

14

. While many of the studies

described above concluded a beneficial effect of hydrostatic pressurization, these
experiments were largely short-term and only examined gene expression or protein
biosynthesis. The investigators did not determine whether the effects of pressure were
effectively translated into differences in protein accumulation or altered the functional
mechanical properties of the tissue engineered constructs.
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The duty cycle (4 hrs/day for 5 days/week) and loading duration (4 weeks)
utilized in our study differ greatly from those described in current NP tissue engineering
literature. Nevertheless, they are quite similar to parameters utilized in cartilage tissue
engineering and were chosen to allow investigation of the long-term effect of mechanical
stimulation on the functional properties of NP constructs. A study by Smith et al. showed
that increasing the application of intermittent hydrostatic pressurization (10 MPa, 1 Hz)
from four hours per day for one day to four hours per day for four days increased gene
expression of both COL II and aggrecan in high density chondrocyte monolayers34. A
later study by Ikenoue et al. (5 and 10 MPa, 1 Hz) only observed increases in COL II
gene expression when utilizing the longer, four day loading regimen36. Similarly, Hu and
Athanasiou measured significant increases in collagen synthesis and a prevention of
GAG loss when pressure (10 MPa, 1 Hz) was applied for 4 hours/day, 5 days/week, for
up to 8 weeks using self-assembled articular cartilage constructs35. Nonetheless, as our
current studies did not show a significant effect of pressure in modulating the functional
properties of NP constructs, future work may employ loading parameters that more
closely match those shown to be effective in cartilage and IVD tissue engineering (i.e.,
higher magnitude and frequency).
One potential limitation of this study is that the temporal effect of growth factor
delivery was not examined in conjunction with mechanical stimulation. Lima et al.
reported a decrease in mechanical properties when dynamic deformational loading was
applied concurrently with TGF-β3 supplementation of chondrocyte-seeded agarose
hydrogels over 8 weeks7. However, mechanical properties significantly increased when
loading was applied following transient growth factor delivery over the first 14 days.
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Our study utilized continuous growth factor delivery throughout the experiment as this
was previously shown to vastly improve NP construct development when used in
conjunction with chemically-defined, serum-free medium6.
Deformational mechanical stimulation via dynamic compressive loading may also
be investigated in subsequent investigations. This form of loading has been applied via
an in vivo rat tail model and has been shown to elicit a frequency-dependent response
when magnitude was maintained9, and a magnitude-dependent response when frequency
was held constant48.

More recently, dynamic compression was applied in vitro by

Korecki et al. to NP cell-laden alginate hydrogels to compare the effects of frequency
(0.1, 1, and 3 Hz) and donor age. They found that maturation was a significant factor in
the cellular response to mechanical loading, though the impact of loading frequency was
minimal49.
While integrins play a principal role in the mechanotransduction of biomechanical
signals from the ECM to the cell nucleus in response to deformational loading,
hydrostatic pressurization results in a state of stress without appreciable strain, and
thereby bypasses known integrin signaling pathways. Rather, it has been hypothesized
that the mechanotransduction pathway for hydrostatic pressure involves cell membrane
ion channels, since these transmembrane proteins may alter conformation in response to
load. Specifically, a study by Hall implicated the sodium/potassium (Na+/K+) pump and
the Na+/K+/Cl- transporter, as these were significantly inhibited with increasing
magnitude when bovine chondrocytes were subjected to static hydrostatic pressure50.
Another possible conduit involves G-protein coupled receptor activation of
phospholipase C, which results in subsequent activation of the membrane phospholipid
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cleavage product, IP3, and mobilization of intracellular calcium stores. When combined
with calmodulin, the calcium complex acts as a second messenger to initiate a wide range
of downstream responses.

Browning et al. showed that the intracellular calcium

concentration of chondrocytes increased when subjected to hydrostatic pressurization.
This effect was due in large part to a release of intracellular Ca2+ stores, as the response
was inhibited when phospholipase C activation was blocked51.

Future studies may

investigate putative pressure-mediated mechanotransduction pathways in NP cell-laden
CMC constructs.
Although others have shown an additive or synergistic effect of mechanical
stimulation and growth factor supplementation on the development of constructs for
orthopaedic tissue engineering17-19, TGF-β3 supplementation was the only variable found
to have a significant impact on NP construct maturation using this particular system.
Hydrostatic pressure modulated COL II production in untreated samples at
hyperphysiologic levels (5 MPa) but did not enhance the functional properties of these
constructs, which remained significantly lower than those for unloaded and pressurized
TGF-β3-treated samples. As such, TGF-β3 supplementation alone is most effective for
enhancing the functional development of NP-seeded CMC constructs.
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Chapter 5: Response of Nucleus Pulposus Cells Encapsulated in
Photocrosslinked Carboxymethylcellulose Hydrogels Following
Pretreatment with TGF-β
β3: Differential Maturation in vitro and in vivo

5.1. Introduction

The intervertebral disc (IVD) is a complex, fibrocartilaginous tissue,
comprised of the collagenous annulus fibrosus, located at the periphery of the disc, and
the gelatinous nucleus pulposus (NP) which is located at the center of the disc. The NP is
predominantly composed of type II collagen and negatively charged proteoglycans, such
as aggrecan, which permit the tissue to retain water1. The high water content of the NP
allows the IVD to resist compressive loads placed upon the spine through the generation
of a hydrostatic swelling pressure2. Nevertheless, a decrease in proteoglycan content
occurs in conjunction with age1 or the onset of disc degeneration, which then renders the
disc more fibrous in content and structure and may hinder the ability of the IVD to
sustain applied loads3. In addition, the IVD is the largest avascular, aneural tissue in the
body and is dependent upon bulk fluid flow and diffusion for nutrient transport and waste
removal4, 5. As the disc becomes more fibrotic, these processes are impeded, and the IVD
must rely on anaerobic metabolism to survive. However, this results in the accumulation
of lactic acid waste products, which decrease the local pH and may result in cell death6
and the activation of matrix degrading enzymes, which further compromises the health of
the tissue1.

155

Tissue engineering strategies may present an alternative to current surgical
treatments for disc degeneration. Hydrogels mimic the highly hydrated nature of the NP
and encapsulation of cells within these scaffolds retains the phenotypic rounded
morphology observed in vivo7-10. A wide variety of starting materials have been used to
form hydrogels for NP tissue engineering applications, including hyaluronic acid11-13,
collagen14-17, agarose18, and chitosan19-21.

However, ionically crosslinked alginate,

derived from brown algae, has been the most prevalent material utilized in NP tissue
engineering9, 22-31. While alginate has been well-established for use in short-term studies
examining gene expression or extracellular matrix (ECM) accumulation, cell-laden
alginate scaffolds have been shown to lose mechanical integrity over time when used in
long-term investigations, possibly due to a loss of crosslinking calcium ions via diffusion
or depletion by encapsulated cells24, 32. This has motivated the examination of additional
crosslinking techniques and materials for tissue engineering investigations.
Photopolymerization is a covalent crosslinking method that utilizes biocompatible
photoinitiators to create a 3-D network via radical polymerization upon exposure to light.
Elisseeff et al. first described this technique using methacrylated poly(ethylene oxide) for
cartilage tissue engineering applications33,

34

.

Smeds et al. similarly created

photocrosslinkable polysaccharide-based hydrogels from methacrylated alginate and
hyaluronic acid, indicating the potential of similar photocrosslinkable polysaccharides for
use in tissue engineering applications35.
Carboxymethylcellulose (CMC) is a polysaccharide derived from cellulose, the
main component of plant cell walls. This water-soluble polymer contains a carboxylic
acid moiety within the carboxymethyl group which becomes deprotonated at
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physiological pH, resulting in a negatively charged network, similar to that provided by
the glycosaminoglycans (GAGs) in the native NP matrix.

Photocrosslinked,

methacrylated CMC has been recently shown to produce stable hydrogels, support NP
cell viability, and promote phenotypic matrix deposition capable of maintaining initial
mechanical properties in vitro36. The functional properties of these constructs were later
shown to be enhanced through the use of a serum-free, chemically-defined medium
supplemented with transforming growth factor-β3 (TGF-β3), resulting in a five-fold
increase in the equilibrium Young’s modulus over untreated controls along with
concomitant increases in GAG and type II collagen accumulation37.

However,

continuous exogenous growth factor delivery is not a cost effective or clinically relevant
method of construct modulation due to the short half life of these proteins, and it is
unclear whether the effects of TGF-β3 are retained once growth factor supplementation is
discontinued.
Therefore, the objective of this study was to examine the long-term effects of
TGF-β3 pre-conditioning under both in vitro and subcutaneous in vivo culture conditions.
We hypothesized that TGF-β3-treated constructs would exhibit greater matrix
accumulation and higher mechanical properties in comparison to untreated controls, and
that these properties would be maintained both in vitro and in vivo following the
cessation of growth factor supplementation.
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5.2. Materials and Methods
5.2.1. Macromer Synthesis

Methacrylated carboxymethylcellulose was synthesized through esterification of
hydroxyl groups based on previously described protocols23, 35, 36, 38. Briefly, a 20-fold
excess of methacrylic anhydride (Sigma, St. Louis, MO) was reacted with a 1 wt%
solution of 250 kDa CMC (Sigma) in RNAse/DNAse-free water over 24 hours at 4ºC.
The pH was periodically adjusted to 8.0 using 3N NaOH to modify hydroxyl groups of
the polymer with functional methacrylate groups. The modified CMC solution was
purified via dialysis for 96 hours against RNAse/DNAse-free water (Spectra/Por1, MW
5-8 kDa, Rancho Dominguez, CA) to remove excess, unreacted methacrylic anhydride.
Purified methacrylated CMC was recovered by lyophilization and stored at -20ºC. The
degree of substitution was confirmed using 1H-NMR (360 MHz, DMX360, Bruker,
Madison, WI) following acid hydrolysis of purified methacrylated CMC36.

Molar

percent of methacrylation was determined by the relative integrations of methacrylate
proton peaks (methylene, δ = 6.2 ppm and 5.8 ppm and the methyl peak, δ = 2.0 ppm) to
carbohydrate protons.
5.2.2. Primary Cell Culture and Isolation

All cell culture supplies, including media, antibiotics, and buffering agents, were
purchased from Invitrogen (Carlsbad, CA) unless otherwise noted. Discs C2-C4 were
isolated from bovine caudal IVDs obtained from a local abattoir, and the NP was
separated through gross visual inspection based on previous protocols22, 26. Tissue was
maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 20%

158

fetal bovine serum (FBS) (Hyclone, Logan, UT), 0.075% sodium bicarbonate, 100 U/mL
penicillin, 100 µg/mL streptomycin, and 0.25 µg/mL Fungizone reagent at 37°C, 5% CO2
for two days prior to digestion to ensure no contamination occurred during harvesting. A
single serum lot was used for all experiments to reduce potential variability in the cellular
response.
Tissue was diced and NP cells were released by collagenase (Type IV, Sigma)
digestion at an activity of 7000 U collagenase per gram of tissue. Following incubation
in collagenase, undigested tissue was removed using a 40 µm mesh filter. Cells from
multiple levels (C2-C4) were pooled and rinsed in sterile Dulbecco’s Phosphate Buffered
Saline (DPBS). These primary cells were plated onto tissue culture flasks, designated as
passage 0, and maintained in DMEM with 10% FBS, 0.075% sodium bicarbonate, 100
U/mL penicillin, and 100 µg/mL streptomycin (growth medium). Cells were subcultured
twice to obtain the necessary number of cells, and passage 2 cells26 were used in all
experiments, as these cells have been shown to retain phenotypic differences observed in
vivo up to the second passage22. Medium was changed three times per week.
5.2.3. Cell Encapsulation in Photocrosslinked Hydrogels

Lyophilized methacrylated CMC was sterilized by a 30-minute exposure to
germicidal UV light. The sterilized product was then dissolved to 2.5% in filter-sterilized
0.05

wt%

photoinitiator,

2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-

propanone (Irgacure 2959, I2959, Ciba Specialty Chemicals, Basel, Switzerland), in
sterile DPBS at 4°C. Passage 2 NP cells were resuspended in a small volume of 0.05%
I2959 and then homogeneously mixed with dissolved methacrylated CMC at 30 × 106
cells/mL for a final concentration of 2.25%. The seeding density was selected based on
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previous studies using cell-seeded constructs for engineering of cartilaginous tissues39-43.
The 2.25% CMC solution was cast in a custom-made glass casting device and exposed to
long-wave UV light (EIKO, Shawnee, KS, peak 368 nm, 1.2W) for 10 minutes to
produce covalently photocrosslinked hydrogel disks of 5-mm diameter x 2-mm thickness.
Each hydrogel was incubated in 1.5 mL of growth medium at 37ºC, 5% CO2. At day 1,
growth medium was fully exchanged with chemically-defined medium (Cells-), which
was comprised of DMEM with 1% insulin-transferrin-selenium + universal culture
supplement (BD Biosciences, San Jose, CA), 100 U/mL penicillin, 100 µg/mL
streptomycin, 40 µg/mL L-proline (Sigma), 1 mM sodium pyruvate (Mediatech, Inc.,
Manassas, VA), 50 µg/mL ascorbic acid 2-phosphate (Sigma), and 100 nM
dexamethasone (Sigma)44.

This medium was further supplemented with 10 ng/mL

rhTGF-β3 (R&D Systems, Minneapolis, MN) (Cells+).

The TGF-β3 concentration

utilized was chosen based on previous IVD and cartilage tissue engineering studies44-48.
Media were changed three times per week. Cell-free control gels cast at 2.25% were
maintained for all groups (Ctrl-, Ctrl+).
5.2.4. in vivo Subcutaneous Pouch Model

After 14 days of in vitro pre-culture, growth factor supplementation was
discontinued, and cell-laden (Cells-, Cells+) and cell-free constructs (Ctrl-, Ctrl+) were
subcutaneously implanted (Cells- in vivo, Cells+ in vivo, Ctrl- in vivo, Ctrl+ in vivo) in
immunocompromised nude mice (4-6 week old female mice, Strain: NIH-III-NU, Charles
River Laboratories, Wilimington, MA) in accordance with University of Pennsylvania
guidelines for the use of vertebrate animals for research (Animal Protocol #800209).
Surgery was performed aseptically under anesthesia induced by injection of 140 mg/kg
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body weight of ketamine (Fort Dodge, Animal Health, Fort Dodge, IA), 7 mg/kg xylazine
(Phoenix Pharmaceuticals, St. Joseph, MO), and 1 mg/kg acepromazine (Burns
Veterinary Supply, Farmers Branch, TX). A mid-longitudinal sagittal skin incision on
the dorsum of each mouse was expanded by blunt dissection to create a subcutaneous
pocket into which six implants were placed. Each group (4 groups total: cell-free control
gels with and without TGF-β3; cell-laden gels with and without TGF-β3) consisted of a
total of 18 constructs implanted in 3 animals per time point. Subcutaneous constructs
were harvested at 4 and 8 weeks following implantation. The animals were euthanized
by CO2 asphyxiation in accordance with the guidelines established by the American
Veterinary Medical Association Panel on Euthanasia.

Corresponding controls were

maintained in vitro throughout the course of the study (Cells- in vitro, Cells+ in vitro,
Ctrl- in vitro, Ctrl+ in vitro). A schematic detailing the timeline of this investigation is
shown below (Figure 5.1).

Figure 5.1. Timeline for the investigation of the long-term effects of TGF-β3 pre-treatment.
Constructs were cultured with or without TGF-β3 through 14 days of in vitro pre-culture, at
which time a subset of constructs was implanted subcutaneously, while others remained in vitro
without TGF-β3.
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5.2.5. Swelling Ratio

The equilibrium weight swelling ratio, Qw, was calculated after 14 days of in vitro
pre-culture (prior to subcutaneous implantation) and after 4 and 8 weeks of subcutaneous
implantation (n=5).

Constructs were weighed to determine the wet weight (Ws),

lyophilized, and then weighed again to measure the dry weight (Wd). Qw was calculated
using the following equation:
Qw = Ws/Wd
5.2.6. Biochemistry

Following lyophilization, total protein and DNA (n=5) were extracted at day 14 of
in vitro pre-culture, 4 weeks, and 8 weeks by pepsin digestion based on previous

studies22.

Briefly, lyophilized samples were homogenized and treated with pepsin

(Sigma) in 0.05N acetic acid (1.9 mg/mL) for 48 hrs at 4ºC. Afterwards, pepsin was
neutralized by the addition of 10X tris buffered saline. Cell-free hydrogels (n=4) were
maintained for all groups and served as negative controls. Total DNA content was
measured using the PicoGreen DNA assay49 (Molecular Probes, Eugene, OR) with calf
thymus DNA (Sigma) as the standard22. Samples were analyzed at 480 nm excitation and
520 nm emission using a Bio-Tek Instruments microplate reader (Synergy HTTM,
Winooski, VT).
Total sulfated GAG content was measured at day 14 of pre-culture, 4 weeks, and
8 weeks using the 1,9 dimethylmethylene blue (DMMB) assay50. The DMMB dye was
reduced to pH 1.5 to minimize the formation of CMC carboxyl group-DMMB dye
complexes51 and absorbance was determined at 595 nm using a chondroitin-6 sulfate
standard curve (Sigma).
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Collagen production was quantified at day 14 of pre-culture, 4 weeks, and 8
weeks via an indirect enzyme-linked immunosorbent assay using polyclonal antibodies to
type I collagen (COL I) (rabbit anti-bovine, 1:2000, AbD Serotec, Raleigh, NC) and type
II collagen (COL II) (rabbit anti-bovine, 1:2000, Millipore, Billerica, MA) based on
previous protocols22, 24. A biotinylated secondary antibody (goat anti-rabbit IgG (H+L),
Vector Labs, Burlingame, CA) and a streptavidin-horseradish peroxidase enzyme
conjugate (R&D Systems, Minneapolis, MN) were employed. Protein values for each
sample were determined using a standard curve generated from bovine COL I and COL II
(Rockland Immunochemicals, Gilbertsville, PA). Absorbance was measured at 450 nm.
DNA, GAG, and collagen content are presented normalized to wet weight.
5.2.7. Histology and Immunohistochemistry

Constructs were fixed for 45 minutes in acid formalin at room temperature and
processed for paraffin embedding after graded serial ethanol dehydration. Samples were
sectioned at a thickness of 8 µm using a Leica microtome (Model 2030, Nussloch,
Germany), and hematoxylin and eosin staining was conducted to visualize cellular
distribution throughout the hydrogel. Immunohistochemical analyses were performed to
assess ECM accumulation according to previous studies24. Briefly, polyclonal antibodies
to COL I (1:1000 dilution in blocking solution, comprised of 10% goat serum diluted in
DPBS) and COL II (1:40 dilution in blocking solution, composed of 10% goat serum
diluted in DPBS), and a monoclonal antibody to chondroitin sulfate proteoglycan (1:100
dilution in blocking solution, consisting of 10% goat serum, 10% evaporated milk, and
1% Goat Anti-Mouse IgG+A+M (H+L) (Invitrogen) diluted in DPBS) (CSPG, Sigma)
were used, followed by incubation in biotinylated goat/anti-rabbit IgG (H+L) (COL I,
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COL II) or biotinylated goat/anti-mouse IgM (CSPG) secondary antibody (1:50 dilution
in blocking solution) (Vector Labs). A peroxidase-based detection system (Vectastain
Elite ABC, Vector Labs) and 3,3’ diaminobenzidine (Vector Labs) were employed to
visualize ECM localization. Non-immune controls were processed in blocking solution
without primary antibody. Samples were viewed with a Zeiss Axioskop 40 optical
microscope and images were captured using AxioVision software (Carl Zeiss, Inc.,
Thornwood, NY). Fibrous capsule thickness was measured using AxioVision software.
5.2.8. Mechanical Testing

Unconfined compression testing was conducted on CMC hydrogels (n=5) isolated
at day 1 of pre-culture, prior to TGF-β3 treatment, and day 14 of pre-culture, prior to
implantation. Additionally, excised in vivo and corresponding in vitro samples were
tested at 4 and 8 weeks of implantation using a custom-built apparatus, as previously
described23, 36, 52. Briefly, the unconfined compression testing protocol was comprised of
a creep test followed by a multi-ramp stress-relaxation test. The creep test consisted of a
1 g tare load applied at a 10 µm/s ramp velocity for 1800 seconds until equilibrium was
reached (equilibrium criteria: <10 µm change in 10 minutes). The multi-ramp stressrelaxation test consisted of three 5% strain ramps applied at 10 µm/s, each followed by a
2000 second relaxation period (equilibrium criteria: <0.5 g change in 10 minutes).
Equilibrium stress was calculated at each ramp using surface area measurements and
plotted against the applied strain. An average equilibrium Young’s modulus, Ey, was
calculated from the slope of the stress versus strain curves and reported for each sample.
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5.2.9. Statistical Analysis

A three-way ANOVA was used to determine the effects of time, TGF-β3, and
culture condition (in vivo vs. in vitro) on DNA content, GAG and collagen accumulation
(n=5). A three-way ANOVA was also used to determine the effects of time, cells (cellladen vs. cell-free gels), and TGF-β3 on Qw and mechanical properties (n=5) for in vitro
and in vivo samples analyzed separately. A Tukey’s post-hoc test was performed on the
three-factor interactions. A four-way ANOVA was used to determine the effects of time,
cells, TGF-β3, and culture condition on Qw and mechanical properties (n=5) at 4 and 8
weeks.

A Tukey’s post-hoc test was performed on the four-factor interaction.

Significance was set at p<0.05. Data represent the mean ± standard deviation. All
statistical analyses were performed using JMP software (SAS Institute, Cary, NC).

5.3. Results

CMC was methacrylated at an 8.15% modification, as verified by 1H-NMR.
Cell-laden and cell-free constructs were initially cultured in vitro for 14 days with or
without TGF-β3, at which time samples were implanted subcutaneously in nude mice or
were maintained in vitro without growth factor supplementation for an additional 4 or 8
weeks (Figure 5.1). Qw remained consistent over time in all Ctrl- and Cells+ (Figure
5.2). Qw was similarly stable over time across all in vitro Ctrl+ samples; however, Qw
was significantly greater at 8 weeks in Ctrl+ in vivo samples in comparison to the
corresponding group at 4 weeks. There was no effect of the presence of cells in
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Figure 5.2. Equilibrium weight welling ratio (Qw) for cell-laden and cell-free CMC constructs
with and without TGF-β3 maintained under in vitro or in vivo culture conditions. $ significant vs.
14-day pre-culture time point. ^ significant vs. 8wk within group. * Significant vs. cell-laden
gel within group (Ctrl- vs. Cells-). # significant vs. corresponding TGF-β3-treated constructs
within group (Cells- vs. Cells+). ‡ significant effect of culture condition (in vitro vs. in vivo).

comparing untreated constructs (Cells- vs. Ctrl-), while Cells+ scaffolds exhibited a
significantly lower Qw in comparison to Ctrl+ samples in both in vitro and in vivo culture.
TGF-β3 treatment resulted in a significantly lower Qw at 4 and 8 weeks when comparing
Cells+ in vitro to Cells- in vitro samples, while this comparison was only significant at 4
weeks for Cells+ in vivo versus Cells- in vivo specimens. Subcutaneous culture resulted
in a marked decrease in Qw for Cells- samples at 8 weeks in comparison to the
corresponding in vitro group (Cells- in vivo vs. Cells- in vitro).
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Hematoxylin and eosin (H&E) staining of in vitro and in vivo cell-laden
constructs revealed more prevalent formation of lacunae in untreated (Cells-) in vivo
samples (Figure 5.3 C, E) in comparison to corresponding in vitro constructs (Figure 5.3
B, D). Cells+ samples cultured in vitro (Figure 5.3 F, G, I arrows) exhibited signs of
clonal cell expansion, while Cells+ in vivo constructs (Figure 5.3 H, J) demonstrated
lacunae formation similar to that seen in Cells- in vivo scaffolds. The fibrous capsule
surrounding cell-free and cell-laden hydrogels ranged from ~30-75 µm in thickness at 4
and 8 weeks of implantation, with no observed cellular infiltration into the scaffold
(Figure 5.4).

Figure 5.3. Hematoxylin and eosin staining of cell-laden CMC constructs cultured in vitro (A,
B, D, F, G, I) and in vivo (C, E, H, J) with (F-J) and without (A-E) TGF-β3. Arrows indicate the
presence of cell clusters. Bar = 50 µm.
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Figure 5.4. Hematoxylin and eosin staining of fibrous capsule formation for cell-free (A, C) and
cell-laden (B, D) CMC constructs at 8 weeks of in vivo culture. Fibrous capsule thickness
measurements are indicated in each panel. Bar = 50 µm.

Immunohistochemical analyses indicated interterritorial deposition and localized
pericellular accumulation of CSPG in Cells- constructs after 14 days of in vitro preculture (Figure 5.5A). In contrast, Cells+ constructs exhibited a more even distribution of
CSPG accompanied by more intense interterritorial deposition (Figure 5.5F). At 4 and 8
weeks, Cells- in vivo samples (Figure 5.5 C, E, respectively) demonstrated enhanced
interterritorial staining in comparison to in vitro constructs (Figure 5.5 B, D,
respectively). Conversely, there was no differential effect of culture condition observed
histologically in Cells+ constructs at 4 weeks (Figure 5.5 G, H), and CSPG accumulation
was reduced in 8 week in vivo samples in comparison to Cells+ scaffolds cultured in
vitro. GAG accumulation, quantified using the DMMB assay, indicated a significant

effect of TGF-β3 treatment for both in vitro and in vivo samples prior to implantation (14day pre-culture) and at 4 weeks (Cells+ vs. Cells-); however, no significant difference
was detected between Cells+ and Cells- in vivo samples at the 8-week time point (Figure
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5.5K). GAG accumulation in Cells+ in vivo constructs decreased markedly at each time
point but remained constant over time in Cells- samples regardless of culture condition
(in vitro vs. in vivo). GAG accumulation in Cells+ samples was also significantly
affected by culture condition, as in vitro constructs retained greater amounts of GAGs at
both 4 and 8 weeks.

Figure 5.5. Immunohistochemical analyses of chondroitin sulfate proteoglycan localization in
cell-laden CMC constructs cultured in vitro (A, B, D, F, G, I) and in vivo (C, E, H, J) with (F-J)
and without (A-E) TGF-β3. Biochemical quantification of GAG accumulation (K) in constructs
under various culture conditions. Bar = 50 µm. + significant vs. all other time points within
group.

# significant vs. corresponding TGF-β3-treated constructs within group (Cells- vs.

Cells+). ‡ significant effect of culture condition (in vitro vs. in vivo).

169

COL II immunohistochemical analyses indicated a significant effect of TGF-β3
treatment at all time points in all groups, as Cells+ constructs (Figure 5.6, F-J) displayed
more intense staining than corresponding Cells- samples (Figure 5.6, A-E). COL II
quantification (Figure 5.6K) verified a significant effect of growth factor treatment at the
8-week time point (Cells+ in vitro and in vivo vs. Cells- in vitro and in vivo), and
accumulation in Cells+ constructs increased significantly over time.

All groups

demonstrated minimal staining for COL I at all time points and quantification of COL I
content did not exceed 20 pg/mg (Figure 5.7).

Figure 5.6. Immunohistochemical analyses of type II collagen (COL II) localization in cellladen CMC constructs cultured in vitro (A, B, D, F, G, I) and in vivo (C, E, H, J) with (F-J) and
without (A-E) TGF-β3. Biochemical quantification of COL II accumulation (K) in constructs.
Bar = 50 µm. + significant vs. all other time points within group. $ significant vs. 14-day preculture. # significant vs. corresponding TGF-β3-treated constructs within group (Cells- vs.
Cells+). ‡ significant effect of culture condition (in vitro vs. in vivo).
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Figure 5.7. Immunohistochemical analyses of type I collagen (COL I) localization in cell-laden
CMC constructs cultured in vitro (A, B, D, F, G, I) and in vivo (C, E, H, J) with (F-J) and
without (A-E) TGF-β3. Biochemical quantification of COL I accumulation (K) in constructs
under various culture conditions. Bar = 50 µm. + significant vs. all other time points within
group.

# significant vs. corresponding TGF-β3-treated constructs within group (Cells- vs.

Cells+). ‡ significant effect of culture condition (in vitro vs. in vivo).

TGF-β3 treatment significantly increased DNA content in Cells+ constructs at the
14-day pre-culture time point and at 4 weeks in both in vitro and in vivo samples (Figure
5.8). However, by 8 weeks, the DNA content of the Cells+ in vivo group experienced a
significant temporal decrease in comparison to Cells+ in vitro measurements at this time

171

point. Furthermore, at 8 weeks, Cells+ in vivo constructs were not significantly different
from untreated Cells- in vivo samples.

Figure 5.8. DNA content of constructs cultured in vitro and in vivo with and without TGF-β3. +
significant vs. all other time points within group. # significant vs. corresponding TGF-β3-treated
constructs within group (Cells- vs. Cells+). ‡ significant effect of culture condition (in vitro vs.
in vivo).

Gross observation of both in vitro and in vivo samples (following excision and
capsule removal) at 8 weeks indicated increased opacity in cell-laden TGF-β3-treated
constructs (Figure 5.9 G, H). In addition, subcutaneously implanted cell-free hydrogels,
with and without TGF-β3 treatment (Figure 5.9 B, F), did not demonstrate any cellular
infiltration into the scaffold, consistent with H&E staining shown in Figure 5.4, as
samples remained transparent upon excision and removal of the fibrous capsule.
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Figure 5.9. Gross images of constructs cultured in vitro (A, C, E, G) and in vivo (following
excision and fibrous capsule removal) (B, D, F, H), with (E-H) and without (A-D) TGF-β3 at 8
weeks following the in vitro pre-culture period. Scale in millimeters.

Construct diameter and thickness were measured prior to mechanical testing
(Table 5.1). By 14 days of pre-culture, Cells+ samples were significantly larger than
Cells- specimens and corresponding cell-free controls (Ctrl+). In contrast, there were no
differences in diameter or thickness when comparing untreated Cells- gels to cell-free
Ctrl- samples in any culture condition, at any time point throughout the study, indicating
no effect of the presence of cells when cultured without TGF-β3. At 4 weeks, Cells+
samples remained significantly larger than Cells- gels, both in vitro and in vivo, as TGFβ3 treatment had a marked effect on construct dimensions. However, the diameter of
Cells+ in vivo samples at 4 weeks was significantly lower in comparison to the 14-day
time point, indicating a temporal loss following subcutaneous implantation which was not
seen in Cells+ in vitro constructs. In addition, the culture condition markedly affected
scaffold dimensions at 4 weeks, as both Cells- and Cells+ in vitro constructs were
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significantly larger than corresponding in vivo samples. Furthermore, the diameter of
Cells+ in vivo constructs was not significantly different than that for cell-free in vivo
controls (Ctrl+) at 4 weeks. By 8 weeks, the diameter and thickness measurements of
Cells+ in vivo constructs were not significantly different from those of Cells- in vivo or
Ctrl+ in vivo scaffolds, demonstrating a loss in the effect of TGF-β3 treatment and the
presence of cells by this later time point. In contrast, Cells+ in vitro samples were
significantly larger than Cells- and Ctrl+ in vitro scaffolds at 8 weeks. Overall, in vivo
conditions resulted in a significant decrease in diameter for both Cells- and Cells+
constructs in comparison to scaffolds cultured in vitro.
Constructs were tested in unconfined compression to determine the mechanical
properties (Figure 5.10). Cell-free control gels, with and without TGF-β3 (Ctrl+, Ctrl-),
maintained initial mechanical properties throughout the study, regardless of culture
condition (in vitro vs. in vivo).

TGF-β3 treatment of cell-laden constructs (Cells+)

resulted in a significant increase in Ey from day 1 to day 14 of the in vitro pre-culture
period, markedly increasing Ey over Cells- and Ctrl+ samples at 14 days. Cells+ in vitro
constructs maintained these mechanical properties over the remainder of the experiment.
In contrast, Ey for Cells+ in vivo samples decreased following subcutaneous implantation,
and by 8 weeks, Ey was not significantly different when compared to Cells- or Ctrl+ in
vivo scaffolds or versus Cells+ measurements recorded at the 1-day pre-culture time

point.

The presence of cells did not affect the mechanical properties of untreated

constructs, as there were no significant differences detected between Ctrl- or Cellssamples at any time point, regardless of culture condition. In addition, at 8 weeks, Ey
decreased below 1-day pre-culture values in both Cells- in vivo and in vitro scaffolds.
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Table 5.1. Diameter and thickness measurements of in vitro and in vivo constructs cultured with
and without TGF-β3. + significant vs. all other in vitro time points within group. ^ significant
vs. 8wk within group. - significant vs. 1-day pre-culture within group. $ significant vs. 14-day
pre-culture within group.

* significant vs. cell-laden gel within group.

# significant vs.

corresponding TGF-β3-treated constructs within group. ‡ significant effect of culture condition
(in vitro vs. in vivo).
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Figure 5.10. Equilibrium Young’s modulus of in vitro and in vivo constructs cultured with and
without TGF-β3. + significant vs. all other in vitro time points within group. ^ significant vs.
8wk in vitro and in vivo within group. $ significant vs. 14-day pre-culture within group. *
significant vs. cell-laden gel within group (Ctrl- vs. Cells-). # significant vs. corresponding
TGF-β3-treated constructs within group (Cells- vs. Cells+).

‡ significant effect of culture

condition (in vitro vs. in vivo).

5.4. Discussion

This is the first study to compare the long-term effect of in vitro TGF-β3 preconditioning prior to in vitro and in vivo culture using photocrosslinked CMC hydrogels
encapsulated with NP cells. Consistent with our original hypothesis, a 14-day pre-culture
period in the presence of TGF-β3 produced significant increases in matrix accumulation
(GAGs, COL II) and mechanical properties, which were maintained for up to 8 weeks in
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vitro following the cessation of growth factor supplementation. However, samples which

were exposed to TGF-β3 and subsequently implanted in vivo experienced a significant
decrease in retained GAGs, a loss of DNA content, and a reduction in mechanical
properties over time, contrary to our hypothesis. These results indicate a differential
effect on construct maturation in response to TGF-β3 supplementation, which is
dependent upon culture condition (in vitro vs. in vivo).
Qw remained constant in all groups throughout the study, except for 4wk Ctrl+ in
vivo and 8wk Cells- in vitro samples.

A stable swelling ratio is an important

characteristic of any potential intradiscal material in that this will decrease the likelihood
of extrusion into the annulus.

Furthermore, the addition of TGF-β3 produced a

significant decrease in Qw in cell-laden samples (Cells+) in comparison to untreated
constructs (Cells-) and treated, cell-free controls (Ctrl+), indicating a pronounced
accumulation of ECM proteins within Cells+ gels. Qw for Cells- was similar to that for
cell-free controls (Ctrl-), as the presence of cells had no effect when cultured in the
absence of TGF-β3.

Qw for Cells+ samples was 23.53 ± 2.81, which closely

approximates the Qw measured for native NP tissue (19.94 ± 3.09, unpublished data).
The mechanical and material properties of untreated (Cells-) scaffolds remained
indistinguishable from Ctrl- samples throughout the study, indicating that, although these
cells remained viable both in vitro and in vivo, they had entered a basal, senescent-like
state in comparison to Cells+ scaffolds. As such, the minimal amount of accumulated
ECM in Cells- constructs was insufficient to affect the overall properties of these
hydrogels. Nonetheless, Cells- in vivo samples exhibited prevalent lacuna formation and
enhanced interterritorial CSPG accumulation in comparison to Cells- in vitro constructs.

177

Cellular localization within lacunae is characteristic of cartilaginous tissues, such as the
NP53, 54. While subcutaneous implantation does not replicate a load-bearing environment,
in vivo samples were exposed to various mechanical stimuli which were not present in

static, free-swelling, in vitro culture, including tension from the skin and forces produced
in response to locomotion of the mice.

These loads may have stimulated matrix

deposition and lacuna formation by untreated cells cultured in vivo; however, this was not
sufficient to impact mechanical properties, as Cells- in vivo constructs remained similar
to Cells- in vitro scaffolds and cell-free Ctrl- samples.
TGF-β3 supplementation significantly enhanced matrix accumulation in cell-laden
samples (Cells+) in comparison to untreated controls (Cells-). Cells+ constructs
demonstrated uniform interterritorial accumulation of CSPG at later time points, while
CSPG remained highly localized within the pericellular matrix of Cells- scaffolds. In
addition, at 8 weeks after the cessation of TGF-β3 treatment, Cells+ in vitro samples
contained ~70 times greater GAG content than the corresponding Cells- in vitro group.
Furthermore, Ey measured for Cells+ in vitro constructs at 8 weeks was six-fold greater
than that for Cells- in vitro specimens at that time point, indicating a significant and longterm improvement in the maturation of these construct resulting from a two-week
exposure to TGF-β3. These data support a similar study conducted by our group which
examined the effect of continuous treatment with TGF-β3 over 28 days of in vitro
culture37. While the absolute values observed at 8 weeks for in vitro GAG content and Ey
in this current 14-day TGF-β3-treatment study are less than those observed after 28 days
of continuous growth factor treatment (GAGs: 4.39 ± 0.26 vs. 9.46 ± 1.51 µg/mg,
respectively; Ey: 14.82 ± 1.68 vs. 18.84 ± 1.63 kPa, respectively), a decrease in the
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period of TGF-β3 treatment and increase in the overall duration of the experiment
represents a study design that is more relevant to a clinically-applicable tissue
engineering therapy.
Although TGF-β3 supplementation resulted in significant improvements after 14
days of in vitro pre-culture, immunohistochemical and biochemical analyses of Cells+ in
vivo scaffolds implanted after this period indicated a decrease in CSPG and GAG

accumulation. A similar trend was observed via COL II immunohistochemistry (IHC), as
interterritorial staining for Cells+ in vivo constructs decreased from 4 to 8 weeks and
reverted to localized intracellular staining similar to, though more intense than, that seen
after the 14-day pre-culture period. Cells+ in vivo constructs experienced a concomitant
loss in mechanical properties, and by 4 weeks, these samples were significantly weaker
than Cells+ in vitro constructs.

In contrast, CSPG accumulation in Cells+ in vitro

samples was similar at 8 weeks to that observed at the time of implantation, while COL II
IHC depicted more intense staining and greater interterritorial deposition at 8 weeks in
comparison to earlier time points. As such, culture condition was shown to significantly
affect the matrix retention and mechanical properties of TGF-β3-treated scaffolds.
Measurements of Ey for cell-free controls (Ctrl-, Ctrl+) indicated that these
covalently photocrosslinked CMC scaffolds experienced no significant degradation over
the course of the study, as constructs did not exhibit a loss in mechanical properties in
vitro or in vivo. Given the load bearing function of the NP, a biomaterial scaffold utilized

as an intradiscal replacement material must provide immediate and sustained structural
support to withstand the stresses to which the native tissue is subjected. However,
biomaterials that serve as cell-laden scaffolds for tissue engineering applications must
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balance mechanical demands with construct degradation in order to allow for nutrient and
waste diffusion and provide void space for ECM deposition and tissue formation over
time.

Bryant and Anseth incorporated hydrolyzable lactic acid units into a non-

degrading, photocrosslinkable poly(glycolic acid) (PEG) hydrogel used in cartilage tissue
engineering applications55.

As the concentration of incorporated lactic acid units

increased, DNA, GAG, and total collagen content increased as well over 6 weeks of in
vitro culture. PEG constructs with the lowest concentration of degradable units exhibited

localized pericellular deposition of COL II, while more rapidly degrading hydrogels
demonstrated diffusion of COL II into the extracellular, interterritorial space, illustrating
the importance of scaffold degradation in proper matrix assembly. Sahoo et al. similarly
incorporated degradable lactic acid units into a methacrylated hyaluronic acid hydrogel
used to encapsulate mesenchymal stem cells cultured in chondrogenic medium and
observed increased chondroitin sulfate distribution throughout the scaffold with increased
lactic acid concentration after 2 weeks of in vitro culture56.
Cell proliferation, as measured by DNA content, and matrix accumulation in
Cells+ constructs significantly exceeded that in Cells- constructs in vitro. Free-swelling
in vitro culture provided sufficient nutrient diffusion through the scaffold and opportunity

for the hydrolysis of ester crosslinks. As a result, void space was created over time,
allowing for cell proliferation and ECM assembly in vitro, which is a known anabolic
effect of TGF-β3. Histological analyses of Cells+ scaffolds revealed clonal expansion, as
evidenced by cell clusters, and increased deposition of COL II, which is a large matrix
protein that may require increased void space for proper assembly. Mauck et al. observed
a similar phenomenon of clonal expansion when examining the effect of TGF-β1
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supplementation on chondrocyte-seeded agarose gels over 5 weeks of free-swelling in
vitro culture. A peripheral mass composed of multiple cell layers located on the outer

surface of the scaffold was also identified and these occurrences were attributed to the
known proliferative effect57 of TGF-β58.
H&E staining of in vivo constructs showed the formation of a fibrous capsule
surrounding hydrogels from all groups. While in vitro diffusion conditions may have
provided adequate ester hydrolysis to create void space for cell expansion and matrix
deposition, the fibrous capsule observed in vivo may have impaired nutrient transport and
constricted the hydrogel, resulting in a stiffer, less hospitable environment for the
encapsulated cells. When combined with the limited hydrolytically-labile nature of the
CMC scaffold, these conditions may have caused the metabolic and biosynthetic activity
of in vivo TGF-β3-treated cells to plummet to basal levels seen in Cells- constructs. The
remaining cells may have subsequently entered a senescent state similar to that seen in
Cells- constructs, decreasing the production of matrix components and thereby increasing
matrix turnover. As a result, by 8 weeks, GAG accumulation and Ey for in vivo TGF-β3treated scaffolds fell to baseline levels comparable to that of untreated, cell-laden
controls.
One limitation to the in vivo portion of this study is that it was conducted using
nude mice, which prevents the full characterization of the foreign body response to
construct implantation. However, as these constructs contained encapsulated xenogeneic
bovine NP cells, an immunocompromised animal model was necessary in order to form
an initial assessment of in vivo tissue development.

A similar photocrosslinkable

methylcellulose hydrogel platform was recently developed and cell-free constructs were
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implanted in normal CD-1 mice59.

After 80 days of implantation, samples were

circumscribed by a thin (~50 µm), translucent fibrous capsule with no inflammatory
exudates observed, indicating a mild inflammatory response and supporting the use of the
CMC constructs described here.
Early studies examining photocrosslinked CMC for NP cell encapsulation utilized
a formulation with an initial Ey of ~1.5 kPa36. However, cell-laden constructs weakened
as the hydrolytic degradation rate exceeded the rate of matrix production by the
encapsulated cells. A stiffer hydrogel was subsequently selected (Ey ~4.5 kPa) and the
mechanical properties of cell-laden constructs were shown to remain stable over the 14day study; however, it should be noted that these investigations were conducted without
growth factor supplementation. As such, future studies will examine a less stiff CMC
hydrogel, which can be formulated by decreasing the macromer concentration (weight
percent), degree of methacrylation (% modification), or molecular weight38,

60

. Over

time, this less rigid gel will provide more void space for matrix accumulation, and this
will be studied in conjunction with TGF-β3 supplementation in order to assess functional
matrix deposition by encapsulated cells. These upcoming studies will assess the cellular
metabolic activity and matrix turnover processes (i.e., matrix metalloproteinase function)
in NP construct development.
Taken together, this study has demonstrated a long-term enhancement in the
matrix accumulation and mechanical properties of constructs maintained in vitro in
response to a two-week period of TGF-β3 supplementation.

However, in order to

improve the clinical application of this tissue engineering therapy, the CMC scaffold
formulation must be optimized for in vivo conditions.
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Chapter 6: Conclusions, Limitations, and Future Directions

6.1. Overview

Carboxymethylcellulose (CMC) was characterized and developed for potential
use as a tissue engineering scaffold for the replacement of the nucleus pulposus (NP) of
the intervertebral disc (IVD).

Covalently photocrosslinked CMC hydrogels were

produced by modifying CMC hydroxyl groups with functional methacrylate moieties,
which were able to undergo radical polymerization, creating a three-dimensional
crosslinked network. The material properties of these hydrogels were controlled by
varying the macromer concentration and molecular weight in order to identify a
formulation capable of supporting encapsulated NP cells (Chapter 2). Upon selection of
a suitable CMC scaffold, medium formulation and transforming growth factor-β3 (TGFβ3) supplementation were examined as a method to enhance the development of cellseeded constructs (Chapter 3). Mechanical stimulation via hydrostatic pressurization,
applied in the presence and absence of TGF-β3, was explored as a technique to increase
the matrix deposition and functional properties of cell-laden CMC scaffolds (Chapter 4).
Finally, the long-term effects of in vitro pre-conditioning with TGF-β3 were examined in
vitro and in vivo using a subcutaneous murine pouch model to characterize functional

matrix elaboration (Chapter 5). The major findings and limitations of these studies, as
well as future directions for this work, are presented in this chapter.
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6.2.

Characterization of Photocrosslinked CMC for NP Cell Encapsulation

(Chapter 2)

Although ionically crosslinked alginate has been the prevalent biomaterial
scaffold choice for NP tissue engineering applications1-11, this hydrogel has been shown
to lose mechanical integrity over time, as crosslinking calcium ions diffuse out of the gel
or are depleted by encapsulated cells5,

12

. This study sought to establish a covalently

photocrosslinked CMC hydrogel with tunable properties that was capable of supporting
encapsulated NP cells and promoting phenotypic matrix deposition. We hypothesized
that an increase in CMC macromer concentration and molecular weight would result in
an increase in hydrogel mechanical properties and a decrease in the swelling ratio.
In a series of initial studies, we evaluated photocrosslinked hydrogels composed
of 90 kDa and 250 kDa CMC cast at a variety of weight percents and subsequently
characterized these scaffolds by quantifying the elastic modulus and cell viability over
seven days of in vitro culture. Gross observations revealed a decrease in structural
stability with decreasing macromer concentration, as indicated by the amorphous
composition of 1% 250 kDa CMC constructs.

This assessment was verified

quantitatively by determining the elastic modulus of these scaffolds under compression,
and, in agreement with our hypothesis and results shown by others4,

13

, increasing

macromer concentration resulted in an increase in mechanical properties. Cells remained
viable in all groups over the 7-day study.
From these early investigations, we chose a 4% 90 kDa and 2% 250 kDa CMC
formulation for further examination, in which we quantified the swelling ratio (Qw) and
equilibrium mechanical properties (Ey). Although Qw remained stable in all groups over
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the 14-day study, cell-laden and cell-free constructs experienced a significant decrease in
Ey over time, indicating that hydrolysis of the ester crosslinks was occurring more rapidly
than the elaboration of extracellular matrix (ECM) components. As such, a 3% 250 kDa
CMC was chosen in order to provide a stiffer initial environment for a subsequent study.
Qw for 3% 250 kDa CMC constructs remained constant over time and significantly lower
in cell-laden samples in comparison to cell-free gels, indicating that the presence of cells
resulted in an increase in the overall dry weight due to matrix production. This was
confirmed by mechanical testing which demonstrated a significant loss in the mechanical
properties of cell-free constructs, while cell-laden samples were able to maintain the
initial Ey. Histological and immunohistochemical analyses showed the formation of
lacunae and pericellular deposition of chondroitin sulfate proteoglycan (CSPG), a
phenotypic matrix component. Overall, these findings identified a suitable CMC
formulation for NP tissue engineering applications.

6.3. Biochemical Stimulation of Cell-laden CMC Constructs (Chapter 3)

Growth factor supplementation has been shown to enhance matrix deposition of
cartilage and IVD tissue-engineered constructs14-17, and studies have demonstrated the
importance of medium formulation in modulating the effectiveness of such biochemical
signaling molecules. Although it was demonstrated in Chapter 2 that cell-laden CMC
constructs were able to maintain their initial mechanical properties over time, we sought
to investigate TGF-β3 supplementation and medium composition as a means to increase
functional properties.

This study compared a standard serum-containing medium

formulation, which was utilized in the experiments detailed in Chapter 2, to a chemically-
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defined, serum-free medium commonly used in cartilage tissue engineering.

We

hypothesized that a chemically-defined, serum-free medium would support the stability
of the NP cellular phenotype, as evidenced by phenotypic GAG and type II collagen
(COL II) accumulation, and TGF-β3 supplementation would further improve matrix
deposition and functional material properties.
TGF-β3 significantly decreased Qw to near native values and increased DNA
content, GAG accumulation, and COL II deposition, in agreement with our hypothesis.
There was no detectable type I collagen (COL I) accumulation in constructs cultured in
chemically-defined, serum-free medium. However, scaffolds maintained in TGF-β3supplemented, serum-containing medium were circumscribed by a ring of fibroblast-like
cells which stained positive for COL I, consistent with fibrous tissue rather than the
native NP phenotype. The effects of TGF-β3 were most pronounced in serum-free,
chemically-defined medium, as these constructs exhibited the largest Ey while
maintaining phenotypic matrix deposition. Therefore, serum-free, chemically-defined
medium supplemented with TGF-β3 was selected for use in all future NP tissue
engineering studies.

6.4. Biomechanical and Biochemical Stimulation of Cell-laden CMC Constructs
(Chapter 4)

Hydrostatic pressurization of tissue engineered IVD constructs has been shown to
stimulate matrix production when applied at magnitudes within the physiologic range
(0.1 – 3 MPa) to mimic the loads experienced in vivo7,

8, 18, 19

. Although TGF-β3

supplementation of chemically-defined, serum-free medium produced a five-fold increase
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in mechanical properties in comparison to untreated constructs, GAG accumulation (210
µg/mg dry weight) remained ~40% of that seen in the native NP (~550 µg/mg)20. We
sought to examine the effects of hydrostatic pressurization and growth factor
supplementation on the matrix production and functional properties of cell-laden CMC
scaffolds in an effort to further enhance construct development. We hypothesized that
the application of hydrostatic pressure would increase the matrix accumulation (GAGs,
COL II) and functional properties of cell-laden constructs and that these values would be
further augmented by TGF-β3 supplementation.
Hydrostatic pressure was applied at 2 MPa and 0.5 Hz from day 3 to day 28 of in
vitro culture. Constructs were loaded for 4 hrs/day, 5 days/week for 4 weeks. In support

of the findings from Chapter 3, TGF-β3 supplementation resulted in significant increases
in GAG and COL II accumulation and produced a marked increase in Ey in comparison
to untreated constructs. However, there was no significant difference between TGF-β3treated unloaded controls and TGF-β3-treated pressurized constructs, or untreated,
unloaded controls and the corresponding pressurized scaffolds, which was in contrast to
our hypothesis.
Earlier work from our laboratory examined the effect of pressure on outer and
inner annulus fibrosus cells seeded on a fibrous poly(L-lactic acid) reinforced
poly(glycolic acid) mesh and found significantly increased COL II deposition and
improved matrix distribution when pressure was elevated to the hyperphysiologic level of
5 MPa, with no effects observed at 2 MPa21. As such, an additional study was conducted
applying a pressure of 5 MPa.
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TGF-β3 supplementation again produced significant increases in GAG and COL
II accumulation and a marked increase in Ey in comparison to untreated constructs.
However, as with the 2 MPa study, there was no significant difference between TGF-β3treated unloaded controls and TGF-β3-treated constructs pressurized at 5 MPa, indicating
no significant effect of pressurization at this magnitude in TGF-β3-treated constructs. In
contrast, scaffolds cultured without TGF-β3 and subjected to 5 MPa hydrostatic pressure
exhibited a significant increase in COL II accumulation in comparison to unloaded,
untreated controls, in agreement with our hypothesis. Still, GAG accumulation, which
was shown to have a more direct relationship with Ey than COL II, was comparable
between these two groups. Not surprisingly, there was no detectable difference in the
functional properties of untreated, pressurized constructs and untreated, unloaded
controls. Ey for all untreated groups (3.14 ± 0.62 kPa) was over five-fold lower in
comparison to TGF-β3-treated samples (17.56 ± 3.18 kPa).
Hydrostatic pressure applied within the physiologic range experienced within the
IVD (2 MPa) did not have any significant effect on construct properties. Although
increasing the load to the hyperphysiologic magnitude of 5 MPa resulted in a slight
modulation, increasing COL II deposition in untreated, pressurized constructs, this had no
effect on overall functional properties. It is important to note that the application of
hydrostatic pressure at this elevated magnitude did not affect cell viability, as the DNA
content of unloaded controls and pressurized samples were similar in groups maintained
both with and without TGF-β3. While the goal of this study was to recapitulate the
primary form of mechanical loading experienced in vivo within the disc, our bioreactor
system nevertheless represented a highly artificial, engineered environment, as many
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variables (i.e., annular confinement) found in the native tissue were not recreated in our
in vitro loading paradigm.

Since dynamic hydrostatic pressure applied at 5 MPa

exhibited a marginal impact on cell-seeded constructs, future studies may employ higher
magnitudes, similar to those utilized in cartilage tissue engineering (10 MPa)22-24, to
examine the effect on construct development, monitoring the expression of both anabolic
(COL II, GAGs) and catabolic (matrix metalloproteinases – MMPs) factors to ensure that
these hyperphysiologic forces do not produce negative effects.
Taken together, these data indicate that while pressure applied at 5 MPa in the
absence of TGF-β3 modulated COL II production, this did not impact the overall
functional properties of cell-laden constructs. Instead, TGF-β3 supplementation utilized
alone rather than in conjunction with hydrostatic pressure was shown to be effective in
enhancing the development of NP tissue engineered CMC constructs.

6.5. Long-term Assessment of in vitro Pre-Conditioning with TGF-β3 (Chapter 5)

Although TGF-β3 supplementation to serum-free, chemically-defined medium
was shown to be an effective means of modulating NP cell-laden CMC construct
development, continuous delivery of exogenous growth factors is not a cost-effective or
clinically relevant method due to the short half-life of these proteins. In addition, it is not
clear whether the beneficial effects of TGF-β3 treatment are retained once growth factor
supplementation is discontinued. Therefore, we investigated the long-term effects of a
two-week in vitro pre-culture period in the presence of TGF-β3. This response was
characterized in vitro and in vivo using a subcutaneous murine pouch model.

We

hypothesized that TGF-β3-treated constructs would exhibit greater matrix accumulation
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and higher mechanical properties in comparison to untreated controls, and that these
properties would be maintained both in vitro and in vivo following the cessation of
growth factor supplementation.
TGF-β3 supplementation resulted in a significant decrease in Qw by the end of the
14-day in vitro pre-culture period in comparison to treated, cell-free controls, while Qw
for untreated cell-laden constructs was similar to that for untreated, cell-free controls.
TGF-β3 additionally produced increased GAG and COL II accumulation with a
concomitant increase in Ey in comparison to untreated cell-laden gels after 14 days, in
support of our hypothesis. At the 14-day time point, growth factor supplementation was
discontinued and both cell-laden and cell-free constructs cultured with and without TGFβ3 were subcutaneously implanted in nude mice, while a subset of these groups was
maintained in vitro in the absence of TGF-β3.
UNTREATED CONSTRUCTS – in vitro and in vivo:

Constructs cultured

without TGF-β3 were mechanically indistinguishable from corresponding cell-free
controls, indicating that although the encapsulated cells remained viable both in vitro and
in vivo, they were not metabolically active and did not deposit sufficient ECM to impact

the overall mechanical function of the scaffold. Untreated cells remained in a basal,
senescent-like state in comparison to TGF-β3-treated cells. However, untreated cells
cultured in vivo exhibited more prevalent lacuna formation, an increase in interterritorial
accumulation of CSPG, and a slight increase in interterritorial COL II deposition in
comparison to corresponding in vitro scaffolds. While subcutaneous implantation does
not recapitulate the native loading environment of the NP, this form of in vivo culture
does expose constructs to various forms of mechanical loading, and this may have
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stimulated matrix deposition by the encapsulated cells. Nonetheless, the mechanical
properties of in vivo scaffolds were not significantly affected by this culture condition, as
untreated in vivo constructs exhibited a similar Ey as corresponding in vitro scaffolds.
TGF-β3-TREATED CONSTRUCTS – in vitro:

TGF-β3-treated constructs

cultured in vitro were able to maintain the gains in GAG and COL II accumulation and Ey
that resulted from the pre-culture period, in support of our hypothesis. Specifically, TGFβ3-treated scaffolds exhibited an Ey approximately six-fold greater than corresponding
untreated samples up to 8 weeks after growth factor supplementation was ceased. The in
vitro, free-swelling culture conditions provided adequate nutrient diffusion through the

scaffold and opportunity for the hydrolysis of ester crosslinks. As such, void space was
created over time, allowing for cell proliferation, which is a known anabolic effect of
TGF-β3 supplementation. Histological analyses of TGF-β3-treated scaffolds revealed
clonal expansion, as evidenced by cell clusters, and increased deposition of COL II,
which is a large matrix protein that may require increased void space for proper
assembly.
TGF-β3-TREATED CONSTRUCTS – in vivo: Samples which were exposed to
TGF-β3 and subsequently implanted in vivo experienced a significant decrease in the
retention of GAGs, a loss of DNA content, and a reduction in mechanical properties over
time. This was contrary to our hypothesis and indicated that such conditions were less
favorable than in vitro culture. Given the increased number of cells and greater matrix
accumulation in comparison to untreated constructs upon implantation, TGF-β3-treated
constructs required an ample nutrient supply to maintain homeostasis.

While free-

swelling in vitro conditions may have provided adequate diffusion for ester hydrolysis to
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create void space for matrix deposition, in vivo constructs were surrounded by a fibrous
capsule which may have impaired nutrient transport and constricted the hydrogel. The
extracellular matrix that had been established during the TGF-β3 pre-culture period may
have also contracted, resulting in a more stiff, locally confined pericellular environment
that was consequently less hospitable. In addition, as indicated by mechanical testing
data for cell-free constructs, photocrosslinked CMC hydrogels did not undergo
significant degradation over time, which may have further hindered matrix accumulation
while promoting the expression of matrix degrading enzymes. Therefore, even though
the subcutaneous pouch model is an accepted model to assess in vivo tissue formation,
the overall combination of conditions may have caused in vivo TGF-β3-treated cells to
enter a senescent state similar to that seen in untreated constructs. Values of GAG
accumulation and Ey for treated scaffolds fell to baseline levels comparable to those of
untreated, cell-laden controls, with the cells likely undergoing programmed cell death in
the absence of stimulatory signals (giving rise to decreased DNA content).

One

technique to address this issue would be to utilize a less stiff hydrogel with a lower initial
modulus and crosslinking density. Such gels would allow for more rapid hydrolytic
degradation of the network structure during the in vitro pre-culture period. This would
create void space for future matrix accumulation, while TGF-β3 treatment would promote
matrix deposition that would overcome the loss in material properties. Future studies will
monitor MMP activity to better assess matrix turnover under in vitro and in vivo
conditions.
This study demonstrated a long-term enhancement in the matrix accumulation and
mechanical properties of constructs maintained in vitro in response to a short-term TGF-
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β3 treatment.

However, in order to improve the clinical application of this tissue

engineering therapy, the CMC scaffold formulation must be optimized for in vivo
conditions.

6.6. Limitations and Future Directions

Although this dissertation has characterized and developed a novel CMC hydrogel
scaffold for use in NP tissue engineering, there are several limitations which must be
considered when interpreting this work. Because the IVD is less characterized at the
cellular and tissue levels in comparison to other orthopaedic tissues, such as cartilage,
primary bovine NP cells were utilized throughout this study in order to gain a better
understanding of native cell behavior under in vitro conditions. However, primary NP
cells are not a clinically feasible cell source, and autologous mesenchymal stem cells
(MSCs) represent a more clinically relevant option. These multipotent progenitor cells
have been identified in various adult tissues, including bone marrow, trabecular bone,
cartilage, muscle, and adipose tissue25.

MSCs have been shown to be capable of

undergoing chondrogenesis when cultured in a 3-D environment in the presence of
growth factors, such as TGF-β26-28. In addition, recent work has shown that MSCs can be
induced along an NP-like differentiation pathway when cultured under hypoxic
conditions in the presence of TGF-β129. Steck et al. reported IVD-like differentiation
when MSCs in spheroid culture were maintained in the presence of TGF-β3,
dexamethasone, and ascorbate30.

As such, future studies should employ MSCs for

encapsulation in CMC scaffolds. Matrix production and functional properties could then
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be compared to those measurements described in this work, using primary NP cells as a
benchmark for construct development.
As growth factor delivery has been shown to aid in MSC differentiation, gene
therapy is an alternative approach to exogenous supplementation in which cells are
genetically modified in order to induce sustained growth factor synthesis endogenously.
Cells can be transduced ex vivo using viral (i.e., adenoviral, retroviral, baculoviral)
vectors and then incorporated into tissue engineered scaffolds or delivered in vivo.
However, although viral vectors have high transfection efficiency, they also present
certain safety concerns, such as induction of viral protein production that may stimulate a
host immune reaction. Still, this technique has been safely implemented in IVD cell
culture, as primary IVD cells have been successfully transduced using adenoviral BMP12 and TGF-β1, resulting in increased matrix synthesis17, 31. Other methods of growth
factor delivery include encapsulation within microspheres32, covalent tethers33, and
affinity ligands34.
Another limitation to covalently photocrosslinked CMC hydrogels is the slow
degradation of the scaffold (as introduced in Chapter 5). Although any biomaterial
scaffold intended for use within a load-bearing tissue, such as the NP, must provide
immediate structural support, the degradation properties of this material should coincide
with ECM accumulation within the scaffold, eventually leaving behind a biologically
functional tissue replacement. To achieve more rapid ester hydrolysis, a softer CMC
hydrogel may be formulated by decreasing the macromer concentration (weight percent),
degree of methacrylation (% modification), or molecular weight13, 35. Another alternative
is incorporating degradable units onto the CMC backbone to alter the degradation profile.
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Bryant and Anseth incorporated rapidly degradable lactic acid units into a non-degrading,
inert poly(ethylene glycol) (PEG) hydrogel36, while Sahoo et al. similarly incorporated
hydrolyzable lactic acid units into an enzymatically degradable hyaluronic acid
construct37. MMP-sensitive peptides have also been used to crosslink PEG hydrogels
encapsulated with bovine chondrocytes, resulting in scaffold degradation in concert with
matrix turnover38.
While the photopolymerizable CMC system described in this dissertation could be
effectively incorporated into a tissue engineered IVD composite, such as those described
by Mizuno et al.39, 40 and Bowles et al.41, this platform may not be suitable for use as an
intradiscal therapy in the early stages of degeneration, as polymerization cannot be
performed uniformly through the fibrous annular tissue where light penetration is limited.
Instead, an injectable, in situ-curing redox-initiated system may provide a minimallyinvasive, clinically-relevant option. Redox initiators utilize two reagents which, when
mixed, generate free radicals capable of initiating polymerization. Oxidizing agents
which have been studied include sodium persulfate and ammonium persulfate, and
reducing agents include ascorbic acid, ascorbate, and ascorbate-2-phosphate42.

One

commonly used oxidizing/reducing agent combination is ammonium persulfate (APS)/ N,
N, N’, N’-tetramethylethylenediamine (TEMED), which is a cytocompatible, watersoluble redox initiation system43-46 which has been shown to be non-cytotoxic at low
initiator concentrations44.
We recently conducted a pilot study examining APS/TEMED redox-initiated
crosslinking of methacrylated CMC. Certain factors to consider when designing an
injectable system include viscosity of the solution in order to maintain injectability and
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the rate of polymerization, as the solution should not crosslink too rapidly which would
prevent any clinical manipulation, but polymerization should also not progress too
slowly, which would allow the solution to diffuse from the injection site. Similar to the
photoinitiated CMC system described in this dissertation, redox polymerization rate is
affected by initiator concentration and macromer concentration, whereby increasing these
values will decrease the amount of time required for polymerization.
Cell-free CMC hydrogels were cast at 2% and 2.5% using APS and TEMED
initiators, each at a 10 mM concentration. Constructs were maintained in sterile DPBS
for 24 hrs at 37°C, 5% CO2, at which time they were isolated to assess the compressive
elastic modulus using the DMA apparatus described in Chapter 2. Similar to the results
from Chapter 2, an increase in macromer concentration (weight percent) resulted in an
increase in construct stiffness, although this trend was not statistically significant
(p=0.565) (Figure 6.1). Bovine NP cells were encapsulated in 2.5% 10 mM CMC
hydrogels at 30x106 cells/mL and viability was determined at day 1 using the Live/Dead
stain (Figure 6.2).

Viable cells were evenly distributed throughout the construct.

However, a larger population of dead cells was present in comparison to similar
photocrosslinked gels described in Chapter 2. Therefore, additional formulations should
be examined by varying the initiator concentration and/or macromer concentration in
order to improve this potential injectable intradiscal therapy.
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Figure 6.1. Day 1 compressive elastic modulus of 2% and 2.5% cell-free CMC hydrogels
formed via redox-initiated polymerization, with corresponding representative stereo micrograph
images below (scale in mm).

Figure 6.2. Live/Dead image of 2.5% 10 mM CMC hydrogels at day 1, with live cells stained
green and dead cells shown in red (Bar = 100 µm).
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One major goal of this dissertation was to examine the effect of mechanical
stimulation on matrix production by encapsulated NP cells. We investigated the effects
of hydrostatic pressure and found that, although pressure increased COL II accumulation
in untreated constructs, it did not enhance mechanical properties, and had no impact on
TGF-β3-treated scaffolds.

A number of variables exist that can affect the cellular

response to mechanical stimulation.

Previous IVD tissue engineering studies have

examined mechanical stimulation via hydrostatic pressurization applied at a variety of
magnitudes (0.25-6 MPa) and frequencies (0-20 Hz), duty cycles (30 min/day to 12
hr/day) and loading durations (1 day to 4 weeks)7-10, 18, 19, 47-49. While these investigations
have mainly examined the short-term response to pressure, they provide a starting point
for various loading regimens that may be incorporated into future work examining the
long-term effect of pressure on the functional properties of tissue engineered constructs.
Additionally, as pressure applied at the hyperphysiologic magnitude of 5 MPa in this
artificial environment resulted in a slight modulation of NP matrix production, future
studies may examine loading protocols utilized in cartilage tissue engineering which
routinely pressurize samples to a magnitude of 10 MPa22-24.
Deformational mechanical loading via dynamic compression may also serve as an
effective stimulus for matrix production. While compressive load has been traditionally
utilized in vivo using a rat tail model, it has recently been applied in vitro by Korecki et
al. who used NP cell-laden alginate hydrogels to compare the effects of compression
frequency (0.1, 1, and 3 Hz) and donor age50.

As such, this form of mechanical

stimulation may also be investigated in future studies as a method to augment the
functional properties of tissue engineered constructs.
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Finally, once a CMC platform has been developed, constructs should be assessed
in an animal model of disc degeneration. Although Chapter 5 has detailed the effects of
subcutaneous implantation in nude mice in an effort to characterize and develop CMC
constructs, this system does not replicate the load-bearing environment of the NP. The
effects of disc degeneration are wide-ranging, impacting mechanical integrity and
biochemical composition. Various in vivo animal models have been created to mimic
these conditions and evaluate potential therapies. Although naturally-occurring animal
models, such as those established in rats, dogs, and primates, allow for thorough
examination of the broad effects of degeneration, the underlying cause of this speciesspecific condition and the potential interaction with therapeutic interventions remain
unclear51.

Experimentally-induced disc degeneration allows for greater control and

reproducibility. Masuda et al. have developed a rabbit model of mild disc degeneration
using the annulus needle puncture technique52, while Boxberger et al. have developed a
chemically-controlled rat lumbar model that results in reduced GAG content following
NP injection with chondroitinase ABC53.

Therefore, the efficacy of the cell-CMC

hydrogel system at restoring mechanical integrity and biochemical composition of
degenerated discs should be evaluated using an appropriate animal model in order to
assess the clinical applications of this potential therapy.

6.7. Final Conclusions

Taken together, this thesis work has established a photocrosslinkable CMC
scaffold with tunable material properties that may be utilized for the encapsulation of NP
cells.

The functional properties of these cell-laden constructs may be modulated via
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TGF-β3 supplementation, as this growth factor was shown to produce long-term
enhancements in matrix accumulation and mechanical properties in vitro after a twoweek pre-culture period. However, the degradative profile of the CMC scaffold must be
optimized for in vivo conditions prior to any clinical applications.
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